id	sid	tid	token	lemma	pos
ijpds-3543	1	1	sonwani	sonwani	PROPN
ijpds-3543	1	2	et	et	PROPN
ijpds-3543	1	3	al	al	PROPN
ijpds-3543	1	4	.	.	PROPN
ijpds-3543	2	1	role	role	NOUN
ijpds-3543	2	2	of	of	ADP
ijpds-3543	2	3	adenosine	adenosine	ADJ
ijpds-3543	2	4	receptor	receptor	NOUN
ijpds-3543	2	5	agonists	agonist	NOUN
ijpds-3543	2	6	in	in	ADP
ijpds-3543	2	7	inflammatory	inflammatory	ADJ
ijpds-3543	2	8	conditions	condition	NOUN
ijpds-3543	2	9	vol	vol	NOUN
ijpds-3543	2	10	2	2	NUM
ijpds-3543	2	11	|	|	NOUN
ijpds-3543	2	12	issue	issue	NOUN
ijpds-3543	2	13	2	2	NUM
ijpds-3543	2	14	|	|	ADV
ijpds-3543	2	15	apr	apr	ADV
ijpds-3543	2	16	–	–	PUNCT
ijpds-3543	2	17	jun	jun	PROPN
ijpds-3543	2	18	2023	2023	NUM
ijpds-3543	2	19	indian	indian	PROPN
ijpds-3543	2	20	j	j	PROPN
ijpds-3543	2	21	pharm	pharm	PROPN
ijpds-3543	2	22	drug	drug	PROPN
ijpds-3543	2	23	studies	study	NOUN
ijpds-3543	2	24	|	|	ADV
ijpds-3543	2	25	69	69	NUM
ijpds-3543	2	26	original	original	ADJ
ijpds-3543	2	27	article	article	NOUN
ijpds-3543	2	28	adenosine	adenosine	VERB
ijpds-3543	2	29	receptor	receptor	NOUN
ijpds-3543	2	30	agonists	agonist	NOUN
ijpds-3543	2	31	suppress	suppress	VERB
ijpds-3543	2	32	macrophage	macrophage	ADJ
ijpds-3543	2	33	inflammatory	inflammatory	ADJ
ijpds-3543	2	34	protein	protein	NOUN
ijpds-3543	2	35	-1α	-1α	NOUN
ijpds-3543	2	36	production	production	NOUN
ijpds-3543	2	37	and	and	CCONJ
ijpds-3543	2	38	collagen	collagen	NOUN
ijpds-3543	2	39	induced	induce	VERB
ijpds-3543	2	40	arthritis	arthritis	NOUN
ijpds-3543	2	41	hari	hari	NOUN
ijpds-3543	2	42	sonwani	sonwani	NOUN
ijpds-3543	2	43	,	,	PUNCT
ijpds-3543	2	44	virendra	virendra	PROPN
ijpds-3543	2	45	kumar	kumar	PROPN
ijpds-3543	2	46	sharma	sharma	PROPN
ijpds-3543	2	47	,	,	PUNCT
ijpds-3543	2	48	steffi	steffi	PROPN
ijpds-3543	2	49	thomas	thomas	PROPN
ijpds-3543	2	50	,	,	PUNCT
ijpds-3543	2	51	akhlesh	akhlesh	PROPN
ijpds-3543	2	52	kumar	kumar	PROPN
ijpds-3543	2	53	from	from	ADP
ijpds-3543	2	54	,	,	PUNCT
ijpds-3543	2	55	department	department	NOUN
ijpds-3543	2	56	of	of	ADP
ijpds-3543	2	57	pharmacology	pharmacology	NOUN
ijpds-3543	2	58	,	,	PUNCT
ijpds-3543	2	59	school	school	NOUN
ijpds-3543	2	60	of	of	ADP
ijpds-3543	2	61	pharmacy	pharmacy	NOUN
ijpds-3543	2	62	,	,	PUNCT
ijpds-3543	2	63	lnct	lnct	ADJ
ijpds-3543	2	64	university	university	NOUN
ijpds-3543	2	65	,	,	PUNCT
ijpds-3543	2	66	kolar	kolar	PROPN
ijpds-3543	2	67	road	road	PROPN
ijpds-3543	2	68	,	,	PUNCT
ijpds-3543	2	69	bhopal	bhopal	NOUN
ijpds-3543	2	70	462042	462042	NUM
ijpds-3543	3	1	[	[	X
ijpds-3543	3	2	m.p	m.p	X
ijpds-3543	3	3	]	]	X
ijpds-3543	3	4	india	india	PROPN
ijpds-3543	3	5	.	.	PUNCT
ijpds-3543	4	1	correspondence	correspondence	NOUN
ijpds-3543	4	2	to	to	ADP
ijpds-3543	4	3	:	:	PUNCT
ijpds-3543	4	4	hari	hari	NOUN
ijpds-3543	4	5	sonwani	sonwani	NOUN
ijpds-3543	4	6	,	,	PUNCT
ijpds-3543	4	7	department	department	NOUN
ijpds-3543	4	8	of	of	ADP
ijpds-3543	4	9	pharmacology	pharmacology	NOUN
ijpds-3543	4	10	,	,	PUNCT
ijpds-3543	4	11	school	school	NOUN
ijpds-3543	4	12	of	of	ADP
ijpds-3543	4	13	pharmacy	pharmacy	NOUN
ijpds-3543	4	14	,	,	PUNCT
ijpds-3543	4	15	lnct	lnct	ADJ
ijpds-3543	4	16	university	university	NOUN
ijpds-3543	4	17	,	,	PUNCT
ijpds-3543	4	18	kolar	kolar	PROPN
ijpds-3543	4	19	road	road	NOUN
ijpds-3543	4	20	,	,	PUNCT
ijpds-3543	4	21	bhopal462042	bhopal462042	PROPN
ijpds-3543	4	22	madhya	madhya	PROPN
ijpds-3543	4	23	pradesh	pradesh	PROPN
ijpds-3543	4	24	,	,	PUNCT
ijpds-3543	4	25	india	india	PROPN
ijpds-3543	4	26	.	.	PUNCT
ijpds-3543	4	27	email	email	NOUN
ijpds-3543	4	28	:	:	PUNCT
ijpds-3543	5	1	harisonwani10@gmail.com	harisonwani10@gmail.com	X
ijpds-3543	5	2	abstract	abstract	ADJ
ijpds-3543	5	3	the	the	DET
ijpds-3543	5	4	production	production	NOUN
ijpds-3543	5	5	of	of	ADP
ijpds-3543	5	6	proand	proand	NOUN
ijpds-3543	5	7	anti	anti	ADJ
ijpds-3543	5	8	-	-	ADJ
ijpds-3543	5	9	inflammatory	inflammatory	ADJ
ijpds-3543	5	10	cytokines	cytokine	NOUN
ijpds-3543	5	11	is	be	AUX
ijpds-3543	5	12	modulated	modulate	VERB
ijpds-3543	5	13	by	by	ADP
ijpds-3543	5	14	ligands	ligand	NOUN
ijpds-3543	5	15	of	of	ADP
ijpds-3543	5	16	various	various	ADJ
ijpds-3543	5	17	adenosine	adenosine	ADJ
ijpds-3543	5	18	receptor	receptor	NOUN
ijpds-3543	5	19	subtypes	subtype	NOUN
ijpds-3543	5	20	.	.	PUNCT
ijpds-3543	6	1	in	in	ADP
ijpds-3543	6	2	this	this	DET
ijpds-3543	6	3	study	study	NOUN
ijpds-3543	6	4	,	,	PUNCT
ijpds-3543	6	5	we	we	PRON
ijpds-3543	6	6	looked	look	VERB
ijpds-3543	6	7	at	at	ADP
ijpds-3543	6	8	how	how	SCONJ
ijpds-3543	6	9	adenosine	adenosine	ADJ
ijpds-3543	6	10	and	and	CCONJ
ijpds-3543	6	11	different	different	ADJ
ijpds-3543	6	12	ligands	ligand	NOUN
ijpds-3543	6	13	for	for	ADP
ijpds-3543	6	14	the	the	DET
ijpds-3543	6	15	adenosine	adenosine	ADJ
ijpds-3543	6	16	receptor	receptor	NOUN
ijpds-3543	6	17	subtypes	subtype	NOUN
ijpds-3543	6	18	(	(	PUNCT
ijpds-3543	6	19	a1	a1	NOUN
ijpds-3543	6	20	,	,	PUNCT
ijpds-3543	6	21	a2	a2	PROPN
ijpds-3543	6	22	,	,	PUNCT
ijpds-3543	6	23	a3	a3	NOUN
ijpds-3543	6	24	)	)	PUNCT
ijpds-3543	6	25	affected	affect	VERB
ijpds-3543	6	26	the	the	DET
ijpds-3543	6	27	production	production	NOUN
ijpds-3543	6	28	of	of	ADP
ijpds-3543	6	29	the	the	DET
ijpds-3543	6	30	chemokine	chemokine	ADJ
ijpds-3543	6	31	macrophage	macrophage	ADJ
ijpds-3543	6	32	inflammatory	inflammatory	ADJ
ijpds-3543	6	33	protein	protein	NOUN
ijpds-3543	6	34	(	(	PUNCT
ijpds-3543	6	35	mip	mip	PROPN
ijpds-3543	6	36	)	)	PUNCT
ijpds-3543	6	37	1a	1a	PROPN
ijpds-3543	6	38	in	in	ADP
ijpds-3543	6	39	immune	immune	NOUN
ijpds-3543	6	40	-	-	PUNCT
ijpds-3543	6	41	stimulated	stimulate	VERB
ijpds-3543	6	42	raw	raw	ADJ
ijpds-3543	6	43	macrophages	macrophage	NOUN
ijpds-3543	6	44	in	in	ADP
ijpds-3543	6	45	vitro	vitro	VERB
ijpds-3543	6	46	.	.	PUNCT
ijpds-3543	7	1	in	in	ADP
ijpds-3543	7	2	addition	addition	NOUN
ijpds-3543	7	3	,	,	PUNCT
ijpds-3543	7	4	we	we	PRON
ijpds-3543	7	5	investigated	investigate	VERB
ijpds-3543	7	6	whether	whether	SCONJ
ijpds-3543	7	7	an	an	DET
ijpds-3543	7	8	a3	a3	NOUN
ijpds-3543	7	9	adenosine	adenosine	NOUN
ijpds-3543	7	10	receptor	receptor	NOUN
ijpds-3543	7	11	agonist	agonist	NOUN
ijpds-3543	7	12	reduces	reduce	VERB
ijpds-3543	7	13	mip-1α	mip-1α	NOUN
ijpds-3543	7	14	production	production	NOUN
ijpds-3543	7	15	and	and	CCONJ
ijpds-3543	7	16	influences	influence	VERB
ijpds-3543	7	17	the	the	DET
ijpds-3543	7	18	course	course	NOUN
ijpds-3543	7	19	of	of	ADP
ijpds-3543	7	20	inflammation	inflammation	NOUN
ijpds-3543	7	21	in	in	ADP
ijpds-3543	7	22	collagen	collagen	NOUN
ijpds-3543	7	23	-	-	PUNCT
ijpds-3543	7	24	induced	induce	VERB
ijpds-3543	7	25	arthritis	arthritis	NOUN
ijpds-3543	7	26	.	.	PUNCT
ijpds-3543	8	1	the	the	DET
ijpds-3543	8	2	a3	a3	NOUN
ijpds-3543	8	3	receptor	receptor	NOUN
ijpds-3543	8	4	agonist	agonist	NOUN
ijpds-3543	8	5	n6-(3	n6-(3	PROPN
ijpds-3543	8	6	-	-	PUNCT
ijpds-3543	8	7	iodobenzyl)-adenosine-5'-n	iodobenzyl)-adenosine-5'-n	PROPN
ijpds-3543	8	8	-	-	PUNCT
ijpds-3543	8	9	methyluronamide	methyluronamide	NOUN
ijpds-3543	8	10	(	(	PUNCT
ijpds-3543	8	11	ib	ib	NOUN
ijpds-3543	8	12	-	-	PUNCT
ijpds-3543	8	13	meca	meca	PROPN
ijpds-3543	8	14	)	)	PUNCT
ijpds-3543	8	15	and	and	CCONJ
ijpds-3543	8	16	,	,	PUNCT
ijpds-3543	8	17	less	less	ADV
ijpds-3543	8	18	potently	potently	ADV
ijpds-3543	8	19	,	,	PUNCT
ijpds-3543	8	20	the	the	DET
ijpds-3543	8	21	a2	a2	PROPN
ijpds-3543	8	22	receptor	receptor	NOUN
ijpds-3543	8	23	agonist	agonist	NOUN
ijpds-3543	8	24	2	2	NUM
ijpds-3543	8	25	-	-	PUNCT
ijpds-3543	8	26	p-(2	p-(2	NOUN
ijpds-3543	8	27	-	-	PUNCT
ijpds-3543	8	28	carboxyethyl	carboxyethyl	NOUN
ijpds-3543	8	29	)	)	PUNCT
ijpds-3543	8	30	phenethylamino-5'-n	phenethylamino-5'-n	NOUN
ijpds-3543	8	31	-	-	PUNCT
ijpds-3543	8	32	ethylamino-5'-n	ethylamino-5'-n	NOUN
ijpds-3543	8	33	-	-	PUNCT
ijpds-3543	8	34	ethylamino-5'-nethylamino-5'-n	ethylamino-5'-nethylamino-5'-n	NOUN
ijpds-3543	8	35	adenosine	adenosine	NOUN
ijpds-3543	8	36	was	be	AUX
ijpds-3543	8	37	a	a	DET
ijpds-3543	8	38	mild	mild	ADJ
ijpds-3543	8	39	inhibitor	inhibitor	NOUN
ijpds-3543	8	40	,	,	PUNCT
ijpds-3543	8	41	and	and	CCONJ
ijpds-3543	8	42	the	the	DET
ijpds-3543	8	43	selective	selective	ADJ
ijpds-3543	8	44	a1	a1	NOUN
ijpds-3543	8	45	receptor	receptor	NOUN
ijpds-3543	8	46	agonist	agonist	NOUN
ijpds-3543	8	47	2	2	NUM
ijpds-3543	8	48	-	-	PUNCT
ijpds-3543	8	49	chloron	chloron	NOUN
ijpds-3543	8	50	-	-	PUNCT
ijpds-3543	8	51	cyclopentyladenosine	cyclopentyladenosine	PROPN
ijpds-3543	8	52	(	(	PUNCT
ijpds-3543	8	53	ccpa	ccpa	VERB
ijpds-3543	8	54	,	,	PUNCT
ijpds-3543	8	55	1	1	NUM
ijpds-3543	8	56	200	200	NUM
ijpds-3543	8	57	m	m	NOUN
ijpds-3543	8	58	)	)	PUNCT
ijpds-3543	8	59	proved	prove	VERB
ijpds-3543	8	60	ineffective	ineffective	ADJ
ijpds-3543	8	61	.	.	PUNCT
ijpds-3543	9	1	mip-1α	mip-1α	NOUN
ijpds-3543	9	2	production	production	NOUN
ijpds-3543	9	3	is	be	AUX
ijpds-3543	9	4	inhibited	inhibit	VERB
ijpds-3543	9	5	by	by	ADP
ijpds-3543	9	6	suppression	suppression	NOUN
ijpds-3543	9	7	of	of	ADP
ijpds-3543	9	8	its	its	PRON
ijpds-3543	9	9	steady	steady	ADJ
ijpds-3543	9	10	-	-	PUNCT
ijpds-3543	9	11	state	state	NOUN
ijpds-3543	9	12	mrna	mrna	NOUN
ijpds-3543	9	13	levels	level	NOUN
ijpds-3543	9	14	and	and	CCONJ
ijpds-3543	9	15	was	be	AUX
ijpds-3543	9	16	linked	link	VERB
ijpds-3543	9	17	to	to	ADP
ijpds-3543	9	18	the	the	DET
ijpds-3543	9	19	a3	a3	NOUN
ijpds-3543	9	20	and	and	CCONJ
ijpds-3543	9	21	a2	a2	PROPN
ijpds-3543	9	22	agonists	agonist	NOUN
ijpds-3543	9	23	.	.	PUNCT
ijpds-3543	10	1	we	we	PRON
ijpds-3543	10	2	concluded	conclude	VERB
ijpds-3543	10	3	that	that	SCONJ
ijpds-3543	10	4	stimulation	stimulation	NOUN
ijpds-3543	10	5	of	of	ADP
ijpds-3543	10	6	a3	a3	NOUN
ijpds-3543	10	7	and	and	CCONJ
ijpds-3543	10	8	,	,	PUNCT
ijpds-3543	10	9	to	to	ADP
ijpds-3543	10	10	a	a	DET
ijpds-3543	10	11	lesser	less	ADJ
ijpds-3543	10	12	extent	extent	NOUN
ijpds-3543	10	13	,	,	PUNCT
ijpds-3543	10	14	a2	a2	NOUN
ijpds-3543	10	15	adenosine	adenosine	NOUN
ijpds-3543	10	16	receptors	receptor	NOUN
ijpds-3543	10	17	decreases	decrease	VERB
ijpds-3543	10	18	mip-1α	mip-1α	NOUN
ijpds-3543	10	19	expression	expression	NOUN
ijpds-3543	10	20	based	base	VERB
ijpds-3543	10	21	on	on	ADP
ijpds-3543	10	22	our	our	PRON
ijpds-3543	10	23	in	in	X
ijpds-3543	10	24	vitro	vitro	X
ijpds-3543	10	25	findings	finding	NOUN
ijpds-3543	10	26	.	.	PUNCT
ijpds-3543	11	1	we	we	PRON
ijpds-3543	11	2	studied	study	VERB
ijpds-3543	11	3	whether	whether	SCONJ
ijpds-3543	11	4	ib	ib	NOUN
ijpds-3543	11	5	-	-	PUNCT
ijpds-3543	11	6	meca	meca	NOUN
ijpds-3543	11	7	,	,	PUNCT
ijpds-3543	11	8	as	as	ADP
ijpds-3543	11	9	the	the	DET
ijpds-3543	11	10	most	most	ADV
ijpds-3543	11	11	powerful	powerful	ADJ
ijpds-3543	11	12	inhibitor	inhibitor	NOUN
ijpds-3543	11	13	of	of	ADP
ijpds-3543	11	14	mip-1α	mip-1α	NOUN
ijpds-3543	11	15	expression	expression	NOUN
ijpds-3543	11	16	,	,	PUNCT
ijpds-3543	11	17	also	also	ADV
ijpds-3543	11	18	influences	influence	VERB
ijpds-3543	11	19	the	the	DET
ijpds-3543	11	20	production	production	NOUN
ijpds-3543	11	21	of	of	ADP
ijpds-3543	11	22	other	other	ADJ
ijpds-3543	11	23	pro	pro	ADJ
ijpds-3543	11	24	-	-	ADJ
ijpds-3543	11	25	inflammatory	inflammatory	ADJ
ijpds-3543	11	26	mediators	mediator	NOUN
ijpds-3543	11	27	.	.	PUNCT
ijpds-3543	12	1	ibmeca	ibmeca	NOUN
ijpds-3543	12	2	(	(	PUNCT
ijpds-3543	12	3	1	1	NUM
ijpds-3543	12	4	300	300	NUM
ijpds-3543	12	5	m	m	NOUN
ijpds-3543	12	6	)	)	PUNCT
ijpds-3543	12	7	reduced	reduce	VERB
ijpds-3543	12	8	the	the	DET
ijpds-3543	12	9	production	production	NOUN
ijpds-3543	12	10	of	of	ADP
ijpds-3543	12	11	il-12	il-12	NOUN
ijpds-3543	12	12	,	,	PUNCT
ijpds-3543	12	13	il-	il-	X
ijpds-3543	12	14	,	,	PUNCT
ijpds-3543	12	15	and	and	CCONJ
ijpds-3543	12	16	,	,	PUNCT
ijpds-3543	12	17	to	to	ADP
ijpds-3543	12	18	a	a	DET
ijpds-3543	12	19	lesser	less	ADJ
ijpds-3543	12	20	extent	extent	NOUN
ijpds-3543	12	21	,	,	PUNCT
ijpds-3543	12	22	nitric	nitric	ADJ
ijpds-3543	12	23	oxide	oxide	NOUN
ijpds-3543	12	24	in	in	ADP
ijpds-3543	12	25	immune	immune	NOUN
ijpds-3543	12	26	-	-	PUNCT
ijpds-3543	12	27	stimulated	stimulate	VERB
ijpds-3543	12	28	cultured	cultured	ADJ
ijpds-3543	12	29	macrophages	macrophage	NOUN
ijpds-3543	12	30	in	in	ADP
ijpds-3543	12	31	a	a	DET
ijpds-3543	12	32	dose	dose	NOUN
ijpds-3543	12	33	-	-	PUNCT
ijpds-3543	12	34	dependent	dependent	ADJ
ijpds-3543	12	35	manner	manner	NOUN
ijpds-3543	12	36	.	.	PUNCT
ijpds-3543	13	1	we	we	PRON
ijpds-3543	13	2	explored	explore	VERB
ijpds-3543	13	3	whether	whether	SCONJ
ijpds-3543	13	4	the	the	DET
ijpds-3543	13	5	a3	a3	NOUN
ijpds-3543	13	6	agonist	agonist	NOUN
ijpds-3543	13	7	ib	ib	PROPN
ijpds-3543	13	8	-	-	PUNCT
ijpds-3543	13	9	meca	meca	PROPN
ijpds-3543	13	10	alters	alter	VERB
ijpds-3543	13	11	the	the	DET
ijpds-3543	13	12	course	course	NOUN
ijpds-3543	13	13	of	of	ADP
ijpds-3543	13	14	inflammation	inflammation	NOUN
ijpds-3543	13	15	,	,	PUNCT
ijpds-3543	13	16	mip	mip	PROPN
ijpds-3543	13	17	-	-	PUNCT
ijpds-3543	13	18	a	a	DET
ijpds-3543	13	19	production	production	NOUN
ijpds-3543	13	20	,	,	PUNCT
ijpds-3543	13	21	and	and	CCONJ
ijpds-3543	13	22	the	the	DET
ijpds-3543	13	23	degree	degree	NOUN
ijpds-3543	13	24	of	of	ADP
ijpds-3543	13	25	neutrophil	neutrophil	ADJ
ijpds-3543	13	26	recruitment	recruitment	NOUN
ijpds-3543	13	27	in	in	ADP
ijpds-3543	13	28	arthritis	arthritis	NOUN
ijpds-3543	13	29	because	because	SCONJ
ijpds-3543	13	30	mip	mip	PROPN
ijpds-3543	13	31	-	-	PUNCT
ijpds-3543	13	32	α	α	PROPN
ijpds-3543	13	33	is	be	AUX
ijpds-3543	13	34	a	a	DET
ijpds-3543	13	35	chemokine	chemokine	NOUN
ijpds-3543	13	36	that	that	PRON
ijpds-3543	13	37	increases	increase	VERB
ijpds-3543	13	38	neutrophil	neutrophil	ADJ
ijpds-3543	13	39	recruitment	recruitment	NOUN
ijpds-3543	13	40	into	into	ADP
ijpds-3543	13	41	inflammatory	inflammatory	ADJ
ijpds-3543	13	42	areas	area	NOUN
ijpds-3543	13	43	.	.	PUNCT
ijpds-3543	14	1	in	in	ADP
ijpds-3543	14	2	the	the	DET
ijpds-3543	14	3	case	case	NOUN
ijpds-3543	14	4	of	of	ADP
ijpds-3543	14	5	ibmeca	ibmeca	NOUN
ijpds-3543	14	6	(	(	PUNCT
ijpds-3543	14	7	0.5	0.5	NUM
ijpds-3543	14	8	mg	mg	PROPN
ijpds-3543	14	9	/	/	SYM
ijpds-3543	14	10	kg	kg	PROPN
ijpds-3543	14	11	/	/	SYM
ijpds-3543	14	12	day	day	NOUN
ijpds-3543	14	13	)	)	PUNCT
ijpds-3543	14	14	decreased	decrease	VERB
ijpds-3543	14	15	the	the	DET
ijpds-3543	14	16	degree	degree	NOUN
ijpds-3543	14	17	of	of	ADP
ijpds-3543	14	18	joint	joint	ADJ
ijpds-3543	14	19	inflammation	inflammation	NOUN
ijpds-3543	14	20	in	in	ADP
ijpds-3543	14	21	a	a	DET
ijpds-3543	14	22	mouse	mouse	NOUN
ijpds-3543	14	23	model	model	NOUN
ijpds-3543	14	24	of	of	ADP
ijpds-3543	14	25	collagen	collagen	NOUN
ijpds-3543	14	26	-	-	PUNCT
ijpds-3543	14	27	induced	induce	VERB
ijpds-3543	14	28	arthritis	arthritis	NOUN
ijpds-3543	14	29	.	.	PUNCT
ijpds-3543	15	1	ib	ib	PROPN
ijpds-3543	15	2	-	-	PUNCT
ijpds-3543	15	3	meca	meca	PROPN
ijpds-3543	15	4	decreased	decrease	VERB
ijpds-3543	15	5	neutrophil	neutrophil	ADJ
ijpds-3543	15	6	infiltration	infiltration	NOUN
ijpds-3543	15	7	and	and	CCONJ
ijpds-3543	15	8	inhibited	inhibit	VERB
ijpds-3543	15	9	the	the	DET
ijpds-3543	15	10	production	production	NOUN
ijpds-3543	15	11	of	of	ADP
ijpds-3543	15	12	mip-1α	mip-1α	NOUN
ijpds-3543	15	13	,	,	PUNCT
ijpds-3543	15	14	il-12	il-12	NOUN
ijpds-3543	15	15	,	,	PUNCT
ijpds-3543	15	16	and	and	CCONJ
ijpds-3543	15	17	nitrotyrosine	nitrotyrosine	NOUN
ijpds-3543	15	18	(	(	PUNCT
ijpds-3543	15	19	a	a	DET
ijpds-3543	15	20	marker	marker	NOUN
ijpds-3543	15	21	of	of	ADP
ijpds-3543	15	22	reactive	reactive	ADJ
ijpds-3543	15	23	nitrogen	nitrogen	NOUN
ijpds-3543	15	24	species	specie	NOUN
ijpds-3543	15	25	)	)	PUNCT
ijpds-3543	15	26	in	in	ADP
ijpds-3543	15	27	the	the	DET
ijpds-3543	15	28	paws	paw	NOUN
ijpds-3543	15	29	.	.	PUNCT
ijpds-3543	16	1	we	we	PRON
ijpds-3543	16	2	conclude	conclude	VERB
ijpds-3543	16	3	that	that	DET
ijpds-3543	16	4	adenosine	adenosine	NOUN
ijpds-3543	16	5	receptor	receptor	NOUN
ijpds-3543	16	6	agonists	agonist	NOUN
ijpds-3543	16	7	,	,	PUNCT
ijpds-3543	16	8	particularly	particularly	ADV
ijpds-3543	16	9	the	the	DET
ijpds-3543	16	10	a3	a3	NOUN
ijpds-3543	16	11	agonist	agonist	NOUN
ijpds-3543	16	12	ib	ib	PROPN
ijpds-3543	16	13	-	-	PUNCT
ijpds-3543	16	14	meca	meca	PROPN
ijpds-3543	16	15	,	,	PUNCT
ijpds-3543	16	16	inhibit	inhibit	PROPN
ijpds-3543	16	17	mip	mip	PROPN
ijpds-3543	16	18	-	-	PUNCT
ijpds-3543	16	19	α	α	NOUN
ijpds-3543	16	20	synthesis	synthesis	NOUN
ijpds-3543	16	21	and	and	CCONJ
ijpds-3543	16	22	have	have	VERB
ijpds-3543	16	23	anti	anti	ADJ
ijpds-3543	16	24	-	-	ADJ
ijpds-3543	16	25	inflammatory	inflammatory	ADJ
ijpds-3543	16	26	properties	property	NOUN
ijpds-3543	16	27	.	.	PUNCT
ijpds-3543	17	1	as	as	ADP
ijpds-3543	17	2	a	a	DET
ijpds-3543	17	3	result	result	NOUN
ijpds-3543	17	4	,	,	PUNCT
ijpds-3543	17	5	stimulating	stimulate	VERB
ijpds-3543	17	6	adenosine	adenosine	ADJ
ijpds-3543	17	7	receptor	receptor	NOUN
ijpds-3543	17	8	subtypes	subtype	NOUN
ijpds-3543	17	9	a3	a3	NOUN
ijpds-3543	17	10	and	and	CCONJ
ijpds-3543	17	11	a2	a2	PROPN
ijpds-3543	17	12	may	may	AUX
ijpds-3543	17	13	be	be	AUX
ijpds-3543	17	14	a	a	DET
ijpds-3543	17	15	promising	promising	ADJ
ijpds-3543	17	16	technique	technique	NOUN
ijpds-3543	17	17	for	for	ADP
ijpds-3543	17	18	the	the	DET
ijpds-3543	17	19	treatment	treatment	NOUN
ijpds-3543	17	20	of	of	ADP
ijpds-3543	17	21	acute	acute	ADJ
ijpds-3543	17	22	and	and	CCONJ
ijpds-3543	17	23	chronic	chronic	ADJ
ijpds-3543	17	24	inflammatory	inflammatory	ADJ
ijpds-3543	17	25	diseases	disease	NOUN
ijpds-3543	17	26	.	.	PUNCT
ijpds-3543	18	1	key	key	ADJ
ijpds-3543	18	2	words	word	NOUN
ijpds-3543	18	3	:	:	PUNCT
ijpds-3543	18	4	inflammation	inflammation	NOUN
ijpds-3543	18	5	,	,	PUNCT
ijpds-3543	18	6	cytokines	cytokine	NOUN
ijpds-3543	18	7	,	,	PUNCT
ijpds-3543	18	8	adenosine	adenosine	ADJ
ijpds-3543	18	9	receptor	receptor	NOUN
ijpds-3543	18	10	,	,	PUNCT
ijpds-3543	18	11	arthritis	arthritis	NOUN
ijpds-3543	18	12	denosine	denosine	NOUN
ijpds-3543	18	13	is	be	AUX
ijpds-3543	18	14	a	a	DET
ijpds-3543	18	15	purine	purine	NOUN
ijpds-3543	18	16	nucleoside	nucleoside	NOUN
ijpds-3543	18	17	generated	generate	VERB
ijpds-3543	18	18	by	by	ADP
ijpds-3543	18	19	a	a	DET
ijpds-3543	18	20	number	number	NOUN
ijpds-3543	18	21	of	of	ADP
ijpds-3543	18	22	cells	cell	NOUN
ijpds-3543	18	23	in	in	ADP
ijpds-3543	18	24	response	response	NOUN
ijpds-3543	18	25	to	to	ADP
ijpds-3543	18	26	metabolic	metabolic	NOUN
ijpds-3543	18	27	stress	stress	NOUN
ijpds-3543	18	28	adenosine	adenosine	NOUN
ijpds-3543	18	29	receptor	receptor	NOUN
ijpds-3543	18	30	ligands	ligand	NOUN
ijpds-3543	18	31	a1	a1	NOUN
ijpds-3543	18	32	,	,	PUNCT
ijpds-3543	18	33	a2a	a2a	PROPN
ijpds-3543	18	34	,	,	PUNCT
ijpds-3543	18	35	a2b	a2b	PROPN
ijpds-3543	18	36	,	,	PUNCT
ijpds-3543	18	37	and	and	CCONJ
ijpds-3543	18	38	a3	a3	NOUN
ijpds-3543	18	39	have	have	AUX
ijpds-3543	18	40	been	be	AUX
ijpds-3543	18	41	found	find	VERB
ijpds-3543	18	42	to	to	PART
ijpds-3543	18	43	inhibit	inhibit	VERB
ijpds-3543	18	44	the	the	DET
ijpds-3543	18	45	synthesis	synthesis	NOUN
ijpds-3543	18	46	of	of	ADP
ijpds-3543	18	47	pro	pro	ADJ
ijpds-3543	18	48	-	-	ADJ
ijpds-3543	18	49	inflammatory	inflammatory	ADJ
ijpds-3543	18	50	mediators	mediator	NOUN
ijpds-3543	18	51	,	,	PUNCT
ijpds-3543	18	52	diminish	diminish	VERB
ijpds-3543	18	53	the	the	DET
ijpds-3543	18	54	recruitment	recruitment	NOUN
ijpds-3543	18	55	of	of	ADP
ijpds-3543	18	56	polymorphonuclear	polymorphonuclear	NOUN
ijpds-3543	18	57	leukocytes	leukocyte	NOUN
ijpds-3543	18	58	(	(	PUNCT
ijpds-3543	18	59	pmns	pmn	NOUN
ijpds-3543	18	60	)	)	PUNCT
ijpds-3543	18	61	,	,	PUNCT
ijpds-3543	18	62	and	and	CCONJ
ijpds-3543	18	63	exhibit	exhibit	VERB
ijpds-3543	18	64	anti	anti	ADJ
ijpds-3543	18	65	-	-	ADJ
ijpds-3543	18	66	inflammatory	inflammatory	ADJ
ijpds-3543	18	67	properties	property	NOUN
ijpds-3543	18	68	[	[	X
ijpds-3543	18	69	1	1	NUM
ijpds-3543	18	70	]	]	PUNCT
ijpds-3543	18	71	.	.	PUNCT
ijpds-3543	19	1	furthermore	furthermore	ADV
ijpds-3543	19	2	,	,	PUNCT
ijpds-3543	19	3	the	the	DET
ijpds-3543	19	4	ability	ability	NOUN
ijpds-3543	19	5	to	to	PART
ijpds-3543	19	6	release	release	VERB
ijpds-3543	19	7	adenosine	adenosine	NOUN
ijpds-3543	19	8	is	be	AUX
ijpds-3543	19	9	related	relate	VERB
ijpds-3543	19	10	to	to	ADP
ijpds-3543	19	11	the	the	DET
ijpds-3543	19	12	anti	anti	ADJ
ijpds-3543	19	13	-	-	ADJ
ijpds-3543	19	14	inflammatory	inflammatory	ADJ
ijpds-3543	19	15	activitie	activitie	NOUN
ijpds-3543	19	16	of	of	ADP
ijpds-3543	19	17	medicines	medicine	NOUN
ijpds-3543	19	18	such	such	ADJ
ijpds-3543	19	19	methotrexate	methotrexate	NOUN
ijpds-3543	19	20	,	,	PUNCT
ijpds-3543	19	21	sulphasalazine	sulphasalazine	ADJ
ijpds-3543	19	22	,	,	PUNCT
ijpds-3543	19	23	and	and	CCONJ
ijpds-3543	19	24	adenosine	adenosine	ADJ
ijpds-3543	19	25	kinase	kinase	NOUN
ijpds-3543	19	26	inhibitors	inhibitor	NOUN
ijpds-3543	19	27	both	both	CCONJ
ijpds-3543	19	28	a1	a1	NOUN
ijpds-3543	19	29	and	and	CCONJ
ijpds-3543	19	30	a2	a2	PROPN
ijpds-3543	19	31	receptor	receptor	NOUN
ijpds-3543	19	32	agonists	agonist	NOUN
ijpds-3543	19	33	were	be	AUX
ijpds-3543	19	34	reported	report	VERB
ijpds-3543	19	35	to	to	PART
ijpds-3543	19	36	decrease	decrease	VERB
ijpds-3543	19	37	tnfα	tnfα	NOUN
ijpds-3543	19	38	production	production	NOUN
ijpds-3543	19	39	in	in	ADP
ijpds-3543	19	40	raw	raw	ADJ
ijpds-3543	19	41	24.7	24.7	NUM
ijpds-3543	19	42	cells	cell	NOUN
ijpds-3543	19	43	in	in	ADP
ijpds-3543	19	44	recent	recent	ADJ
ijpds-3543	19	45	research	research	NOUN
ijpds-3543	19	46	macrophages	macrophage	NOUN
ijpds-3543	19	47	or	or	CCONJ
ijpds-3543	19	48	human	human	ADJ
ijpds-3543	19	49	monocytes	monocyte	NOUN
ijpds-3543	19	50	,	,	PUNCT
ijpds-3543	19	51	and	and	CCONJ
ijpds-3543	19	52	the	the	DET
ijpds-3543	19	53	rank	rank	NOUN
ijpds-3543	19	54	order	order	NOUN
ijpds-3543	19	55	of	of	ADP
ijpds-3543	19	56	agonist	agonist	NOUN
ijpds-3543	19	57	potency	potency	NOUN
ijpds-3543	19	58	was	be	AUX
ijpds-3543	19	59	not	not	PART
ijpds-3543	19	60	typical	typical	ADJ
ijpds-3543	19	61	of	of	ADP
ijpds-3543	19	62	either	either	CCONJ
ijpds-3543	19	63	a1	a1	NOUN
ijpds-3543	19	64	or	or	CCONJ
ijpds-3543	19	65	a2	a2	NOUN
ijpds-3543	19	66	receptors	receptor	NOUN
ijpds-3543	19	67	implying	imply	VERB
ijpds-3543	19	68	that	that	SCONJ
ijpds-3543	19	69	the	the	DET
ijpds-3543	19	70	a3	a3	NOUN
ijpds-3543	19	71	receptor	receptor	NOUN
ijpds-3543	19	72	may	may	AUX
ijpds-3543	19	73	be	be	AUX
ijpds-3543	19	74	involved	involve	VERB
ijpds-3543	19	75	.	.	PUNCT
ijpds-3543	20	1	furthermore	furthermore	ADV
ijpds-3543	20	2	,	,	PUNCT
ijpds-3543	20	3	adenosine	adenosine	VERB
ijpds-3543	20	4	,	,	PUNCT
ijpds-3543	20	5	but	but	CCONJ
ijpds-3543	20	6	not	not	PART
ijpds-3543	20	7	adenosine	adenosine	VERB
ijpds-3543	20	8	,	,	PUNCT
ijpds-3543	20	9	in	in	ADP
ijpds-3543	20	10	human	human	ADJ
ijpds-3543	20	11	monocytes	monocyte	NOUN
ijpds-3543	20	12	,	,	PUNCT
ijpds-3543	20	13	selective	selective	ADJ
ijpds-3543	20	14	a1	a1	NOUN
ijpds-3543	20	15	and	and	CCONJ
ijpds-3543	20	16	a2	a2	PROPN
ijpds-3543	20	17	receptor	receptor	NOUN
ijpds-3543	20	18	agonists	agonist	NOUN
ijpds-3543	20	19	increased	increase	VERB
ijpds-3543	20	20	il-10	il-10	DET
ijpds-3543	20	21	production	production	NOUN
ijpds-3543	20	22	it	it	PRON
ijpds-3543	20	23	was	be	AUX
ijpds-3543	20	24	further	far	ADV
ijpds-3543	20	25	proven	prove	VERB
ijpds-3543	20	26	that	that	DET
ijpds-3543	20	27	suppression	suppression	NOUN
ijpds-3543	20	28	of	of	ADP
ijpds-3543	20	29	tnf	tnf	PROPN
ijpds-3543	20	30	-	-	PUNCT
ijpds-3543	20	31	α	α	PROPN
ijpds-3543	20	32	generation	generation	NOUN
ijpds-3543	20	33	by	by	ADP
ijpds-3543	20	34	lps	lps	PROPN
ijpds-3543	20	35	-	-	PUNCT
ijpds-3543	20	36	stimulated	stimulate	VERB
ijpds-3543	20	37	u937	u937	PROPN
ijpds-3543	20	38	(	(	PUNCT
ijpds-3543	20	39	human	human	ADJ
ijpds-3543	20	40	monocyte	monocyte	NOUN
ijpds-3543	20	41	)	)	PUNCT
ijpds-3543	20	42	cells	cell	NOUN
ijpds-3543	20	43	was	be	AUX
ijpds-3543	20	44	primarily	primarily	ADV
ijpds-3543	20	45	an	an	DET
ijpds-3543	20	46	a3	a3	NOUN
ijpds-3543	20	47	receptor	receptor	NOUN
ijpds-3543	20	48	mediated	mediate	VERB
ijpds-3543	20	49	mechanism	mechanism	NOUN
ijpds-3543	20	50	using	use	VERB
ijpds-3543	20	51	particular	particular	ADJ
ijpds-3543	20	52	a1	a1	NOUN
ijpds-3543	20	53	,	,	PUNCT
ijpds-3543	20	54	a2	a2	PROPN
ijpds-3543	20	55	and	and	CCONJ
ijpds-3543	20	56	a3	a3	NOUN
ijpds-3543	20	57	receptor	receptor	NOUN
ijpds-3543	20	58	-	-	PUNCT
ijpds-3543	20	59	mediated	mediate	VERB
ijpds-3543	20	60	mechanism	mechanism	NOUN
ijpds-3543	20	61	using	use	VERB
ijpds-3543	20	62	particular	particular	ADJ
ijpds-3543	20	63	a1	a1	NOUN
ijpds-3543	20	64	,	,	PUNCT
ijpds-3543	20	65	a2	a2	PROPN
ijpds-3543	20	66	,	,	PUNCT
ijpds-3543	20	67	and	and	CCONJ
ijpds-3543	20	68	a3	a3	NOUN
ijpds-3543	20	69	receptor	receptor	NOUN
ijpds-3543	20	70	agonists	agonist	NOUN
ijpds-3543	20	71	and	and	CCONJ
ijpds-3543	20	72	antagonists	antagonist	NOUN
ijpds-3543	20	73	in	in	ADP
ijpds-3543	20	74	the	the	DET
ijpds-3543	20	75	murine	murine	ADJ
ijpds-3543	20	76	j774.1	j774.1	DET
ijpds-3543	20	77	macrophage	macrophage	ADJ
ijpds-3543	20	78	cell	cell	NOUN
ijpds-3543	20	79	line	line	NOUN
ijpds-3543	20	80	,	,	PUNCT
ijpds-3543	20	81	ado	ado	NOUN
ijpds-3543	20	82	receptor	receptor	NOUN
ijpds-3543	20	83	agonists	agonist	NOUN
ijpds-3543	20	84	prevented	prevent	VERB
ijpds-3543	20	85	endotoxin	endotoxin	ADJ
ijpds-3543	20	86	activation	activation	NOUN
ijpds-3543	20	87	of	of	ADP
ijpds-3543	20	88	the	the	DET
ijpds-3543	20	89	tnfα	tnfα	NOUN
ijpds-3543	20	90	gene	gene	NOUN
ijpds-3543	20	91	and	and	CCONJ
ijpds-3543	20	92	protein	protein	NOUN
ijpds-3543	20	93	expression	expression	NOUN
ijpds-3543	20	94	in	in	ADP
ijpds-3543	20	95	a	a	DET
ijpds-3543	20	96	dose	dose	NOUN
ijpds-3543	20	97	-	-	PUNCT
ijpds-3543	20	98	dependent	dependent	ADJ
ijpds-3543	20	99	manner	manner	NOUN
ijpds-3543	20	100	similar	similar	ADJ
ijpds-3543	20	101	to	to	ADP
ijpds-3543	20	102	the	the	DET
ijpds-3543	20	103	a3	a3	NOUN
ijpds-3543	20	104	receptor	receptor	NOUN
ijpds-3543	21	1	[	[	X
ijpds-3543	21	2	2	2	NUM
ijpds-3543	21	3	]	]	PUNCT
ijpds-3543	21	4	.	.	PUNCT
ijpds-3543	22	1	although	although	SCONJ
ijpds-3543	22	2	the	the	DET
ijpds-3543	22	3	above	above	ADJ
ijpds-3543	22	4	research	research	NOUN
ijpds-3543	22	5	showed	show	VERB
ijpds-3543	22	6	that	that	SCONJ
ijpds-3543	22	7	several	several	ADJ
ijpds-3543	22	8	adenosine	adenosine	ADJ
ijpds-3543	22	9	receptor	receptor	NOUN
ijpds-3543	22	10	agonists	agonist	NOUN
ijpds-3543	22	11	can	can	AUX
ijpds-3543	22	12	affect	affect	VERB
ijpds-3543	22	13	the	the	DET
ijpds-3543	22	14	production	production	NOUN
ijpds-3543	22	15	of	of	ADP
ijpds-3543	22	16	pro	pro	ADJ
ijpds-3543	22	17	and	and	CCONJ
ijpds-3543	22	18	anti	anti	ADJ
ijpds-3543	22	19	-	-	ADJ
ijpds-3543	22	20	inflammatory	inflammatory	ADJ
ijpds-3543	22	21	cytokines	cytokine	VERB
ijpds-3543	22	22	no	no	DET
ijpds-3543	22	23	information	information	NOUN
ijpds-3543	22	24	on	on	ADP
ijpds-3543	22	25	the	the	DET
ijpds-3543	22	26	modification	modification	NOUN
ijpds-3543	22	27	of	of	ADP
ijpds-3543	22	28	the	the	DET
ijpds-3543	22	29	production	production	NOUN
ijpds-3543	22	30	of	of	ADP
ijpds-3543	22	31	chemokines	chemokine	NOUN
ijpds-3543	22	32	by	by	ADP
ijpds-3543	22	33	adenosine	adenosine	ADJ
ijpds-3543	22	34	receptor	receptor	NOUN
ijpds-3543	22	35	ligands	ligand	NOUN
ijpds-3543	22	36	was	be	AUX
ijpds-3543	22	37	previously	previously	ADV
ijpds-3543	22	38	published	publish	VERB
ijpds-3543	22	39	.	.	PUNCT
ijpds-3543	23	1	mip-1	mip-1	ADP
ijpds-3543	23	2	α	α	NOUN
ijpds-3543	23	3	(	(	PUNCT
ijpds-3543	23	4	macrophage	macrophage	ADJ
ijpds-3543	23	5	inflammatory	inflammatory	ADJ
ijpds-3543	23	6	protein	protein	NOUN
ijpds-3543	23	7	)	)	PUNCT
ijpds-3543	23	8	is	be	AUX
ijpds-3543	23	9	a	a	DET
ijpds-3543	23	10	low	low	ADJ
ijpds-3543	23	11	-	-	PUNCT
ijpds-3543	23	12	molecular	molecular	ADJ
ijpds-3543	23	13	-	-	PUNCT
ijpds-3543	23	14	weight	weight	NOUN
ijpds-3543	23	15	cc	cc	NOUN
ijpds-3543	23	16	chemokine	chemokine	ADJ
ijpds-3543	23	17	that	that	PRON
ijpds-3543	23	18	has	have	VERB
ijpds-3543	23	19	significant	significant	ADJ
ijpds-3543	23	20	inflammatory	inflammatory	ADJ
ijpds-3543	23	21	effects	effect	NOUN
ijpds-3543	23	22	[	[	X
ijpds-3543	23	23	3	3	NUM
ijpds-3543	23	24	]	]	PUNCT
ijpds-3543	23	25	.	.	PUNCT
ijpds-3543	24	1	the	the	DET
ijpds-3543	24	2	enhancement	enhancement	NOUN
ijpds-3543	24	3	of	of	ADP
ijpds-3543	24	4	neutrophil	neutrophil	ADJ
ijpds-3543	24	5	recruitment	recruitment	NOUN
ijpds-3543	24	6	is	be	AUX
ijpds-3543	24	7	the	the	DET
ijpds-3543	24	8	key	key	ADJ
ijpds-3543	24	9	mechanism	mechanism	NOUN
ijpds-3543	24	10	for	for	ADP
ijpds-3543	24	11	inflammatory	inflammatory	ADJ
ijpds-3543	24	12	sites	site	NOUN
ijpds-3543	24	13	.	.	PUNCT
ijpds-3543	25	1	we	we	PRON
ijpds-3543	25	2	investigated	investigate	VERB
ijpds-3543	25	3	whether	whether	SCONJ
ijpds-3543	25	4	adenosine	adenosine	NOUN
ijpds-3543	25	5	receptor	receptor	NOUN
ijpds-3543	25	6	ligands	ligand	NOUN
ijpds-3543	25	7	affect	affect	VERB
ijpds-3543	25	8	the	the	DET
ijpds-3543	25	9	production	production	NOUN
ijpds-3543	25	10	of	of	ADP
ijpds-3543	25	11	mip-1	mip-1	X
ijpds-3543	25	12	α	α	PROPN
ijpds-3543	25	13	a	a	DET
ijpds-3543	25	14	mailto:harisonwani10@gmail.com	mailto:harisonwani10@gmail.com	NOUN
ijpds-3543	25	15	sonwani	sonwani	NOUN
ijpds-3543	25	16	et	et	PROPN
ijpds-3543	25	17	al	al	PROPN
ijpds-3543	25	18	.	.	PROPN
ijpds-3543	25	19	role	role	NOUN
ijpds-3543	25	20	of	of	ADP
ijpds-3543	25	21	adenosine	adenosine	ADJ
ijpds-3543	25	22	receptor	receptor	NOUN
ijpds-3543	25	23	agonists	agonist	NOUN
ijpds-3543	25	24	in	in	ADP
ijpds-3543	25	25	inflammatory	inflammatory	ADJ
ijpds-3543	25	26	conditions	condition	NOUN
ijpds-3543	25	27	vol	vol	NOUN
ijpds-3543	25	28	2	2	NUM
ijpds-3543	25	29	|	|	NOUN
ijpds-3543	25	30	issue	issue	NOUN
ijpds-3543	25	31	2	2	NUM
ijpds-3543	25	32	|	|	ADV
ijpds-3543	25	33	apr	apr	ADV
ijpds-3543	25	34	–	–	PUNCT
ijpds-3543	25	35	jun	jun	PROPN
ijpds-3543	25	36	2023	2023	NUM
ijpds-3543	25	37	indian	indian	PROPN
ijpds-3543	25	38	j	j	PROPN
ijpds-3543	25	39	pharm	pharm	PROPN
ijpds-3543	25	40	drug	drug	PROPN
ijpds-3543	25	41	studies	study	NOUN
ijpds-3543	25	42	|	|	ADV
ijpds-3543	25	43	70	70	NUM
ijpds-3543	25	44	protein	protein	NOUN
ijpds-3543	25	45	and	and	CCONJ
ijpds-3543	25	46	mrna	mrna	NOUN
ijpds-3543	25	47	in	in	ADP
ijpds-3543	25	48	macrophages	macrophage	NOUN
ijpds-3543	25	49	because	because	SCONJ
ijpds-3543	25	50	mip-1	mip-1	VERB
ijpds-3543	25	51	α	α	PRON
ijpds-3543	25	52	is	be	AUX
ijpds-3543	25	53	an	an	DET
ijpds-3543	25	54	important	important	ADJ
ijpds-3543	25	55	mediator	mediator	NOUN
ijpds-3543	25	56	of	of	ADP
ijpds-3543	25	57	acute	acute	ADJ
ijpds-3543	25	58	inflammation	inflammation	NOUN
ijpds-3543	25	59	anadenosine	anadenosine	NOUN
ijpds-3543	25	60	receptor	receptor	NOUN
ijpds-3543	25	61	ligands	ligand	NOUN
ijpds-3543	25	62	can	can	AUX
ijpds-3543	25	63	exert	exert	VERB
ijpds-3543	25	64	potent	potent	ADJ
ijpds-3543	25	65	anti	anti	ADJ
ijpds-3543	25	66	-	-	ADJ
ijpds-3543	25	67	inflammatory	inflammatory	ADJ
ijpds-3543	25	68	effects	effect	NOUN
ijpds-3543	25	69	.	.	PUNCT
ijpds-3543	26	1	we	we	PRON
ijpds-3543	26	2	investigated	investigate	VERB
ijpds-3543	26	3	whether	whether	SCONJ
ijpds-3543	26	4	the	the	DET
ijpds-3543	26	5	a3	a3	NOUN
ijpds-3543	26	6	agonist	agonist	NOUN
ijpds-3543	26	7	ib	ib	PROPN
ijpds-3543	26	8	-	-	PUNCT
ijpds-3543	26	9	meca	meca	PROPN
ijpds-3543	26	10	impacts	impact	VERB
ijpds-3543	26	11	mip-1α	mip-1α	NOUN
ijpds-3543	26	12	production	production	NOUN
ijpds-3543	26	13	,	,	PUNCT
ijpds-3543	26	14	the	the	DET
ijpds-3543	26	15	course	course	NOUN
ijpds-3543	26	16	of	of	ADP
ijpds-3543	26	17	inflammation	inflammation	NOUN
ijpds-3543	26	18	,	,	PUNCT
ijpds-3543	26	19	and	and	CCONJ
ijpds-3543	26	20	neutrophil	neutrophil	ADJ
ijpds-3543	26	21	recruitment	recruitment	NOUN
ijpds-3543	26	22	in	in	ADP
ijpds-3543	26	23	a	a	DET
ijpds-3543	26	24	model	model	NOUN
ijpds-3543	26	25	of	of	ADP
ijpds-3543	26	26	collagen	collagen	NOUN
ijpds-3543	26	27	-	-	PUNCT
ijpds-3543	26	28	induced	induce	VERB
ijpds-3543	26	29	arthritis	arthritis	NOUN
ijpds-3543	26	30	after	after	ADP
ijpds-3543	26	31	finding	find	VERB
ijpds-3543	26	32	that	that	DET
ijpds-3543	26	33	adenosine	adenosine	ADJ
ijpds-3543	26	34	receptor	receptor	NOUN
ijpds-3543	26	35	agonists	agonist	NOUN
ijpds-3543	26	36	,	,	PUNCT
ijpds-3543	26	37	most	most	ADV
ijpds-3543	26	38	notably	notably	ADV
ijpds-3543	26	39	the	the	DET
ijpds-3543	26	40	a3	a3	NOUN
ijpds-3543	26	41	agonist	agonist	NOUN
ijpds-3543	26	42	,	,	PUNCT
ijpds-3543	26	43	suppress	suppress	VERB
ijpds-3543	26	44	mip-1α	mip-1α	NOUN
ijpds-3543	26	45	expression	expression	NOUN
ijpds-3543	26	46	.	.	PUNCT
ijpds-3543	27	1	methods	method	NOUN
ijpds-3543	27	2	adenosine	adenosine	VERB
ijpds-3543	27	3	agonists	agonist	NOUN
ijpds-3543	27	4	have	have	VERB
ijpds-3543	27	5	an	an	DET
ijpds-3543	27	6	effect	effect	NOUN
ijpds-3543	27	7	on	on	ADP
ijpds-3543	27	8	mip	mip	PROPN
ijpds-3543	27	9	-	-	PUNCT
ijpds-3543	27	10	la	la	PROPN
ijpds-3543	27	11	production	production	NOUN
ijpds-3543	27	12	in	in	ADP
ijpds-3543	27	13	ran	run	VERB
ijpds-3543	27	14	264.3	264.3	NUM
ijpds-3543	27	15	cells	cell	NOUN
ijpds-3543	27	16	:	:	PUNCT
ijpds-3543	27	17	the	the	DET
ijpds-3543	27	18	mouse	mouse	NOUN
ijpds-3543	27	19	macrophage	macrophage	ADJ
ijpds-3543	27	20	cell	cell	NOUN
ijpds-3543	27	21	line	line	NOUN
ijpds-3543	27	22	raw	raw	ADJ
ijpds-3543	27	23	24.7	24.7	NUM
ijpds-3543	27	24	was	be	AUX
ijpds-3543	27	25	grown	grow	VERB
ijpds-3543	27	26	.	.	PUNCT
ijpds-3543	28	1	1	1	NUM
ijpds-3543	28	2	ml	ml	NOUN
ijpds-3543	28	3	of	of	ADP
ijpds-3543	28	4	1300	1300	NUM
ijpds-3543	28	5	mm	mm	NOUN
ijpds-3543	28	6	adenosine	adenosine	NOUN
ijpds-3543	28	7	,	,	PUNCT
ijpds-3543	28	8	the	the	DET
ijpds-3543	28	9	a1	a1	NOUN
ijpds-3543	28	10	receptor	receptor	NOUN
ijpds-3543	28	11	agonist	agonist	NOUN
ijpds-3543	28	12	2	2	NUM
ijpds-3543	28	13	-	-	PUNCT
ijpds-3543	28	14	chloro	chloro	NOUN
ijpds-3543	28	15	-	-	PUNCT
ijpds-3543	28	16	n	n	CCONJ
ijpds-3543	28	17	-	-	PUNCT
ijpds-3543	28	18	cyclopentyladenosine	cyclopentyladenosine	NOUN
ijpds-3543	28	19	(	(	PUNCT
ijpds-3543	28	20	ccpa	ccpa	NOUN
ijpds-3543	28	21	)	)	PUNCT
ijpds-3543	28	22	,	,	PUNCT
ijpds-3543	28	23	the	the	DET
ijpds-3543	28	24	a2	a2	PROPN
ijpds-3543	28	25	receptor	receptor	NOUN
ijpds-3543	28	26	agonist	agonist	NOUN
ijpds-3543	28	27	2	2	NUM
ijpds-3543	28	28	-	-	PUNCT
ijpds-3543	28	29	p-(2	p-(2	NOUN
ijpds-3543	28	30	-	-	PUNCT
ijpds-3543	28	31	carboxyethyl	carboxyethyl	NOUN
ijpds-3543	28	32	)	)	PUNCT
ijpds-3543	28	33	phenethylamino-5'-nethyl	phenethylamino-5'-nethyl	PROPN
ijpds-3543	28	34	-	-	PUNCT
ijpds-3543	28	35	carboxamidoadenosine	carboxamidoadenosine	NOUN
ijpds-3543	28	36	(	(	PUNCT
ijpds-3543	28	37	cgs2180	cgs2180	NOUN
ijpds-3543	28	38	)	)	PUNCT
ijpds-3543	28	39	,	,	PUNCT
ijpds-3543	28	40	and	and	CCONJ
ijpds-3543	28	41	the	the	DET
ijpds-3543	28	42	a3	a3	NOUN
ijpds-3543	28	43	receptor	receptor	NOUN
ijpds-3543	28	44	agonist	agonist	NOUN
ijpds-3543	28	45	n-(3	n-(3	PROPN
ijpds-3543	28	46	-	-	PUNCT
ijpds-3543	28	47	iodobenzyl)-adeno	iodobenzyl)-adeno	PROPN
ijpds-3543	28	48	.	.	PUNCT
ijpds-3543	29	1	research	research	PROPN
ijpds-3543	29	2	biochemicals	biochemicals	PROPN
ijpds-3543	29	3	inc	inc	PROPN
ijpds-3543	29	4	.	.	PROPN
ijpds-3543	29	5	provided	provide	VERB
ijpds-3543	29	6	adenosine	adenosine	NOUN
ijpds-3543	29	7	agonists	agonist	NOUN
ijpds-3543	29	8	.	.	PUNCT
ijpds-3543	30	1	after	after	ADP
ijpds-3543	30	2	30	30	NUM
ijpds-3543	30	3	minutes	minute	NOUN
ijpds-3543	30	4	,	,	PUNCT
ijpds-3543	30	5	cells	cell	NOUN
ijpds-3543	30	6	were	be	AUX
ijpds-3543	30	7	stimulated	stimulate	VERB
ijpds-3543	30	8	with	with	ADP
ijpds-3543	30	9	lps	lps	PROPN
ijpds-3543	30	10	,	,	PUNCT
ijpds-3543	30	11	and	and	CCONJ
ijpds-3543	30	12	supernatants	supernatant	NOUN
ijpds-3543	30	13	or	or	CCONJ
ijpds-3543	30	14	cells	cell	NOUN
ijpds-3543	30	15	were	be	AUX
ijpds-3543	30	16	collected	collect	VERB
ijpds-3543	30	17	1–3	1–3	NUM
ijpds-3543	30	18	hours	hour	NOUN
ijpds-3543	30	19	later	later	ADV
ijpds-3543	30	20	for	for	ADP
ijpds-3543	30	21	mip-1α	mip-1α	NOUN
ijpds-3543	30	22	protein	protein	NOUN
ijpds-3543	30	23	or	or	CCONJ
ijpds-3543	30	24	mrna	mrna	PROPN
ijpds-3543	30	25	assays	assay	NOUN
ijpds-3543	30	26	.	.	PUNCT
ijpds-3543	31	1	the	the	DET
ijpds-3543	31	2	effect	effect	NOUN
ijpds-3543	31	3	of	of	ADP
ijpds-3543	31	4	a	a	DET
ijpds-3543	31	5	1	1	NUM
ijpds-3543	31	6	-	-	PUNCT
ijpds-3543	31	7	h	h	NOUN
ijpds-3543	31	8	pretreatment	pretreatment	NOUN
ijpds-3543	31	9	with	with	ADP
ijpds-3543	31	10	the	the	DET
ijpds-3543	31	11	adenosine	adenosine	ADJ
ijpds-3543	31	12	deaminase	deaminase	NOUN
ijpds-3543	31	13	inhibitor	inhibitor	NOUN
ijpds-3543	31	14	erythro-9-(2	erythro-9-(2	NOUN
ijpds-3543	31	15	-	-	PUNCT
ijpds-3543	31	16	hydroxy-3	hydroxy-3	NOUN
ijpds-3543	31	17	-	-	PUNCT
ijpds-3543	31	18	nonyl	nonyl	ADJ
ijpds-3543	31	19	)	)	PUNCT
ijpds-3543	31	20	adenine	adenine	NOUN
ijpds-3543	31	21	(	(	PUNCT
ijpds-3543	31	22	ehna	ehna	NOUN
ijpds-3543	31	23	,	,	PUNCT
ijpds-3543	31	24	50	50	NUM
ijpds-3543	31	25	m	m	NOUN
ijpds-3543	31	26	)	)	PUNCT
ijpds-3543	31	27	on	on	ADP
ijpds-3543	31	28	the	the	DET
ijpds-3543	31	29	inhibitory	inhibitory	ADJ
ijpds-3543	31	30	effect	effect	NOUN
ijpds-3543	31	31	of	of	ADP
ijpds-3543	31	32	adenosine	adenosine	NOUN
ijpds-3543	31	33	on	on	ADP
ijpds-3543	31	34	mip-1α	mip-1α	NOUN
ijpds-3543	31	35	production	production	NOUN
ijpds-3543	31	36	was	be	AUX
ijpds-3543	31	37	investigated	investigate	VERB
ijpds-3543	31	38	in	in	ADP
ijpds-3543	31	39	a	a	DET
ijpds-3543	31	40	second	second	ADJ
ijpds-3543	31	41	set	set	NOUN
ijpds-3543	31	42	of	of	ADP
ijpds-3543	31	43	tests	test	NOUN
ijpds-3543	31	44	.	.	PUNCT
ijpds-3543	32	1	mip-1α	mip-1α	NOUN
ijpds-3543	32	2	is	be	AUX
ijpds-3543	32	3	a	a	DET
ijpds-3543	32	4	protein	protein	NOUN
ijpds-3543	32	5	that	that	PRON
ijpds-3543	32	6	was	be	AUX
ijpds-3543	32	7	discovered	discover	VERB
ijpds-3543	32	8	in	in	ADP
ijpds-3543	32	9	the	the	DET
ijpds-3543	32	10	human	human	ADJ
ijpds-3543	32	11	body	body	NOUN
ijpds-3543	32	12	as	as	SCONJ
ijpds-3543	32	13	previously	previously	ADV
ijpds-3543	32	14	described	describe	VERB
ijpds-3543	32	15	,	,	PUNCT
ijpds-3543	32	16	using	use	VERB
ijpds-3543	32	17	murine	murine	ADJ
ijpds-3543	32	18	elisa	elisa	NOUN
ijpds-3543	32	19	kits	kit	NOUN
ijpds-3543	32	20	bought	buy	VERB
ijpds-3543	32	21	from	from	ADP
ijpds-3543	32	22	genzyme	genzyme	PROPN
ijpds-3543	32	23	)	)	PUNCT
ijpds-3543	33	1	(	(	PUNCT
ijpds-3543	33	2	detection	detection	NOUN
ijpds-3543	33	3	limit	limit	NOUN
ijpds-3543	33	4	:	:	PUNCT
ijpds-3543	33	5	1.5	1.5	NUM
ijpds-3543	33	6	pg	pg	NOUN
ijpds-3543	33	7	/	/	SYM
ijpds-3543	33	8	ml	ml	ADP
ijpds-3543	33	9	)	)	PUNCT
ijpds-3543	33	10	the	the	DET
ijpds-3543	33	11	experiment	experiment	NOUN
ijpds-3543	33	12	was	be	AUX
ijpds-3543	33	13	not	not	PART
ijpds-3543	33	14	hampered	hamper	VERB
ijpds-3543	33	15	by	by	ADP
ijpds-3543	33	16	any	any	DET
ijpds-3543	33	17	test	test	NOUN
ijpds-3543	33	18	chemicals	chemical	NOUN
ijpds-3543	33	19	.	.	PUNCT
ijpds-3543	34	1	adenosine	adenosine	NOUN
ijpds-3543	34	2	agonists	agonist	NOUN
ijpds-3543	34	3	'	'	PART
ijpds-3543	34	4	effects	effect	NOUN
ijpds-3543	34	5	on	on	ADP
ijpds-3543	34	6	mip	mip	PROPN
ijpds-3543	34	7	-	-	PUNCT
ijpds-3543	34	8	la	la	PRON
ijpds-3543	34	9	steady	steady	ADJ
ijpds-3543	34	10	-	-	PUNCT
ijpds-3543	34	11	state	state	NOUN
ijpds-3543	34	12	mrna	mrna	PROPN
ijpds-3543	34	13	levels	level	NOUN
ijpds-3543	34	14	:	:	PUNCT
ijpds-3543	34	15	a	a	DET
ijpds-3543	34	16	guanidinium	guanidinium	NOUN
ijpds-3543	34	17	isothiocyanate	isothiocyanate	NOUN
ijpds-3543	34	18	/	/	SYM
ijpds-3543	34	19	chloroform	chloroform	NOUN
ijpds-3543	34	20	-	-	PUNCT
ijpds-3543	34	21	based	base	VERB
ijpds-3543	34	22	approach	approach	NOUN
ijpds-3543	34	23	(	(	PUNCT
ijpds-3543	34	24	trizol	trizol	VERB
ijpds-3543	34	25	)	)	PUNCT
ijpds-3543	34	26	was	be	AUX
ijpds-3543	34	27	used	use	VERB
ijpds-3543	34	28	to	to	PART
ijpds-3543	34	29	extract	extract	VERB
ijpds-3543	34	30	total	total	ADJ
ijpds-3543	34	31	rna	rna	NOUN
ijpds-3543	34	32	from	from	ADP
ijpds-3543	34	33	each	each	PRON
ijpds-3543	34	34	well	well	ADV
ijpds-3543	34	35	,	,	PUNCT
ijpds-3543	34	36	followed	follow	VERB
ijpds-3543	34	37	by	by	ADP
ijpds-3543	34	38	isopropanol	isopropanol	NOUN
ijpds-3543	34	39	precipitation	precipitation	NOUN
ijpds-3543	34	40	.	.	PUNCT
ijpds-3543	35	1	on	on	ADP
ijpds-3543	35	2	a	a	DET
ijpds-3543	35	3	1	1	NUM
ijpds-3543	35	4	%	%	NOUN
ijpds-3543	35	5	formaldehyde	formaldehyde	NOUN
ijpds-3543	35	6	gel	gel	NOUN
ijpds-3543	35	7	,	,	PUNCT
ijpds-3543	35	8	cytoplas	cytoplas	NOUN
ijpds-3543	35	9	mic	mic	PROPN
ijpds-3543	35	10	rna	rna	PROPN
ijpds-3543	35	11	(	(	PUNCT
ijpds-3543	35	12	15	15	NUM
ijpds-3543	35	13	g	g	NOUN
ijpds-3543	35	14	)	)	PUNCT
ijpds-3543	35	15	was	be	AUX
ijpds-3543	35	16	separated	separate	VERB
ijpds-3543	35	17	and	and	CCONJ
ijpds-3543	35	18	transferred	transfer	VERB
ijpds-3543	35	19	to	to	ADP
ijpds-3543	35	20	a	a	DET
ijpds-3543	35	21	nylon	nylon	NOUN
ijpds-3543	35	22	membrane	membrane	NOUN
ijpds-3543	35	23	.	.	PUNCT
ijpds-3543	36	1	the	the	DET
ijpds-3543	36	2	rat	rat	NOUN
ijpds-3543	36	3	mip-1α	mip-1α	PROPN
ijpds-3543	36	4	cdna	cdna	PROPN
ijpds-3543	36	5	sequence	sequence	NOUN
ijpds-3543	36	6	is	be	AUX
ijpds-3543	36	7	92	92	NUM
ijpds-3543	36	8	percent	percent	NOUN
ijpds-3543	36	9	identical	identical	ADJ
ijpds-3543	36	10	to	to	ADP
ijpds-3543	36	11	the	the	DET
ijpds-3543	36	12	mouse	mouse	NOUN
ijpds-3543	36	13	sequence	sequence	NOUN
ijpds-3543	36	14	,	,	PUNCT
ijpds-3543	36	15	indicating	indicate	VERB
ijpds-3543	36	16	cross	cross	NOUN
ijpds-3543	36	17	-	-	NOUN
ijpds-3543	36	18	hybridization	hybridization	NOUN
ijpds-3543	36	19	between	between	ADP
ijpds-3543	36	20	the	the	DET
ijpds-3543	36	21	two	two	NUM
ijpds-3543	36	22	species	specie	NOUN
ijpds-3543	36	23	.	.	PUNCT
ijpds-3543	37	1	by	by	ADP
ijpds-3543	37	2	random	random	ADJ
ijpds-3543	37	3	priming	priming	NOUN
ijpds-3543	37	4	,	,	PUNCT
ijpds-3543	37	5	this	this	DET
ijpds-3543	37	6	cdna	cdna	PROPN
ijpds-3543	37	7	was	be	AUX
ijpds-3543	37	8	radiolabeled	radiolabele	VERB
ijpds-3543	37	9	with	with	ADP
ijpds-3543	37	10	32p	32p	NOUN
ijpds-3543	37	11	-	-	SYM
ijpds-3543	37	12	dctp	dctp	NOUN
ijpds-3543	37	13	(	(	PUNCT
ijpds-3543	37	14	specific	specific	ADJ
ijpds-3543	37	15	activity	activity	NOUN
ijpds-3543	37	16	,	,	PUNCT
ijpds-3543	37	17	3,000	3,000	NUM
ijpds-3543	37	18	.	.	PUNCT
ijpds-3543	38	1	the	the	DET
ijpds-3543	38	2	radioactivity	radioactivity	NOUN
ijpds-3543	38	3	of	of	ADP
ijpds-3543	38	4	probes	probe	NOUN
ijpds-3543	38	5	was	be	AUX
ijpds-3543	38	6	measured	measure	VERB
ijpds-3543	38	7	.	.	PUNCT
ijpds-3543	39	1	the	the	DET
ijpds-3543	39	2	northern	northern	ADJ
ijpds-3543	39	3	blot	blot	NOUN
ijpds-3543	39	4	was	be	AUX
ijpds-3543	39	5	hybridized	hybridize	VERB
ijpds-3543	39	6	at	at	ADP
ijpds-3543	39	7	42	42	NUM
ijpds-3543	39	8	°	°	ADP
ijpds-3543	39	9	c	c	NOUN
ijpds-3543	39	10	for	for	ADP
ijpds-3543	39	11	1	1	NUM
ijpds-3543	39	12	hour	hour	NOUN
ijpds-3543	39	13	after	after	ADP
ijpds-3543	39	14	scintillation	scintillation	NOUN
ijpds-3543	39	15	counting	counting	NOUN
ijpds-3543	39	16	and	and	CCONJ
ijpds-3543	39	17	1.5107	1.5107	NUM
ijpds-3543	39	18	c.p.m	c.p.m	NOUN
ijpds-3543	39	19	.	.	PROPN
ijpds-3543	39	20	were	be	AUX
ijpds-3543	39	21	applied	apply	VERB
ijpds-3543	39	22	.	.	PUNCT
ijpds-3543	40	1	the	the	DET
ijpds-3543	40	2	hybridized	hybridize	VERB
ijpds-3543	40	3	filters	filter	NOUN
ijpds-3543	40	4	were	be	AUX
ijpds-3543	40	5	washed	wash	VERB
ijpds-3543	40	6	serially	serially	ADV
ijpds-3543	40	7	at	at	ADP
ijpds-3543	40	8	53	53	NUM
ijpds-3543	40	9	°	°	ADP
ijpds-3543	40	10	c	c	NOUN
ijpds-3543	40	11	with	with	ADP
ijpds-3543	40	12	a	a	DET
ijpds-3543	40	13	solution	solution	NOUN
ijpds-3543	40	14	of	of	ADP
ijpds-3543	40	15	2	2	NUM
ijpds-3543	40	16	sodium	sodium	NOUN
ijpds-3543	40	17	citrate	citrate	NOUN
ijpds-3543	40	18	,	,	PUNCT
ijpds-3543	40	19	sodium	sodium	NOUN
ijpds-3543	40	20	chloride	chloride	NOUN
ijpds-3543	40	21	,	,	PUNCT
ijpds-3543	40	22	and	and	CCONJ
ijpds-3543	40	23	0.1	0.1	NUM
ijpds-3543	40	24	percent	percent	NOUN
ijpds-3543	40	25	sds	sds	NOUN
ijpds-3543	40	26	(	(	PUNCT
ijpds-3543	40	27	2ssc	2ssc	NUM
ijpds-3543	40	28	)	)	PUNCT
ijpds-3543	40	29	.	.	PUNCT
ijpds-3543	41	1	autoradiography	autoradiography	NOUN
ijpds-3543	41	2	was	be	AUX
ijpds-3543	41	3	performed	perform	VERB
ijpds-3543	41	4	using	use	VERB
ijpds-3543	41	5	hodak	hodak	PROPN
ijpds-3543	41	6	-omat	-omat	NOUN
ijpds-3543	41	7	-	-	PUNCT
ijpds-3543	41	8	ar	ar	NOUN
ijpds-3543	41	9	film	film	NOUN
ijpds-3543	41	10	at	at	ADP
ijpds-3543	41	11	—	—	PUNCT
ijpds-3543	41	12	70	70	NUM
ijpds-3543	41	13	°	°	NOUN
ijpds-3543	41	14	c	c	NOUN
ijpds-3543	41	15	.	.	PUNCT
ijpds-3543	42	1	membranes	membrane	NOUN
ijpds-3543	42	2	were	be	AUX
ijpds-3543	42	3	stripped	strip	VERB
ijpds-3543	42	4	with	with	ADP
ijpds-3543	42	5	boiling	boil	VERB
ijpds-3543	42	6	5	5	NUM
ijpds-3543	42	7	mm	mm	NOUN
ijpds-3543	42	8	edta	edta	NOUN
ijpds-3543	42	9	and	and	CCONJ
ijpds-3543	42	10	rehybridized	rehybridize	VERB
ijpds-3543	42	11	with	with	ADP
ijpds-3543	42	12	a	a	DET
ijpds-3543	42	13	32pradiolabeled	32pradiolabeled	NUM
ijpds-3543	42	14	oligonucleotide	oligonucleotide	NOUN
ijpds-3543	42	15	probe	probe	NOUN
ijpds-3543	42	16	for	for	ADP
ijpds-3543	42	17	18s	18s	NUM
ijpds-3543	42	18	ribosomal	ribosomal	NOUN
ijpds-3543	42	19	rna	rna	NOUN
ijpds-3543	42	20	after	after	ADP
ijpds-3543	42	21	probing	probe	VERB
ijpds-3543	42	22	for	for	ADP
ijpds-3543	42	23	mip-1α	mip-1α	NOUN
ijpds-3543	42	24	.	.	PUNCT
ijpds-3543	43	1	in	in	SCONJ
ijpds-3543	43	2	ran	run	VERB
ijpds-3543	43	3	264.3	264.3	NUM
ijpds-3543	43	4	cells	cell	NOUN
ijpds-3543	43	5	,	,	PUNCT
ijpds-3543	43	6	the	the	DET
ijpds-3543	43	7	effect	effect	NOUN
ijpds-3543	43	8	of	of	ADP
ijpds-3543	43	9	ib	ib	PROPN
ijpds-3543	43	10	meca	meca	PROPN
ijpds-3543	43	11	on	on	ADP
ijpds-3543	43	12	cytokine	cytokine	NOUN
ijpds-3543	43	13	and	and	CCONJ
ijpds-3543	43	14	no	no	DET
ijpds-3543	43	15	production	production	NOUN
ijpds-3543	43	16	.	.	PUNCT
ijpds-3543	44	1	in	in	ADP
ijpds-3543	44	2	the	the	DET
ijpds-3543	44	3	instance	instance	NOUN
ijpds-3543	44	4	of	of	ADP
ijpds-3543	44	5	the	the	DET
ijpds-3543	44	6	a3	a3	NOUN
ijpds-3543	44	7	agonist	agonist	NOUN
ijpds-3543	44	8	ib	ib	PROPN
ijpds-3543	44	9	-	-	PUNCT
ijpds-3543	44	10	meca	meca	PROPN
ijpds-3543	44	11	,	,	PUNCT
ijpds-3543	44	12	we	we	PRON
ijpds-3543	44	13	wanted	want	VERB
ijpds-3543	44	14	to	to	PART
ijpds-3543	44	15	see	see	VERB
ijpds-3543	44	16	if	if	SCONJ
ijpds-3543	44	17	it	it	PRON
ijpds-3543	44	18	affected	affect	VERB
ijpds-3543	44	19	the	the	DET
ijpds-3543	44	20	production	production	NOUN
ijpds-3543	44	21	of	of	ADP
ijpds-3543	44	22	il12	il12	PROPN
ijpds-3543	44	23	,	,	PUNCT
ijpds-3543	44	24	il-	il-	X
ijpds-3543	44	25	,	,	PUNCT
ijpds-3543	44	26	and	and	CCONJ
ijpds-3543	44	27	no	no	ADV
ijpds-3543	44	28	in	in	ADP
ijpds-3543	44	29	raw	raw	ADJ
ijpds-3543	44	30	24.7	24.7	NUM
ijpds-3543	44	31	macrophages	macrophage	NOUN
ijpds-3543	44	32	as	as	ADV
ijpds-3543	44	33	well	well	ADV
ijpds-3543	44	34	.	.	PUNCT
ijpds-3543	45	1	the	the	DET
ijpds-3543	45	2	cells	cell	NOUN
ijpds-3543	45	3	were	be	AUX
ijpds-3543	45	4	pretreated	pretreate	VERB
ijpds-3543	45	5	with	with	ADP
ijpds-3543	45	6	1	1	NUM
ijpds-3543	45	7	300	300	NUM
ijpds-3543	45	8	mib	mib	PROPN
ijpds-3543	45	9	-	-	PUNCT
ijpds-3543	45	10	meca	meca	PROPN
ijpds-3543	45	11	in	in	ADP
ijpds-3543	45	12	these	these	DET
ijpds-3543	45	13	tests	test	NOUN
ijpds-3543	45	14	.	.	PUNCT
ijpds-3543	46	1	after	after	ADP
ijpds-3543	46	2	30	30	NUM
ijpds-3543	46	3	minutes	minute	NOUN
ijpds-3543	46	4	,	,	PUNCT
ijpds-3543	46	5	cells	cell	NOUN
ijpds-3543	46	6	were	be	AUX
ijpds-3543	46	7	stimulated	stimulate	VERB
ijpds-3543	46	8	with	with	ADP
ijpds-3543	46	9	either	either	CCONJ
ijpds-3543	46	10	lps	lps	PROPN
ijpds-3543	46	11	(	(	PUNCT
ijpds-3543	46	12	10	10	NUM
ijpds-3543	46	13	g	g	PROPN
ijpds-3543	46	14	ml—1	ml—1	NOUN
ijpds-3543	46	15	)	)	PUNCT
ijpds-3543	46	16	or	or	CCONJ
ijpds-3543	46	17	murine	murine	ADJ
ijpds-3543	46	18	ifn(200	ifn(200	PROPN
ijpds-3543	46	19	u	u	PROPN
ijpds-3543	46	20	ml—1	ml—1	NOUN
ijpds-3543	46	21	;	;	PUNCT
ijpds-3543	46	22	genzyme	genzyme	PROPN
ijpds-3543	46	23	,	,	PUNCT
ijpds-3543	46	24	boston	boston	PROPN
ijpds-3543	46	25	,	,	PUNCT
ijpds-3543	46	26	ma	ma	PROPN
ijpds-3543	46	27	,	,	PUNCT
ijpds-3543	46	28	usa	usa	PROPN
ijpds-3543	46	29	)	)	PUNCT
ijpds-3543	46	30	.	.	PUNCT
ijpds-3543	47	1	this	this	DET
ijpds-3543	47	2	lps	lps	PROPN
ijpds-3543	47	3	concentration	concentration	NOUN
ijpds-3543	47	4	is	be	AUX
ijpds-3543	47	5	higher	high	ADJ
ijpds-3543	47	6	than	than	ADP
ijpds-3543	47	7	that	that	PRON
ijpds-3543	47	8	employed	employ	VERB
ijpds-3543	47	9	in	in	ADP
ijpds-3543	47	10	investigations	investigation	NOUN
ijpds-3543	47	11	on	on	ADP
ijpds-3543	47	12	the	the	DET
ijpds-3543	47	13	effects	effect	NOUN
ijpds-3543	47	14	of	of	ADP
ijpds-3543	47	15	adenosine	adenosine	ADJ
ijpds-3543	47	16	receptor	receptor	NOUN
ijpds-3543	47	17	agonists	agonist	NOUN
ijpds-3543	47	18	on	on	ADP
ijpds-3543	47	19	mip-1α	mip-1α	NOUN
ijpds-3543	47	20	generation	generation	NOUN
ijpds-3543	47	21	.	.	PUNCT
ijpds-3543	48	1	our	our	PRON
ijpds-3543	48	2	early	early	ADJ
ijpds-3543	48	3	research	research	NOUN
ijpds-3543	48	4	has	have	AUX
ijpds-3543	48	5	shown	show	VERB
ijpds-3543	48	6	that	that	SCONJ
ijpds-3543	48	7	greater	great	ADJ
ijpds-3543	48	8	lps	lps	PROPN
ijpds-3543	48	9	concentrations	concentration	NOUN
ijpds-3543	48	10	are	be	AUX
ijpds-3543	48	11	required	require	VERB
ijpds-3543	48	12	to	to	PART
ijpds-3543	48	13	reach	reach	VERB
ijpds-3543	48	14	optimal	optimal	ADJ
ijpds-3543	48	15	no	no	DET
ijpds-3543	48	16	generation	generation	NOUN
ijpds-3543	48	17	levels	level	NOUN
ijpds-3543	48	18	.	.	PUNCT
ijpds-3543	49	1	only	only	ADV
ijpds-3543	49	2	the	the	DET
ijpds-3543	49	3	combination	combination	NOUN
ijpds-3543	49	4	of	of	ADP
ijpds-3543	49	5	a	a	DET
ijpds-3543	49	6	greater	great	ADJ
ijpds-3543	49	7	dose	dose	NOUN
ijpds-3543	49	8	of	of	ADP
ijpds-3543	49	9	lps	lps	PROPN
ijpds-3543	49	10	and	and	CCONJ
ijpds-3543	49	11	ifnresulted	ifnresulte	VERB
ijpds-3543	49	12	in	in	ADP
ijpds-3543	49	13	detectable	detectable	ADJ
ijpds-3543	49	14	il-12	il-12	DET
ijpds-3543	49	15	production	production	NOUN
ijpds-3543	49	16	in	in	ADP
ijpds-3543	49	17	this	this	DET
ijpds-3543	49	18	cell	cell	NOUN
ijpds-3543	49	19	type	type	NOUN
ijpds-3543	49	20	.	.	PUNCT
ijpds-3543	50	1	after	after	ADP
ijpds-3543	50	2	a	a	DET
ijpds-3543	50	3	24	24	NUM
ijpds-3543	50	4	-	-	PUNCT
ijpds-3543	50	5	hour	hour	NOUN
ijpds-3543	50	6	incubation	incubation	NOUN
ijpds-3543	50	7	period	period	NOUN
ijpds-3543	50	8	at	at	ADP
ijpds-3543	50	9	37	37	NUM
ijpds-3543	50	10	°	°	NOUN
ijpds-3543	50	11	c	c	NOUN
ijpds-3543	50	12	,	,	PUNCT
ijpds-3543	50	13	the	the	DET
ijpds-3543	50	14	culture	culture	NOUN
ijpds-3543	50	15	supernatant	supernatant	NOUN
ijpds-3543	50	16	fluids	fluid	NOUN
ijpds-3543	50	17	were	be	AUX
ijpds-3543	50	18	collected	collect	VERB
ijpds-3543	50	19	and	and	CCONJ
ijpds-3543	50	20	kept	keep	VERB
ijpds-3543	50	21	at	at	ADP
ijpds-3543	50	22	—	—	PUNCT
ijpds-3543	50	23	70	70	NUM
ijpds-3543	50	24	°	°	NOUN
ijpds-3543	50	25	c	c	NOUN
ijpds-3543	50	26	.	.	PUNCT
ijpds-3543	51	1	elisa	elisa	PROPN
ijpds-3543	51	2	kits	kit	NOUN
ijpds-3543	51	3	specifically	specifically	ADV
ijpds-3543	51	4	for	for	ADP
ijpds-3543	51	5	murine	murine	ADJ
ijpds-3543	51	6	cytokines	cytokine	NOUN
ijpds-3543	51	7	was	be	AUX
ijpds-3543	51	8	used	use	VERB
ijpds-3543	51	9	to	to	PART
ijpds-3543	51	10	determine	determine	VERB
ijpds-3543	51	11	cytokines	cytokine	NOUN
ijpds-3543	51	12	.	.	PUNCT
ijpds-3543	52	1	elisa	elisa	PROPN
ijpds-3543	52	2	kits	kit	NOUN
ijpds-3543	52	3	from	from	ADP
ijpds-3543	52	4	genzyme	genzyme	PROPN
ijpds-3543	52	5	were	be	AUX
ijpds-3543	52	6	used	use	VERB
ijpds-3543	52	7	to	to	PART
ijpds-3543	52	8	quantify	quantify	VERB
ijpds-3543	52	9	il-12	il-12	PRON
ijpds-3543	52	10	(	(	PUNCT
ijpds-3543	52	11	p40	p40	NOUN
ijpds-3543	52	12	and	and	CCONJ
ijpds-3543	52	13	p70	p70	NOUN
ijpds-3543	52	14	)	)	PUNCT
ijpds-3543	52	15	and	and	CCONJ
ijpds-3543	52	16	ila	ila	PROPN
ijpds-3543	52	17	spectramax	spectramax	PROPN
ijpds-3543	52	18	250	250	NUM
ijpds-3543	52	19	microplate	microplate	PROPN
ijpds-3543	52	20	reader	reader	NOUN
ijpds-3543	52	21	was	be	AUX
ijpds-3543	52	22	used	use	VERB
ijpds-3543	52	23	to	to	PART
ijpds-3543	52	24	read	read	VERB
ijpds-3543	52	25	the	the	DET
ijpds-3543	52	26	plates	plate	NOUN
ijpds-3543	52	27	at	at	ADP
ijpds-3543	52	28	450	450	NUM
ijpds-3543	52	29	nm	nm	NOUN
ijpds-3543	52	30	.	.	PUNCT
ijpds-3543	53	1	il12	il12	PROPN
ijpds-3543	53	2	(	(	PUNCT
ijpds-3543	53	3	p40	p40	NOUN
ijpds-3543	53	4	)	)	PUNCT
ijpds-3543	53	5	had	have	VERB
ijpds-3543	53	6	detection	detection	NOUN
ijpds-3543	53	7	limits	limit	NOUN
ijpds-3543	53	8	of	of	ADP
ijpds-3543	53	9	10	10	NUM
ijpds-3543	53	10	pg	pg	NOUN
ijpds-3543	53	11	ml—1	ml—1	NOUN
ijpds-3543	53	12	,	,	PUNCT
ijpds-3543	53	13	il-12	il-12	NOUN
ijpds-3543	53	14	(	(	PUNCT
ijpds-3543	53	15	p70	p70	PROPN
ijpds-3543	53	16	)	)	PUNCT
ijpds-3543	53	17	had	have	VERB
ijpds-3543	53	18	detection	detection	NOUN
ijpds-3543	53	19	limits	limit	NOUN
ijpds-3543	53	20	of	of	ADP
ijpds-3543	53	21	5	5	NUM
ijpds-3543	53	22	pg	pg	NOUN
ijpds-3543	53	23	ml—1	ml—1	NOUN
ijpds-3543	53	24	,	,	PUNCT
ijpds-3543	53	25	and	and	CCONJ
ijpds-3543	53	26	ilhad	ilhad	VERB
ijpds-3543	53	27	detection	detection	NOUN
ijpds-3543	53	28	limits	limit	NOUN
ijpds-3543	53	29	of	of	ADP
ijpds-3543	53	30	5	5	NUM
ijpds-3543	53	31	pg	pg	NOUN
ijpds-3543	53	32	ml—1	ml—1	NOUN
ijpds-3543	53	33	.	.	PUNCT
ijpds-3543	54	1	assays	assay	NOUN
ijpds-3543	54	2	were	be	AUX
ijpds-3543	54	3	carried	carry	VERB
ijpds-3543	54	4	out	out	ADP
ijpds-3543	54	5	as	as	ADV
ijpds-3543	54	6	previously	previously	ADV
ijpds-3543	54	7	described	describe	VERB
ijpds-3543	54	8	.	.	PUNCT
ijpds-3543	55	1	and	and	CCONJ
ijpds-3543	55	2	mg	mg	PROPN
ijpds-3543	55	3	/	/	SYM
ijpds-3543	55	4	ml	ml	VERB
ijpds-3543	55	5	by	by	ADP
ijpds-3543	55	6	stirring	stir	VERB
ijpds-3543	55	7	at	at	ADP
ijpds-3543	55	8	4	4	NUM
ijpds-3543	55	9	°	°	NOUN
ijpds-3543	55	10	c	c	NOUN
ijpds-3543	55	11	overnight	overnight	ADV
ijpds-3543	55	12	.	.	PUNCT
ijpds-3543	56	1	cii	cii	PROPN
ijpds-3543	56	2	was	be	AUX
ijpds-3543	56	3	dissolved	dissolve	VERB
ijpds-3543	56	4	and	and	CCONJ
ijpds-3543	56	5	stored	store	VERB
ijpds-3543	56	6	at	at	ADP
ijpds-3543	56	7	—	—	PUNCT
ijpds-3543	56	8	70	70	NUM
ijpds-3543	56	9	°	°	NOUN
ijpds-3543	56	10	c	c	NOUN
ijpds-3543	56	11	until	until	SCONJ
ijpds-3543	56	12	needed	need	VERB
ijpds-3543	56	13	.	.	PUNCT
ijpds-3543	57	1	the	the	DET
ijpds-3543	57	2	addition	addition	NOUN
ijpds-3543	57	3	of	of	ADP
ijpds-3543	57	4	mycobacteuium	mycobacteuium	NOUN
ijpds-3543	57	5	tuberculosis	tuberculosis	NOUN
ijpds-3543	57	6	h37ra	h37ra	PROPN
ijpds-3543	57	7	at	at	ADP
ijpds-3543	57	8	a	a	DET
ijpds-3543	57	9	dose	dose	NOUN
ijpds-3543	57	10	of	of	ADP
ijpds-3543	57	11	2	2	NUM
ijpds-3543	57	12	mg	mg	PROPN
ijpds-3543	57	13	ml—1	ml—1	NOUN
ijpds-3543	57	14	yielded	yield	VERB
ijpds-3543	57	15	complete	complete	ADJ
ijpds-3543	57	16	freund	freund	NOUN
ijpds-3543	57	17	's	's	PART
ijpds-3543	57	18	adjuvant	adjuvant	NOUN
ijpds-3543	57	19	(	(	PUNCT
ijpds-3543	57	20	cfa	cfa	PROPN
ijpds-3543	57	21	)	)	PUNCT
ijpds-3543	57	22	.	.	PUNCT
ijpds-3543	58	1	cii	cii	PROPN
ijpds-3543	58	2	was	be	AUX
ijpds-3543	58	3	emulsified	emulsify	VERB
ijpds-3543	58	4	with	with	ADP
ijpds-3543	58	5	an	an	DET
ijpds-3543	58	6	equal	equal	ADJ
ijpds-3543	58	7	volume	volume	NOUN
ijpds-3543	58	8	of	of	ADP
ijpds-3543	58	9	cfa	cfa	PROPN
ijpds-3543	58	10	before	before	ADP
ijpds-3543	58	11	injection	injection	NOUN
ijpds-3543	58	12	.	.	PUNCT
ijpds-3543	59	1	as	as	SCONJ
ijpds-3543	59	2	previously	previously	ADV
ijpds-3543	59	3	described	describe	VERB
ijpds-3543	59	4	(	(	PUNCT
ijpds-3543	59	5	szabo	szabo	PROPN
ijpds-3543	59	6	'	'	PUNCT
ijpds-3543	59	7	et	et	PROPN
ijpds-3543	59	8	al	al	PROPN
ijpds-3543	59	9	.	.	PROPN
ijpds-3543	59	10	,	,	PUNCT
ijpds-3543	59	11	1998	1998	NUM
ijpds-3543	59	12	)	)	PUNCT
ijpds-3543	59	13	,	,	PUNCT
ijpds-3543	59	14	collageninduced	collageninduce	VERB
ijpds-3543	59	15	arthritis	arthritis	NOUN
ijpds-3543	59	16	was	be	AUX
ijpds-3543	59	17	developed	develop	VERB
ijpds-3543	59	18	.	.	PUNCT
ijpds-3543	60	1	on	on	ADP
ijpds-3543	60	2	day	day	NOUN
ijpds-3543	60	3	1	1	NUM
ijpds-3543	60	4	,	,	PUNCT
ijpds-3543	60	5	mice	mouse	NOUN
ijpds-3543	60	6	were	be	AUX
ijpds-3543	60	7	given	give	VERB
ijpds-3543	60	8	100	100	NUM
ijpds-3543	60	9	l	l	NOUN
ijpds-3543	60	10	of	of	ADP
ijpds-3543	60	11	the	the	DET
ijpds-3543	60	12	emulsion	emulsion	NOUN
ijpds-3543	60	13	(	(	PUNCT
ijpds-3543	60	14	containing	contain	VERB
ijpds-3543	60	15	100	100	NUM
ijpds-3543	60	16	g	g	PROPN
ijpds-3543	60	17	cii	cii	PROPN
ijpds-3543	60	18	)	)	PUNCT
ijpds-3543	60	19	intradermally	intradermally	ADV
ijpds-3543	60	20	at	at	ADP
ijpds-3543	60	21	the	the	DET
ijpds-3543	60	22	base	base	NOUN
ijpds-3543	60	23	of	of	ADP
ijpds-3543	60	24	the	the	DET
ijpds-3543	60	25	tail	tail	NOUN
ijpds-3543	60	26	.	.	PUNCT
ijpds-3543	61	1	a	a	DET
ijpds-3543	61	2	second	second	ADJ
ijpds-3543	61	3	injection	injection	NOUN
ijpds-3543	61	4	of	of	ADP
ijpds-3543	61	5	cii	cii	PROPN
ijpds-3543	61	6	in	in	ADP
ijpds-3543	61	7	cfa	cfa	PROPN
ijpds-3543	61	8	was	be	AUX
ijpds-3543	61	9	given	give	VERB
ijpds-3543	61	10	on	on	ADP
ijpds-3543	61	11	day	day	NOUN
ijpds-3543	61	12	21	21	NUM
ijpds-3543	61	13	.	.	PUNCT
ijpds-3543	62	1	animals	animal	NOUN
ijpds-3543	62	2	were	be	AUX
ijpds-3543	62	3	given	give	VERB
ijpds-3543	62	4	ib	ib	PROPN
ijpds-3543	62	5	-	-	PUNCT
ijpds-3543	62	6	meca	meca	NOUN
ijpds-3543	62	7	at	at	ADP
ijpds-3543	62	8	a	a	DET
ijpds-3543	62	9	dose	dose	NOUN
ijpds-3543	62	10	of	of	ADP
ijpds-3543	62	11	0.5	0.5	NUM
ijpds-3543	62	12	mg	mg	PROPN
ijpds-3543	62	13	kg—1	kg—1	NOUN
ijpds-3543	62	14	to	to	PART
ijpds-3543	62	15	stimulate	stimulate	VERB
ijpds-3543	62	16	a3	a3	NOUN
ijpds-3543	62	17	adenosine	adenosine	NOUN
ijpds-3543	62	18	receptors	receptor	NOUN
ijpds-3543	62	19	.	.	PUNCT
ijpds-3543	63	1	this	this	DET
ijpds-3543	63	2	dose	dose	NOUN
ijpds-3543	63	3	was	be	AUX
ijpds-3543	63	4	chosen	choose	VERB
ijpds-3543	63	5	based	base	VERB
ijpds-3543	63	6	on	on	ADP
ijpds-3543	63	7	prior	prior	ADV
ijpds-3543	63	8	in	in	ADP
ijpds-3543	63	9	vivo	vivo	ADJ
ijpds-3543	63	10	investigations	investigation	NOUN
ijpds-3543	63	11	auchampach	auchampach	VERB
ijpds-3543	63	12	et	et	PROPN
ijpds-3543	63	13	al	al	PROPN
ijpds-3543	63	14	.	.	PROPN
ijpds-3543	63	15	,	,	PUNCT
ijpds-3543	63	16	1997	1997	NUM
ijpds-3543	63	17	;	;	PUNCT
ijpds-3543	63	18	tracey	tracey	PROPN
ijpds-3543	63	19	et	et	PROPN
ijpds-3543	63	20	al	al	PROPN
ijpds-3543	63	21	.	.	PROPN
ijpds-3543	63	22	,	,	PUNCT
ijpds-3543	63	23	1994	1994	NUM
ijpds-3543	63	24	;	;	PUNCT
ijpds-3543	63	25	tracey	tracey	PROPN
ijpds-3543	63	26	et	et	PROPN
ijpds-3543	63	27	al	al	PROPN
ijpds-3543	63	28	.	.	PROPN
ijpds-3543	63	29	,	,	PUNCT
ijpds-3543	63	30	1997	1997	NUM
ijpds-3543	63	31	)	)	PUNCT
ijpds-3543	63	32	.	.	PUNCT
ijpds-3543	64	1	starting	start	VERB
ijpds-3543	64	2	on	on	ADP
ijpds-3543	64	3	day	day	NOUN
ijpds-3543	64	4	18	18	NUM
ijpds-3543	64	5	,	,	PUNCT
ijpds-3543	64	6	animals	animal	NOUN
ijpds-3543	64	7	were	be	AUX
ijpds-3543	64	8	given	give	VERB
ijpds-3543	64	9	either	either	CCONJ
ijpds-3543	64	10	vehicle	vehicle	NOUN
ijpds-3543	64	11	(	(	PUNCT
ijpds-3543	64	12	n=18	n=18	NOUN
ijpds-3543	64	13	)	)	PUNCT
ijpds-3543	64	14	or	or	CCONJ
ijpds-3543	64	15	ib	ib	PROPN
ijpds-3543	64	16	meca	meca	PROPN
ijpds-3543	64	17	(	(	PUNCT
ijpds-3543	64	18	n=18	n=18	ADJ
ijpds-3543	64	19	;	;	PUNCT
ijpds-3543	64	20	0.5	0.5	NUM
ijpds-3543	64	21	mg	mg	PROPN
ijpds-3543	64	22	kg—1	kg—1	PROPN
ijpds-3543	64	23	,	,	PUNCT
ijpds-3543	64	24	i.p	i.p	PROPN
ijpds-3543	64	25	.	.	PROPN
ijpds-3543	64	26	)	)	PUNCT
ijpds-3543	65	1	every	every	DET
ijpds-3543	65	2	24	24	NUM
ijpds-3543	65	3	hours	hour	NOUN
ijpds-3543	65	4	.	.	PUNCT
ijpds-3543	66	1	the	the	DET
ijpds-3543	66	2	mice	mouse	NOUN
ijpds-3543	66	3	were	be	AUX
ijpds-3543	66	4	checked	check	VERB
ijpds-3543	66	5	for	for	ADP
ijpds-3543	66	6	arthritis	arthritis	NOUN
ijpds-3543	66	7	on	on	ADP
ijpds-3543	66	8	a	a	DET
ijpds-3543	66	9	daily	daily	ADJ
ijpds-3543	66	10	basis	basis	NOUN
ijpds-3543	66	11	.	.	PUNCT
ijpds-3543	67	1	employing	employ	VERB
ijpds-3543	67	2	a	a	DET
ijpds-3543	67	3	macroscopic	macroscopic	ADJ
ijpds-3543	67	4	scoring	scoring	NOUN
ijpds-3543	67	5	system	system	NOUN
ijpds-3543	67	6	that	that	PRON
ijpds-3543	67	7	ranges	range	VERB
ijpds-3543	67	8	from	from	ADP
ijpds-3543	67	9	0	0	NUM
ijpds-3543	67	10	to	to	ADP
ijpds-3543	67	11	4	4	NUM
ijpds-3543	67	12	(	(	PUNCT
ijpds-3543	67	13	0	0	NUM
ijpds-3543	67	14	=	=	NOUN
ijpds-3543	67	15	no	no	DET
ijpds-3543	67	16	indications	indication	NOUN
ijpds-3543	67	17	of	of	ADP
ijpds-3543	67	18	arthritis	arthritis	NOUN
ijpds-3543	67	19	,	,	PUNCT
ijpds-3543	67	20	1	1	NUM
ijpds-3543	67	21	=	=	NOUN
ijpds-3543	67	22	swelling	swell	VERB
ijpds-3543	67	23	and/or	and/or	CCONJ
ijpds-3543	67	24	redness	redness	NOUN
ijpds-3543	67	25	of	of	ADP
ijpds-3543	67	26	the	the	DET
ijpds-3543	67	27	paw	paw	NOUN
ijpds-3543	67	28	or	or	CCONJ
ijpds-3543	67	29	one	one	NUM
ijpds-3543	67	30	digit	digit	NOUN
ijpds-3543	67	31	,	,	PUNCT
ijpds-3543	67	32	2	2	NUM
ijpds-3543	67	33	=	=	SYM
ijpds-3543	67	34	two	two	NUM
ijpds-3543	67	35	joints	joint	NOUN
ijpds-3543	67	36	involved	involve	VERB
ijpds-3543	67	37	,	,	PUNCT
ijpds-3543	67	38	3	3	NUM
ijpds-3543	67	39	=	=	NUM
ijpds-3543	67	40	more	more	ADJ
ijpds-3543	67	41	than	than	ADP
ijpds-3543	67	42	two	two	NUM
ijpds-3543	67	43	joints	joint	NOUN
ijpds-3543	67	44	involved	involve	VERB
ijpds-3543	67	45	,	,	PUNCT
ijpds-3543	67	46	and	and	CCONJ
ijpds-3543	67	47	4	4	NUM
ijpds-3543	67	48	=	=	NOUN
ijpds-3543	67	49	severe	severe	ADJ
ijpds-3543	67	50	arthritis	arthritis	NOUN
ijpds-3543	67	51	of	of	ADP
ijpds-3543	67	52	the	the	DET
ijpds-3543	67	53	entire	entire	ADJ
ijpds-3543	67	54	paw	paw	NOUN
ijpds-3543	67	55	and	and	CCONJ
ijpds-3543	67	56	digits	digit	NOUN
ijpds-3543	67	57	)	)	PUNCT
ijpds-3543	67	58	.	.	PUNCT
ijpds-3543	68	1	each	each	DET
ijpds-3543	68	2	mouse	mouse	NOUN
ijpds-3543	68	3	's	's	PART
ijpds-3543	68	4	arthritic	arthritic	ADJ
ijpds-3543	68	5	index	index	NOUN
ijpds-3543	68	6	was	be	AUX
ijpds-3543	68	7	computed	compute	VERB
ijpds-3543	68	8	by	by	ADP
ijpds-3543	68	9	adding	add	VERB
ijpds-3543	68	10	the	the	DET
ijpds-3543	68	11	four	four	NUM
ijpds-3543	68	12	unique	unique	ADJ
ijpds-3543	68	13	paw	paw	NOUN
ijpds-3543	68	14	scores	score	NOUN
ijpds-3543	68	15	.	.	PUNCT
ijpds-3543	69	1	no	no	DET
ijpds-3543	69	2	animals	animal	NOUN
ijpds-3543	69	3	were	be	AUX
ijpds-3543	69	4	removed	remove	VERB
ijpds-3543	69	5	from	from	ADP
ijpds-3543	69	6	the	the	DET
ijpds-3543	69	7	calculations	calculation	NOUN
ijpds-3543	69	8	,	,	PUNCT
ijpds-3543	69	9	and	and	CCONJ
ijpds-3543	69	10	severity	severity	NOUN
ijpds-3543	69	11	indices	index	NOUN
ijpds-3543	69	12	were	be	AUX
ijpds-3543	69	13	determined	determine	VERB
ijpds-3543	69	14	for	for	ADP
ijpds-3543	69	15	entire	entire	ADJ
ijpds-3543	69	16	groups	group	NOUN
ijpds-3543	69	17	of	of	ADP
ijpds-3543	69	18	mice	mouse	NOUN
ijpds-3543	69	19	(	(	PUNCT
ijpds-3543	69	20	vehicle	vehicle	NOUN
ijpds-3543	69	21	-	-	PUNCT
ijpds-3543	69	22	treated	treat	VERB
ijpds-3543	69	23	or	or	CCONJ
ijpds-3543	69	24	ibmeca	ibmeca	ADV
ijpds-3543	69	25	-	-	PUNCT
ijpds-3543	69	26	treated	treat	VERB
ijpds-3543	69	27	)	)	PUNCT
ijpds-3543	69	28	.	.	PUNCT
ijpds-3543	70	1	nitrotyrosine	nitrotyrosine	PROPN
ijpds-3543	70	2	immunohistochemistry	immunohistochemistry	PROPN
ijpds-3543	70	3	and	and	CCONJ
ijpds-3543	70	4	histology	histology	NOUN
ijpds-3543	70	5	:	:	PUNCT
ijpds-3543	70	6	animals	animal	NOUN
ijpds-3543	70	7	were	be	AUX
ijpds-3543	70	8	sacrificed	sacrifice	VERB
ijpds-3543	70	9	under	under	ADP
ijpds-3543	70	10	anesthesia	anesthesia	NOUN
ijpds-3543	70	11	at	at	ADP
ijpds-3543	70	12	the	the	DET
ijpds-3543	70	13	end	end	NOUN
ijpds-3543	70	14	of	of	ADP
ijpds-3543	70	15	the	the	DET
ijpds-3543	70	16	experiments	experiment	NOUN
ijpds-3543	70	17	(	(	PUNCT
ijpds-3543	70	18	day	day	NOUN
ijpds-3543	70	19	35	35	NUM
ijpds-3543	70	20	)	)	PUNCT
ijpds-3543	70	21	,	,	PUNCT
ijpds-3543	70	22	and	and	CCONJ
ijpds-3543	70	23	their	their	PRON
ijpds-3543	70	24	paws	paw	NOUN
ijpds-3543	70	25	and	and	CCONJ
ijpds-3543	70	26	knees	knee	NOUN
ijpds-3543	70	27	were	be	AUX
ijpds-3543	70	28	taken	take	VERB
ijpds-3543	70	29	and	and	CCONJ
ijpds-3543	70	30	preserved	preserve	VERB
ijpds-3543	70	31	for	for	ADP
ijpds-3543	70	32	histological	histological	ADJ
ijpds-3543	70	33	analysis	analysis	NOUN
ijpds-3543	70	34	by	by	ADP
ijpds-3543	70	35	an	an	DET
ijpds-3543	70	36	investigator	investigator	NOUN
ijpds-3543	70	37	who	who	PRON
ijpds-3543	70	38	was	be	AUX
ijpds-3543	70	39	blinded	blind	VERB
ijpds-3543	70	40	to	to	ADP
ijpds-3543	70	41	the	the	DET
ijpds-3543	70	42	treatment	treatment	NOUN
ijpds-3543	70	43	regimen	regiman	NOUN
ijpds-3543	70	44	.	.	PUNCT
ijpds-3543	71	1	joints	joint	NOUN
ijpds-3543	71	2	were	be	AUX
ijpds-3543	71	3	embedded	embed	VERB
ijpds-3543	71	4	for	for	ADP
ijpds-3543	71	5	nitrotyrosine	nitrotyrosine	NOUN
ijpds-3543	71	6	immunohistochemistry	immunohistochemistry	PROPN
ijpds-3543	71	7	.	.	PUNCT
ijpds-3543	72	1	snap	snap	PROPN
ijpds-3543	72	2	frozen	freeze	VERB
ijpds-3543	72	3	in	in	ADP
ijpds-3543	72	4	liquid	liquid	ADJ
ijpds-3543	72	5	nitrogen	nitrogen	NOUN
ijpds-3543	72	6	in	in	ADP
ijpds-3543	72	7	m1	m1	PROPN
ijpds-3543	72	8	medium	medium	NOUN
ijpds-3543	72	9	.	.	PUNCT
ijpds-3543	73	1	a	a	DET
ijpds-3543	73	2	microtome	microtome	NOUN
ijpds-3543	73	3	equipped	equip	VERB
ijpds-3543	73	4	with	with	ADP
ijpds-3543	73	5	a	a	DET
ijpds-3543	73	6	carbide	carbide	NOUN
ijpds-3543	73	7	steel	steel	NOUN
ijpds-3543	73	8	knife	knife	NOUN
ijpds-3543	73	9	was	be	AUX
ijpds-3543	73	10	used	use	VERB
ijpds-3543	73	11	to	to	PART
ijpds-3543	73	12	cut	cut	VERB
ijpds-3543	73	13	cryostat	cryostat	ADJ
ijpds-3543	73	14	pieces	piece	NOUN
ijpds-3543	73	15	(	(	PUNCT
ijpds-3543	73	16	m	m	NOUN
ijpds-3543	73	17	)	)	PUNCT
ijpds-3543	73	18	.	.	PUNCT
ijpds-3543	74	1	by	by	ADP
ijpds-3543	74	2	immunohistochemistry	immunohistochemistry	NOUN
ijpds-3543	74	3	,	,	PUNCT
ijpds-3543	74	4	joint	joint	ADJ
ijpds-3543	74	5	slices	slice	NOUN
ijpds-3543	74	6	were	be	AUX
ijpds-3543	74	7	examined	examine	VERB
ijpds-3543	74	8	for	for	ADP
ijpds-3543	74	9	the	the	DET
ijpds-3543	74	10	presence	presence	NOUN
ijpds-3543	74	11	of	of	ADP
ijpds-3543	74	12	nitrotyrosine	nitrotyrosine	PROPN
ijpds-3543	74	13	,	,	PUNCT
ijpds-3543	74	14	a	a	DET
ijpds-3543	74	15	peroxynitrite	peroxynitrite	ADJ
ijpds-3543	74	16	indicator	indicator	NOUN
ijpds-3543	74	17	for	for	ADP
ijpds-3543	74	18	15	15	NUM
ijpds-3543	74	19	minutes	minute	NOUN
ijpds-3543	74	20	,	,	PUNCT
ijpds-3543	74	21	endogenous	endogenous	ADJ
ijpds-3543	74	22	peroxidase	peroxidase	NOUN
ijpds-3543	74	23	was	be	AUX
ijpds-3543	74	24	quenched	quench	VERB
ijpds-3543	74	25	with	with	ADP
ijpds-3543	74	26	0.3	0.3	NUM
ijpds-3543	74	27	sonwani	sonwani	NOUN
ijpds-3543	74	28	et	et	PROPN
ijpds-3543	74	29	al	al	PROPN
ijpds-3543	74	30	.	.	PROPN
ijpds-3543	75	1	role	role	NOUN
ijpds-3543	75	2	of	of	ADP
ijpds-3543	75	3	adenosine	adenosine	ADJ
ijpds-3543	75	4	receptor	receptor	NOUN
ijpds-3543	75	5	agonists	agonist	NOUN
ijpds-3543	75	6	in	in	ADP
ijpds-3543	75	7	inflammatory	inflammatory	ADJ
ijpds-3543	75	8	conditions	condition	NOUN
ijpds-3543	75	9	vol	vol	NOUN
ijpds-3543	75	10	2	2	NUM
ijpds-3543	75	11	|	|	NOUN
ijpds-3543	75	12	issue	issue	NOUN
ijpds-3543	75	13	2	2	NUM
ijpds-3543	75	14	|	|	ADV
ijpds-3543	75	15	apr	apr	ADV
ijpds-3543	75	16	–	–	PUNCT
ijpds-3543	75	17	jun	jun	PROPN
ijpds-3543	75	18	2023	2023	NUM
ijpds-3543	75	19	indian	indian	PROPN
ijpds-3543	75	20	j	j	PROPN
ijpds-3543	75	21	pharm	pharm	PROPN
ijpds-3543	75	22	drug	drug	PROPN
ijpds-3543	75	23	studies	study	NOUN
ijpds-3543	75	24	|	|	ADV
ijpds-3543	75	25	71	71	NUM
ijpds-3543	75	26	percent	percent	NOUN
ijpds-3543	75	27	h2o2	h2o2	X
ijpds-3543	75	28	in	in	ADP
ijpds-3543	75	29	pbs	pbs	PROPN
ijpds-3543	75	30	.	.	PUNCT
ijpds-3543	76	1	by	by	ADP
ijpds-3543	76	2	incubating	incubate	VERB
ijpds-3543	76	3	the	the	DET
ijpds-3543	76	4	slice	slice	NOUN
ijpds-3543	76	5	in	in	ADP
ijpds-3543	76	6	2	2	NUM
ijpds-3543	76	7	percent	percent	NOUN
ijpds-3543	76	8	normal	normal	ADJ
ijpds-3543	76	9	goat	goat	PROPN
ijpds-3543	76	10	serum	serum	NOUN
ijpds-3543	76	11	in	in	ADP
ijpds-3543	76	12	phosphate	phosphate	NOUN
ijpds-3543	76	13	-	-	PUNCT
ijpds-3543	76	14	buffered	buffer	VERB
ijpds-3543	76	15	saline	saline	NOUN
ijpds-3543	76	16	for	for	ADP
ijpds-3543	76	17	0	0	NUM
ijpds-3543	76	18	minutes	minute	NOUN
ijpds-3543	76	19	,	,	PUNCT
ijpds-3543	76	20	non	non	ADJ
ijpds-3543	76	21	-	-	ADJ
ijpds-3543	76	22	specific	specific	ADJ
ijpds-3543	76	23	adsorption	adsorption	NOUN
ijpds-3543	76	24	was	be	AUX
ijpds-3543	76	25	reduced	reduce	VERB
ijpds-3543	76	26	.	.	PUNCT
ijpds-3543	77	1	after	after	ADP
ijpds-3543	77	2	that	that	PRON
ijpds-3543	77	3	,	,	PUNCT
ijpds-3543	77	4	the	the	DET
ijpds-3543	77	5	sections	section	NOUN
ijpds-3543	77	6	were	be	AUX
ijpds-3543	77	7	treated	treat	VERB
ijpds-3543	77	8	with	with	ADP
ijpds-3543	77	9	a	a	DET
ijpds-3543	77	10	1	1	NUM
ijpds-3543	77	11	:	:	SYM
ijpds-3543	77	12	500	500	NUM
ijpds-3543	77	13	dilution	dilution	NOUN
ijpds-3543	77	14	of	of	ADP
ijpds-3543	77	15	primary	primary	ADJ
ijpds-3543	77	16	antinitrotyrosine	antinitrotyrosine	NOUN
ijpds-3543	77	17	antibody	antibody	NOUN
ijpds-3543	77	18	overnight	overnight	ADV
ijpds-3543	77	19	biotin	biotin	NOUN
ijpds-3543	77	20	-	-	PUNCT
ijpds-3543	77	21	conjugated	conjugate	VERB
ijpds-3543	77	22	goat	goat	PROPN
ijpds-3543	77	23	antirabbit	antirabbit	PROPN
ijpds-3543	77	24	igg	igg	PROPN
ijpds-3543	77	25	,	,	PUNCT
ijpds-3543	77	26	and	and	CCONJ
ijpds-3543	77	27	an	an	DET
ijpds-3543	77	28	avidin	avidin	NOUN
ijpds-3543	77	29	-	-	PUNCT
ijpds-3543	77	30	biotin	biotin	NOUN
ijpds-3543	77	31	-	-	PUNCT
ijpds-3543	77	32	peroxidase	peroxidase	NOUN
ijpds-3543	77	33	complex	complex	NOUN
ijpds-3543	77	34	was	be	AUX
ijpds-3543	77	35	used	use	VERB
ijpds-3543	77	36	to	to	PART
ijpds-3543	77	37	identify	identify	VERB
ijpds-3543	77	38	specific	specific	ADJ
ijpds-3543	77	39	labeling	labeling	NOUN
ijpds-3543	77	40	.	.	PUNCT
ijpds-3543	78	1	anti	anti	ADJ
ijpds-3543	78	2	-	-	ADJ
ijpds-3543	78	3	nitrotyrosine	nitrotyrosine	ADJ
ijpds-3543	78	4	antibodies	antibody	NOUN
ijpds-3543	78	5	were	be	AUX
ijpds-3543	78	6	used	use	VERB
ijpds-3543	78	7	to	to	PART
ijpds-3543	78	8	incubate	incubate	VERB
ijpds-3543	78	9	sections	section	NOUN
ijpds-3543	78	10	in	in	ADP
ijpds-3543	78	11	control	control	NOUN
ijpds-3543	78	12	studies	study	NOUN
ijpds-3543	78	13	.	.	PUNCT
ijpds-3543	79	1	in	in	ADP
ijpds-3543	79	2	the	the	DET
ijpds-3543	79	3	presence	presence	NOUN
ijpds-3543	79	4	of	of	ADP
ijpds-3543	79	5	10	10	NUM
ijpds-3543	79	6	mm	mm	PROPN
ijpds-3543	79	7	nitrotyrosine	nitrotyrosine	NOUN
ijpds-3543	79	8	,	,	PUNCT
ijpds-3543	79	9	an	an	DET
ijpds-3543	79	10	antibody	antibody	NOUN
ijpds-3543	79	11	was	be	AUX
ijpds-3543	79	12	produced	produce	VERB
ijpds-3543	79	13	.	.	PUNCT
ijpds-3543	80	1	the	the	DET
ijpds-3543	80	2	nitrotyrosine	nitrotyrosine	NOUN
ijpds-3543	80	3	staining	stain	VERB
ijpds-3543	80	4	in	in	ADP
ijpds-3543	80	5	the	the	DET
ijpds-3543	80	6	figures	figure	NOUN
ijpds-3543	80	7	was	be	AUX
ijpds-3543	80	8	removed	remove	VERB
ijpds-3543	80	9	as	as	ADP
ijpds-3543	80	10	a	a	DET
ijpds-3543	80	11	result	result	NOUN
ijpds-3543	80	12	of	of	ADP
ijpds-3543	80	13	this	this	DET
ijpds-3543	80	14	intervention	intervention	NOUN
ijpds-3543	80	15	.	.	PUNCT
ijpds-3543	81	1	in	in	ADP
ijpds-3543	81	2	paw	paw	NOUN
ijpds-3543	81	3	extracts	extract	NOUN
ijpds-3543	81	4	,	,	PUNCT
ijpds-3543	81	5	cytokines	cytokine	NOUN
ijpds-3543	81	6	,	,	PUNCT
ijpds-3543	81	7	chemokines	chemokine	NOUN
ijpds-3543	81	8	,	,	PUNCT
ijpds-3543	81	9	and	and	CCONJ
ijpds-3543	81	10	nitrotyrosine	nitrotyrosine	NOUN
ijpds-3543	81	11	were	be	AUX
ijpds-3543	81	12	detected	detect	VERB
ijpds-3543	81	13	:	:	PUNCT
ijpds-3543	81	14	aqueous	aqueous	ADJ
ijpds-3543	81	15	joint	joint	ADJ
ijpds-3543	81	16	extracts	extract	NOUN
ijpds-3543	81	17	were	be	AUX
ijpds-3543	81	18	prepared	prepare	VERB
ijpds-3543	81	19	from	from	ADP
ijpds-3543	81	20	control	control	NOUN
ijpds-3543	81	21	animals	animal	NOUN
ijpds-3543	81	22	and	and	CCONJ
ijpds-3543	81	23	animals	animal	NOUN
ijpds-3543	81	24	with	with	ADP
ijpds-3543	81	25	35	35	NUM
ijpds-3543	81	26	days	day	NOUN
ijpds-3543	81	27	of	of	ADP
ijpds-3543	81	28	arthritis	arthritis	NOUN
ijpds-3543	81	29	as	as	SCONJ
ijpds-3543	81	30	described	describe	VERB
ijpds-3543	81	31	by	by	ADP
ijpds-3543	81	32	homogenization	homogenization	NOUN
ijpds-3543	81	33	in	in	ADP
ijpds-3543	81	34	a	a	DET
ijpds-3543	81	35	lysis	lysis	NOUN
ijpds-3543	81	36	buffer	buffer	NOUN
ijpds-3543	81	37	in	in	ADP
ijpds-3543	81	38	the	the	DET
ijpds-3543	81	39	presence	presence	NOUN
ijpds-3543	81	40	of	of	ADP
ijpds-3543	81	41	a	a	DET
ijpds-3543	81	42	mixture	mixture	NOUN
ijpds-3543	81	43	of	of	ADP
ijpds-3543	81	44	protease	protease	NOUN
ijpds-3543	81	45	inhibitors	inhibitor	NOUN
ijpds-3543	81	46	(	(	PUNCT
ijpds-3543	81	47	10	10	NUM
ijpds-3543	81	48	g	g	PROPN
ijpds-3543	81	49	ml—1	ml—1	NOUN
ijpds-3543	81	50	aprotinin	aprotinin	NOUN
ijpds-3543	81	51	,	,	PUNCT
ijpds-3543	81	52	20	20	NUM
ijpds-3543	81	53	g	g	PROPN
ijpds-3543	81	54	ml—1	ml—1	NOUN
ijpds-3543	81	55	leupeptin	leupeptin	NOUN
ijpds-3543	81	56	,	,	PUNCT
ijpds-3543	81	57	10	10	NUM
ijpds-3543	81	58	g	g	PROPN
ijpds-3543	81	59	ml—1	ml—1	NOUN
ijpds-3543	81	60	pepstatin	pepstatin	VERB
ijpds-3543	81	61	a	a	PRON
ijpds-3543	81	62	,	,	PUNCT
ijpds-3543	81	63	and	and	CCONJ
ijpds-3543	81	64	1	1	NUM
ijpds-3543	81	65	mm	mm	NOUN
ijpds-3543	81	66	pmsf	pmsf	NOUN
ijpds-3543	81	67	,	,	PUNCT
ijpds-3543	81	68	ph	ph	NOUN
ijpds-3543	81	69	7.25	7.25	NUM
ijpds-3543	81	70	)	)	PUNCT
ijpds-3543	81	71	elisa	elisa	NOUN
ijpds-3543	81	72	)	)	PUNCT
ijpds-3543	81	73	was	be	AUX
ijpds-3543	81	74	used	use	VERB
ijpds-3543	81	75	to	to	PART
ijpds-3543	81	76	determine	determine	VERB
ijpds-3543	81	77	the	the	DET
ijpds-3543	81	78	presence	presence	NOUN
ijpds-3543	81	79	of	of	ADP
ijpds-3543	81	80	il12	il12	PROPN
ijpds-3543	81	81	,	,	PUNCT
ijpds-3543	81	82	tnf	tnf	PROPN
ijpds-3543	81	83	-	-	PUNCT
ijpds-3543	81	84	α	α	PROPN
ijpds-3543	81	85	,	,	PUNCT
ijpds-3543	81	86	and	and	CCONJ
ijpds-3543	81	87	mip-1α	mip-1α	NOUN
ijpds-3543	81	88	in	in	ADP
ijpds-3543	81	89	the	the	DET
ijpds-3543	81	90	extracts	extract	NOUN
ijpds-3543	81	91	,	,	PUNCT
ijpds-3543	81	92	as	as	ADV
ijpds-3543	81	93	well	well	ADV
ijpds-3543	81	94	as	as	ADP
ijpds-3543	81	95	the	the	DET
ijpds-3543	81	96	presence	presence	NOUN
ijpds-3543	81	97	of	of	ADP
ijpds-3543	81	98	nitrated	nitrated	ADJ
ijpds-3543	81	99	proteins	protein	NOUN
ijpds-3543	81	100	using	use	VERB
ijpds-3543	81	101	western	western	ADJ
ijpds-3543	81	102	blotting	blotting	NOUN
ijpds-3543	81	103	each	each	DET
ijpds-3543	81	104	sample	sample	NOUN
ijpds-3543	81	105	weighed	weigh	VERB
ijpds-3543	81	106	thirty	thirty	NUM
ijpds-3543	81	107	gram	gram	NOUN
ijpds-3543	81	108	heated	heat	VERB
ijpds-3543	81	109	to	to	ADP
ijpds-3543	81	110	95	95	NUM
ijpds-3543	81	111	°	°	ADP
ijpds-3543	81	112	c	c	NOUN
ijpds-3543	81	113	for	for	ADP
ijpds-3543	81	114	3	3	NUM
ijpds-3543	81	115	minutes	minute	NOUN
ijpds-3543	81	116	after	after	ADP
ijpds-3543	81	117	being	be	AUX
ijpds-3543	81	118	diluted	dilute	VERB
ijpds-3543	81	119	in	in	ADP
ijpds-3543	81	120	an	an	DET
ijpds-3543	81	121	equal	equal	ADJ
ijpds-3543	81	122	volume	volume	NOUN
ijpds-3543	81	123	of	of	ADP
ijpds-3543	81	124	treatment	treatment	NOUN
ijpds-3543	81	125	buffer	buffer	NOUN
ijpds-3543	81	126	.	.	PUNCT
ijpds-3543	82	1	after	after	ADP
ijpds-3543	82	2	that	that	PRON
ijpds-3543	82	3	,	,	PUNCT
ijpds-3543	82	4	the	the	DET
ijpds-3543	82	5	samples	sample	NOUN
ijpds-3543	82	6	were	be	AUX
ijpds-3543	82	7	put	put	VERB
ijpds-3543	82	8	into	into	ADP
ijpds-3543	82	9	a	a	DET
ijpds-3543	82	10	1	1	NUM
ijpds-3543	82	11	%	%	NOUN
ijpds-3543	82	12	tris	tris	ADJ
ijpds-3543	82	13	-	-	PUNCT
ijpds-3543	82	14	glycine	glycine	NOUN
ijpds-3543	82	15	solution	solution	NOUN
ijpds-3543	82	16	.	.	PUNCT
ijpds-3543	83	1	gels	gel	NOUN
ijpds-3543	83	2	were	be	AUX
ijpds-3543	83	3	operated	operate	VERB
ijpds-3543	83	4	for	for	ADP
ijpds-3543	83	5	2	2	NUM
ijpds-3543	83	6	hours	hour	NOUN
ijpds-3543	83	7	at	at	ADP
ijpds-3543	83	8	120	120	NUM
ijpds-3543	83	9	volts	volt	NOUN
ijpds-3543	83	10	,	,	PUNCT
ijpds-3543	83	11	then	then	ADV
ijpds-3543	83	12	transferred	transfer	VERB
ijpds-3543	83	13	to	to	ADP
ijpds-3543	83	14	0.45	0.45	NUM
ijpds-3543	83	15	m	m	NOUN
ijpds-3543	83	16	nitrocellulose	nitrocellulose	NOUN
ijpds-3543	83	17	at	at	ADP
ijpds-3543	83	18	30	30	NUM
ijpds-3543	83	19	volts	volt	NOUN
ijpds-3543	83	20	for	for	ADP
ijpds-3543	83	21	0	0	NUM
ijpds-3543	83	22	minutes	minute	NOUN
ijpds-3543	83	23	using	use	VERB
ijpds-3543	83	24	the	the	DET
ijpds-3543	83	25	1/2towbin	1/2towbin	NUM
ijpds-3543	83	26	buffer	buffer	NOUN
ijpds-3543	83	27	system	system	NOUN
ijpds-3543	83	28	(	(	PUNCT
ijpds-3543	83	29	1.45	1.45	NUM
ijpds-3543	83	30	g	g	PRON
ijpds-3543	83	31	tris	tris	NOUN
ijpds-3543	83	32	,	,	PUNCT
ijpds-3543	83	33	7.2	7.2	NUM
ijpds-3543	83	34	g	g	NOUN
ijpds-3543	83	35	glycine	glycine	NOUN
ijpds-3543	83	36	,	,	PUNCT
ijpds-3543	83	37	800	800	NUM
ijpds-3543	83	38	ml	ml	NOUN
ijpds-3543	83	39	di	di	X
ijpds-3543	83	40	h2o	h2o	PROPN
ijpds-3543	83	41	and	and	CCONJ
ijpds-3543	83	42	200	200	NUM
ijpds-3543	83	43	ml	ml	NOUN
ijpds-3543	83	44	meoh	meoh	PROPN
ijpds-3543	83	45	)	)	PUNCT
ijpds-3543	83	46	.	.	PUNCT
ijpds-3543	84	1	the	the	DET
ijpds-3543	84	2	membrane	membrane	NOUN
ijpds-3543	84	3	was	be	AUX
ijpds-3543	84	4	blocked	block	VERB
ijpds-3543	84	5	in	in	ADP
ijpds-3543	84	6	1	1	NUM
ijpds-3543	84	7	percent	percent	NOUN
ijpds-3543	84	8	bsa	bsa	NOUN
ijpds-3543	84	9	:	:	PUNCT
ijpds-3543	84	10	1	1	NUM
ijpds-3543	84	11	percent	percent	NOUN
ijpds-3543	84	12	nonfat	nonfat	NOUN
ijpds-3543	84	13	milk	milk	NOUN
ijpds-3543	84	14	in	in	ADP
ijpds-3543	84	15	pbs	pbs	PROPN
ijpds-3543	84	16	-	-	PUNCT
ijpds-3543	84	17	tween	tween	NOUN
ijpds-3543	84	18	(	(	PUNCT
ijpds-3543	84	19	phosphate	phosphate	NOUN
ijpds-3543	84	20	-	-	PUNCT
ijpds-3543	84	21	buffered	buffer	VERB
ijpds-3543	84	22	saline	saline	NOUN
ijpds-3543	84	23	with	with	ADP
ijpds-3543	84	24	0.05	0.05	NUM
ijpds-3543	84	25	percent	percent	NOUN
ijpds-3543	84	26	tween	tween	NOUN
ijpds-3543	84	27	20	20	NUM
ijpds-3543	84	28	)	)	PUNCT
ijpds-3543	84	29	for	for	ADP
ijpds-3543	84	30	1	1	NUM
ijpds-3543	84	31	hour	hour	NOUN
ijpds-3543	84	32	before	before	ADP
ijpds-3543	84	33	being	be	AUX
ijpds-3543	84	34	probed	probe	VERB
ijpds-3543	84	35	with	with	ADP
ijpds-3543	84	36	rabbit	rabbit	NOUN
ijpds-3543	84	37	anti	anti	ADJ
ijpds-3543	84	38	-	-	NOUN
ijpds-3543	84	39	nitrotyrosine	nitrotyrosine	ADJ
ijpds-3543	84	40	(	(	PUNCT
ijpds-3543	84	41	1	1	NUM
ijpds-3543	84	42	g/	g/	NOUN
ijpds-3543	84	43	ml	ml	X
ijpds-3543	84	44	in	in	ADP
ijpds-3543	84	45	pbstween	pbstween	NOUN
ijpds-3543	84	46	)	)	PUNCT
ijpds-3543	84	47	overnight	overnight	ADV
ijpds-3543	84	48	at	at	ADP
ijpds-3543	84	49	4	4	NUM
ijpds-3543	84	50	°	°	NOUN
ijpds-3543	84	51	c	c	NOUN
ijpds-3543	84	52	.	.	PUNCT
ijpds-3543	85	1	the	the	DET
ijpds-3543	85	2	blot	blot	NOUN
ijpds-3543	85	3	was	be	AUX
ijpds-3543	85	4	washed	wash	VERB
ijpds-3543	85	5	three	three	NUM
ijpds-3543	85	6	times	time	NOUN
ijpds-3543	85	7	with	with	ADP
ijpds-3543	85	8	pbs	pbs	PROPN
ijpds-3543	85	9	-	-	PUNCT
ijpds-3543	85	10	t	t	PROPN
ijpds-3543	85	11	and	and	CCONJ
ijpds-3543	85	12	once	once	ADV
ijpds-3543	85	13	with	with	ADP
ijpds-3543	85	14	h2o	h2o	NOUN
ijpds-3543	85	15	before	before	ADP
ijpds-3543	85	16	being	be	AUX
ijpds-3543	85	17	incubated	incubate	VERB
ijpds-3543	85	18	with	with	ADP
ijpds-3543	85	19	the	the	DET
ijpds-3543	85	20	secondary	secondary	ADJ
ijpds-3543	85	21	antibody	antibody	NOUN
ijpds-3543	85	22	,	,	PUNCT
ijpds-3543	85	23	goat	goat	PROPN
ijpds-3543	85	24	anti	anti	ADJ
ijpds-3543	85	25	-	-	ADJ
ijpds-3543	85	26	rabbit	rabbit	ADJ
ijpds-3543	85	27	-	-	PUNCT
ijpds-3543	85	28	hrp	hrp	NOUN
ijpds-3543	85	29	,	,	PUNCT
ijpds-3543	85	30	for	for	ADP
ijpds-3543	85	31	1.5	1.5	NUM
ijpds-3543	85	32	hours	hour	NOUN
ijpds-3543	85	33	(	(	PUNCT
ijpds-3543	85	34	1	1	NUM
ijpds-3543	85	35	:	:	SYM
ijpds-3543	85	36	3000	3000	NUM
ijpds-3543	85	37	)	)	PUNCT
ijpds-3543	85	38	.	.	PUNCT
ijpds-3543	86	1	after	after	ADP
ijpds-3543	86	2	washing	wash	VERB
ijpds-3543	86	3	the	the	DET
ijpds-3543	86	4	blot	blot	NOUN
ijpds-3543	86	5	three	three	NUM
ijpds-3543	86	6	times	time	NOUN
ijpds-3543	86	7	in	in	ADP
ijpds-3543	86	8	pbs	pbs	PROPN
ijpds-3543	86	9	-	-	PUNCT
ijpds-3543	86	10	t	t	PROPN
ijpds-3543	86	11	and	and	CCONJ
ijpds-3543	86	12	once	once	ADV
ijpds-3543	86	13	in	in	ADP
ijpds-3543	86	14	di	di	X
ijpds-3543	86	15	h2o	h2o	PROPN
ijpds-3543	86	16	,	,	PUNCT
ijpds-3543	86	17	1.5	1.5	NUM
ijpds-3543	86	18	ml	ml	ADV
ijpds-3543	86	19	mixed	mixed	ADJ
ijpds-3543	86	20	ecl	ecl	NOUN
ijpds-3543	86	21	chemiluminescence	chemiluminescence	NOUN
ijpds-3543	86	22	reagent	reagent	NOUN
ijpds-3543	86	23	was	be	AUX
ijpds-3543	86	24	applied	apply	VERB
ijpds-3543	86	25	for	for	ADP
ijpds-3543	86	26	1	1	NUM
ijpds-3543	86	27	minute	minute	NOUN
ijpds-3543	86	28	.	.	PUNCT
ijpds-3543	87	1	after	after	ADP
ijpds-3543	87	2	that	that	PRON
ijpds-3543	87	3	,	,	PUNCT
ijpds-3543	87	4	the	the	DET
ijpds-3543	87	5	blot	blot	NOUN
ijpds-3543	87	6	was	be	AUX
ijpds-3543	87	7	exposed	expose	VERB
ijpds-3543	87	8	to	to	ADP
ijpds-3543	87	9	x	x	ADJ
ijpds-3543	87	10	-	-	NOUN
ijpds-3543	87	11	ray	ray	NOUN
ijpds-3543	87	12	film	film	NOUN
ijpds-3543	87	13	for	for	ADP
ijpds-3543	87	14	0	0	NUM
ijpds-3543	87	15	seconds	second	NOUN
ijpds-3543	87	16	.	.	PUNCT
ijpds-3543	88	1	measurements	measurement	NOUN
ijpds-3543	88	2	of	of	ADP
ijpds-3543	88	3	myeloperoxidase	myeloperoxidase	NOUN
ijpds-3543	88	4	in	in	ADP
ijpds-3543	88	5	paw	paw	NOUN
ijpds-3543	88	6	homogenates	homogenate	NOUN
ijpds-3543	88	7	:	:	PUNCT
ijpds-3543	88	8	in	in	ADP
ijpds-3543	88	9	addition	addition	NOUN
ijpds-3543	88	10	,	,	PUNCT
ijpds-3543	88	11	the	the	DET
ijpds-3543	88	12	activity	activity	NOUN
ijpds-3543	88	13	of	of	ADP
ijpds-3543	88	14	myeloperoxidase	myeloperoxidase	NOUN
ijpds-3543	88	15	,	,	PUNCT
ijpds-3543	88	16	a	a	DET
ijpds-3543	88	17	marker	marker	NOUN
ijpds-3543	88	18	of	of	ADP
ijpds-3543	88	19	neutrophil	neutrophil	ADJ
ijpds-3543	88	20	infiltration	infiltration	NOUN
ijpds-3543	88	21	,	,	PUNCT
ijpds-3543	88	22	was	be	AUX
ijpds-3543	88	23	evaluated	evaluate	VERB
ijpds-3543	88	24	in	in	ADP
ijpds-3543	88	25	the	the	DET
ijpds-3543	88	26	paws	paw	NOUN
ijpds-3543	88	27	as	as	SCONJ
ijpds-3543	88	28	described	describe	VERB
ijpds-3543	88	29	paws	paw	NOUN
ijpds-3543	88	30	were	be	AUX
ijpds-3543	88	31	homogenized	homogenize	VERB
ijpds-3543	88	32	in	in	ADP
ijpds-3543	88	33	a	a	DET
ijpds-3543	88	34	solution	solution	NOUN
ijpds-3543	88	35	of	of	ADP
ijpds-3543	88	36	0.5	0.5	NUM
ijpds-3543	88	37	percent	percent	NOUN
ijpds-3543	88	38	hexadecyl	hexadecyl	ADJ
ijpds-3543	88	39	-	-	PUNCT
ijpds-3543	88	40	trimethylammonium	trimethylammonium	NOUN
ijpds-3543	88	41	bromide	bromide	NOUN
ijpds-3543	88	42	mixed	mix	VERB
ijpds-3543	88	43	in	in	ADP
ijpds-3543	88	44	10	10	NUM
ijpds-3543	88	45	mm	mm	NOUN
ijpds-3543	88	46	potassium	potassium	NOUN
ijpds-3543	88	47	phosphate	phosphate	NOUN
ijpds-3543	88	48	buffer	buffer	NOUN
ijpds-3543	88	49	(	(	PUNCT
ijpds-3543	88	50	ph	ph	NOUN
ijpds-3543	88	51	7	7	NUM
ijpds-3543	88	52	)	)	PUNCT
ijpds-3543	88	53	and	and	CCONJ
ijpds-3543	88	54	centrifuged	centrifuge	VERB
ijpds-3543	88	55	at	at	ADP
ijpds-3543	88	56	20,000	20,000	NUM
ijpds-3543	88	57	g	g	NOUN
ijpds-3543	88	58	for	for	ADP
ijpds-3543	88	59	30	30	NUM
ijpds-3543	88	60	minutes	minute	NOUN
ijpds-3543	88	61	at	at	ADP
ijpds-3543	88	62	4	4	NUM
ijpds-3543	88	63	°	°	NOUN
ijpds-3543	88	64	c	c	NOUN
ijpds-3543	88	65	.	.	PUNCT
ijpds-3543	89	1	an	an	DET
ijpds-3543	89	2	aliquot	aliquot	NOUN
ijpds-3543	89	3	of	of	ADP
ijpds-3543	89	4	the	the	DET
ijpds-3543	89	5	supernatant	supernatant	NOUN
ijpds-3543	89	6	was	be	AUX
ijpds-3543	89	7	allowed	allow	VERB
ijpds-3543	89	8	to	to	PART
ijpds-3543	89	9	react	react	VERB
ijpds-3543	89	10	with	with	ADP
ijpds-3543	89	11	tetramethyl	tetramethyl	NOUN
ijpds-3543	89	12	-	-	PUNCT
ijpds-3543	89	13	benzidine	benzidine	NOUN
ijpds-3543	89	14	(	(	PUNCT
ijpds-3543	89	15	1	1	X
ijpds-3543	89	16	.	.	X
ijpds-3543	89	17	mm	mm	NUM
ijpds-3543	89	18	)	)	PUNCT
ijpds-3543	89	19	and	and	CCONJ
ijpds-3543	89	20	0.1	0.1	NUM
ijpds-3543	89	21	mm	mm	NOUN
ijpds-3543	89	22	h2o2	h2o2	NOUN
ijpds-3543	89	23	in	in	ADP
ijpds-3543	89	24	a	a	DET
ijpds-3543	89	25	solution	solution	NOUN
ijpds-3543	89	26	.	.	PUNCT
ijpds-3543	90	1	at	at	ADP
ijpds-3543	90	2	a	a	DET
ijpds-3543	90	3	wavelength	wavelength	NOUN
ijpds-3543	90	4	of	of	ADP
ijpds-3543	90	5	50	50	NUM
ijpds-3543	90	6	nm	nm	NOUN
ijpds-3543	90	7	,	,	PUNCT
ijpds-3543	90	8	spectrophotometry	spectrophotometry	NOUN
ijpds-3543	90	9	was	be	AUX
ijpds-3543	90	10	used	use	VERB
ijpds-3543	90	11	to	to	PART
ijpds-3543	90	12	determine	determine	VERB
ijpds-3543	90	13	the	the	DET
ijpds-3543	90	14	rate	rate	NOUN
ijpds-3543	90	15	of	of	ADP
ijpds-3543	90	16	change	change	NOUN
ijpds-3543	90	17	in	in	ADP
ijpds-3543	90	18	absorbance	absorbance	NOUN
ijpds-3543	90	19	.	.	PUNCT
ijpds-3543	91	1	myeloperoxidase	myeloperoxidase	NOUN
ijpds-3543	91	2	.	.	PUNCT
ijpds-3543	92	1	the	the	DET
ijpds-3543	92	2	amount	amount	NOUN
ijpds-3543	92	3	of	of	ADP
ijpds-3543	92	4	enzyme	enzyme	NOUN
ijpds-3543	92	5	that	that	PRON
ijpds-3543	92	6	degraded	degrade	VERB
ijpds-3543	92	7	1	1	NUM
ijpds-3543	92	8	mol	mol	NOUN
ijpds-3543	92	9	of	of	ADP
ijpds-3543	92	10	hydrogen	hydrogen	NOUN
ijpds-3543	92	11	peroxide	peroxide	NOUN
ijpds-3543	92	12	per	per	ADP
ijpds-3543	92	13	minute	minute	NOUN
ijpds-3543	92	14	at	at	ADP
ijpds-3543	92	15	37	37	NUM
ijpds-3543	92	16	°	°	NOUN
ijpds-3543	92	17	c	c	NOUN
ijpds-3543	92	18	was	be	AUX
ijpds-3543	92	19	measured	measure	VERB
ijpds-3543	92	20	in	in	ADP
ijpds-3543	92	21	milliunits	milliunit	NOUN
ijpds-3543	92	22	per	per	ADP
ijpds-3543	92	23	mg	mg	PROPN
ijpds-3543	92	24	protein	protein	NOUN
ijpds-3543	92	25	.	.	PUNCT
ijpds-3543	93	1	analyzing	analyze	VERB
ijpds-3543	93	2	and	and	CCONJ
ijpds-3543	93	3	presenting	present	VERB
ijpds-3543	93	4	data	datum	NOUN
ijpds-3543	93	5	:	:	PUNCT
ijpds-3543	93	6	all	all	DET
ijpds-3543	93	7	figures	figure	NOUN
ijpds-3543	93	8	and	and	CCONJ
ijpds-3543	93	9	text	text	NOUN
ijpds-3543	93	10	data	datum	NOUN
ijpds-3543	93	11	are	be	AUX
ijpds-3543	93	12	expressed	express	VERB
ijpds-3543	93	13	as	as	ADP
ijpds-3543	93	14	the	the	DET
ijpds-3543	93	15	mean	mean	NOUN
ijpds-3543	93	16	of	of	ADP
ijpds-3543	93	17	n	n	PRON
ijpds-3543	93	18	observations	observation	NOUN
ijpds-3543	93	19	,	,	PUNCT
ijpds-3543	93	20	where	where	SCONJ
ijpds-3543	93	21	n	n	X
ijpds-3543	93	22	is	be	AUX
ijpds-3543	93	23	the	the	DET
ijpds-3543	93	24	number	number	NOUN
ijpds-3543	93	25	of	of	ADP
ijpds-3543	93	26	wells	well	NOUN
ijpds-3543	93	27	(	(	PUNCT
ijpds-3543	93	28	9	9	NUM
ijpds-3543	93	29	wells	well	NOUN
ijpds-3543	93	30	from	from	ADP
ijpds-3543	93	31	two	two	NUM
ijpds-3543	93	32	to	to	PART
ijpds-3543	93	33	three	three	NUM
ijpds-3543	93	34	independent	independent	ADJ
ijpds-3543	93	35	experiments	experiment	NOUN
ijpds-3543	93	36	)	)	PUNCT
ijpds-3543	93	37	or	or	CCONJ
ijpds-3543	93	38	the	the	DET
ijpds-3543	93	39	number	number	NOUN
ijpds-3543	93	40	of	of	ADP
ijpds-3543	93	41	animals	animal	NOUN
ijpds-3543	93	42	analyzed	analyze	VERB
ijpds-3543	93	43	.	.	PUNCT
ijpds-3543	94	1	oneand	oneand	CCONJ
ijpds-3543	94	2	two	two	NUM
ijpds-3543	94	3	-	-	PUNCT
ijpds-3543	94	4	way	way	NOUN
ijpds-3543	94	5	analysis	analysis	NOUN
ijpds-3543	94	6	of	of	ADP
ijpds-3543	94	7	variance	variance	NOUN
ijpds-3543	94	8	were	be	AUX
ijpds-3543	94	9	used	use	VERB
ijpds-3543	94	10	to	to	PART
ijpds-3543	94	11	investigate	investigate	VERB
ijpds-3543	94	12	the	the	DET
ijpds-3543	94	13	data	data	NOUN
ijpds-3543	94	14	sets	set	NOUN
ijpds-3543	94	15	,	,	PUNCT
ijpds-3543	94	16	and	and	CCONJ
ijpds-3543	94	17	individual	individual	ADJ
ijpds-3543	94	18	group	group	NOUN
ijpds-3543	94	19	averages	average	NOUN
ijpds-3543	94	20	were	be	AUX
ijpds-3543	94	21	compared	compare	VERB
ijpds-3543	94	22	using	use	VERB
ijpds-3543	94	23	dunnett	dunnett	PROPN
ijpds-3543	94	24	's	's	PART
ijpds-3543	94	25	test	test	NOUN
ijpds-3543	94	26	.	.	PUNCT
ijpds-3543	95	1	the	the	DET
ijpds-3543	95	2	statistical	statistical	ADJ
ijpds-3543	95	3	differences	difference	NOUN
ijpds-3543	95	4	in	in	ADP
ijpds-3543	95	5	the	the	DET
ijpds-3543	95	6	arthritic	arthritic	ADJ
ijpds-3543	95	7	indices	index	NOUN
ijpds-3543	95	8	were	be	AUX
ijpds-3543	95	9	tested	test	VERB
ijpds-3543	95	10	using	use	VERB
ijpds-3543	95	11	the	the	DET
ijpds-3543	95	12	mann	mann	PROPN
ijpds-3543	95	13	-	-	PUNCT
ijpds-3543	95	14	whitney	whitney	PROPN
ijpds-3543	95	15	u	u	NOUN
ijpds-3543	95	16	-	-	NOUN
ijpds-3543	95	17	test	test	NOUN
ijpds-3543	95	18	(	(	PUNCT
ijpds-3543	95	19	2	2	NUM
ijpds-3543	95	20	-	-	PUNCT
ijpds-3543	95	21	tailed	tailed	ADJ
ijpds-3543	95	22	,	,	PUNCT
ijpds-3543	95	23	independent	independent	ADJ
ijpds-3543	95	24	)	)	PUNCT
ijpds-3543	95	25	in	in	ADP
ijpds-3543	95	26	the	the	DET
ijpds-3543	95	27	arthritis	arthritis	NOUN
ijpds-3543	95	28	studies	study	NOUN
ijpds-3543	95	29	.	.	PUNCT
ijpds-3543	96	1	statistical	statistical	ADJ
ijpds-3543	96	2	significance	significance	NOUN
ijpds-3543	96	3	was	be	AUX
ijpds-3543	96	4	defined	define	VERB
ijpds-3543	96	5	as	as	ADP
ijpds-3543	96	6	a	a	DET
ijpds-3543	96	7	p	p	NOUN
ijpds-3543	96	8	-	-	PUNCT
ijpds-3543	96	9	value	value	NOUN
ijpds-3543	96	10	of	of	ADP
ijpds-3543	96	11	less	less	ADJ
ijpds-3543	96	12	than	than	ADP
ijpds-3543	96	13	0.05	0.05	NUM
ijpds-3543	96	14	.	.	PUNCT
ijpds-3543	97	1	results	results	PROPN
ijpds-3543	97	2	mip	mip	PROPN
ijpds-3543	97	3	-	-	PUNCT
ijpds-3543	97	4	l	l	NOUN
ijpds-3543	97	5	α	α	NOUN
ijpds-3543	97	6	is	be	AUX
ijpds-3543	97	7	suppressed	suppress	VERB
ijpds-3543	97	8	by	by	ADP
ijpds-3543	97	9	adenosine	adenosine	NOUN
ijpds-3543	97	10	agonists	agonist	NOUN
ijpds-3543	97	11	in	in	ADP
ijpds-3543	97	12	immunestimulated	immunestimulated	ADJ
ijpds-3543	97	13	macrophages.mip-1α	macrophages.mip-1α	NOUN
ijpds-3543	97	14	was	be	AUX
ijpds-3543	97	15	produced	produce	VERB
ijpds-3543	97	16	in	in	ADP
ijpds-3543	97	17	considerable	considerable	ADJ
ijpds-3543	97	18	amounts	amount	NOUN
ijpds-3543	97	19	in	in	ADP
ijpds-3543	97	20	response	response	NOUN
ijpds-3543	97	21	to	to	ADP
ijpds-3543	97	22	lps	lps	PROPN
ijpds-3543	97	23	(	(	PUNCT
ijpds-3543	97	24	10	10	NUM
ijpds-3543	97	25	ng	ng	PROPN
ijpds-3543	97	26	/	/	SYM
ijpds-3543	97	27	ml	ml	NOUN
ijpds-3543	97	28	)	)	PUNCT
ijpds-3543	97	29	.	.	PUNCT
ijpds-3543	98	1	the	the	DET
ijpds-3543	98	2	a3	a3	NOUN
ijpds-3543	98	3	agonist	agonist	NOUN
ijpds-3543	98	4	ib	ib	PROPN
ijpds-3543	98	5	-	-	PUNCT
ijpds-3543	98	6	meca	meca	PROPN
ijpds-3543	98	7	and	and	CCONJ
ijpds-3543	98	8	,	,	PUNCT
ijpds-3543	98	9	to	to	ADP
ijpds-3543	98	10	a	a	DET
ijpds-3543	98	11	lesser	less	ADJ
ijpds-3543	98	12	extent	extent	NOUN
ijpds-3543	98	13	,	,	PUNCT
ijpds-3543	98	14	the	the	DET
ijpds-3543	98	15	a2	a2	PROPN
ijpds-3543	98	16	agonist	agonist	NOUN
ijpds-3543	98	17	cgs-2180	cgs-2180	NOUN
ijpds-3543	98	18	inhibited	inhibit	VERB
ijpds-3543	98	19	mip-1α	mip-1α	NOUN
ijpds-3543	98	20	production	production	NOUN
ijpds-3543	98	21	,	,	PUNCT
ijpds-3543	98	22	whereas	whereas	SCONJ
ijpds-3543	98	23	the	the	DET
ijpds-3543	98	24	a1	a1	NOUN
ijpds-3543	98	25	receptor	receptor	NOUN
ijpds-3543	98	26	agonist	agonist	NOUN
ijpds-3543	98	27	ccpa	ccpa	PROPN
ijpds-3543	98	28	had	have	VERB
ijpds-3543	98	29	no	no	DET
ijpds-3543	98	30	impact	impact	NOUN
ijpds-3543	98	31	(	(	PUNCT
ijpds-3543	98	32	figure	figure	NOUN
ijpds-3543	98	33	1	1	NUM
ijpds-3543	98	34	)	)	PUNCT
ijpds-3543	98	35	.	.	PUNCT
ijpds-3543	99	1	at	at	ADP
ijpds-3543	99	2	200	200	NUM
ijpds-3543	99	3	m	m	NOUN
ijpds-3543	99	4	,	,	PUNCT
ijpds-3543	99	5	adenosine	adenosine	PROPN
ijpds-3543	99	6	had	have	VERB
ijpds-3543	99	7	a	a	DET
ijpds-3543	99	8	minor	minor	ADJ
ijpds-3543	99	9	inhibitory	inhibitory	ADJ
ijpds-3543	99	10	effect	effect	NOUN
ijpds-3543	99	11	,	,	PUNCT
ijpds-3543	99	12	resulting	result	VERB
ijpds-3543	99	13	in	in	ADP
ijpds-3543	99	14	a	a	DET
ijpds-3543	99	15	213	213	NUM
ijpds-3543	99	16	percent	percent	NOUN
ijpds-3543	99	17	inhibition	inhibition	NOUN
ijpds-3543	99	18	(	(	PUNCT
ijpds-3543	99	19	p<0.01	p<0.01	PROPN
ijpds-3543	99	20	)	)	PUNCT
ijpds-3543	99	21	.	.	PUNCT
ijpds-3543	100	1	the	the	DET
ijpds-3543	100	2	mtt	mtt	NOUN
ijpds-3543	100	3	experiment	experiment	NOUN
ijpds-3543	100	4	revealed	reveal	VERB
ijpds-3543	100	5	that	that	SCONJ
ijpds-3543	100	6	the	the	DET
ijpds-3543	100	7	adenosine	adenosine	NOUN
ijpds-3543	100	8	agonists	agonist	NOUN
ijpds-3543	100	9	tested	test	VERB
ijpds-3543	100	10	had	have	VERB
ijpds-3543	100	11	no	no	DET
ijpds-3543	100	12	effect	effect	NOUN
ijpds-3543	100	13	on	on	ADP
ijpds-3543	100	14	mitochondrial	mitochondrial	ADJ
ijpds-3543	100	15	respiration	respiration	NOUN
ijpds-3543	100	16	.	.	PUNCT
ijpds-3543	101	1	because	because	SCONJ
ijpds-3543	101	2	adenosine	adenosine	NOUN
ijpds-3543	101	3	deaminase	deaminase	NOUN
ijpds-3543	101	4	degrades	degrade	VERB
ijpds-3543	101	5	adenosine	adenosine	NOUN
ijpds-3543	101	6	quickly	quickly	ADV
ijpds-3543	101	7	,	,	PUNCT
ijpds-3543	101	8	we	we	PRON
ijpds-3543	101	9	wanted	want	VERB
ijpds-3543	101	10	to	to	PART
ijpds-3543	101	11	see	see	VERB
ijpds-3543	101	12	if	if	SCONJ
ijpds-3543	101	13	inhibiting	inhibit	VERB
ijpds-3543	101	14	adenosine	adenosine	NOUN
ijpds-3543	101	15	deaminase	deaminase	NOUN
ijpds-3543	101	16	changed	change	VERB
ijpds-3543	101	17	the	the	DET
ijpds-3543	101	18	degree	degree	NOUN
ijpds-3543	101	19	of	of	ADP
ijpds-3543	101	20	inhibition	inhibition	NOUN
ijpds-3543	101	21	.	.	PUNCT
ijpds-3543	102	1	there	there	PRON
ijpds-3543	102	2	was	be	VERB
ijpds-3543	102	3	no	no	DET
ijpds-3543	102	4	increase	increase	NOUN
ijpds-3543	102	5	in	in	ADP
ijpds-3543	102	6	the	the	DET
ijpds-3543	102	7	inhibitory	inhibitory	ADJ
ijpds-3543	102	8	action	action	NOUN
ijpds-3543	102	9	of	of	ADP
ijpds-3543	102	10	adenosine	adenosine	NOUN
ijpds-3543	102	11	in	in	ADP
ijpds-3543	102	12	the	the	DET
ijpds-3543	102	13	presence	presence	NOUN
ijpds-3543	102	14	of	of	ADP
ijpds-3543	102	15	the	the	DET
ijpds-3543	102	16	adenosine	adenosine	ADJ
ijpds-3543	102	17	deaminase	deaminase	NOUN
ijpds-3543	102	18	inhibitor	inhibitor	NOUN
ijpds-3543	102	19	ehna	ehna	NOUN
ijpds-3543	102	20	(	(	PUNCT
ijpds-3543	102	21	50	50	NUM
ijpds-3543	102	22	m	m	NOUN
ijpds-3543	102	23	)	)	PUNCT
ijpds-3543	102	24	(	(	PUNCT
ijpds-3543	102	25	245	245	NUM
ijpds-3543	102	26	%	%	NOUN
ijpds-3543	102	27	inhibition	inhibition	NOUN
ijpds-3543	102	28	at	at	ADP
ijpds-3543	102	29	200	200	NUM
ijpds-3543	102	30	mmip-1α	mmip-1α	NOUN
ijpds-3543	102	31	steady	steady	ADJ
ijpds-3543	102	32	-	-	PUNCT
ijpds-3543	102	33	state	state	NOUN
ijpds-3543	102	34	mrna	mrna	PROPN
ijpds-3543	102	35	levels	level	NOUN
ijpds-3543	102	36	rise	rise	VERB
ijpds-3543	102	37	in	in	ADP
ijpds-3543	102	38	a	a	DET
ijpds-3543	102	39	time	time	NOUN
ijpds-3543	102	40	-	-	PUNCT
ijpds-3543	102	41	dependent	dependent	ADJ
ijpds-3543	102	42	manner	manner	NOUN
ijpds-3543	102	43	ib	ib	PROPN
ijpds-3543	102	44	-	-	PUNCT
ijpds-3543	102	45	meca	meca	PROPN
ijpds-3543	102	46	caused	cause	VERB
ijpds-3543	102	47	a	a	DET
ijpds-3543	102	48	significant	significant	ADJ
ijpds-3543	102	49	reduction	reduction	NOUN
ijpds-3543	102	50	in	in	ADP
ijpds-3543	102	51	mip-1α	mip-1α	NOUN
ijpds-3543	102	52	production	production	NOUN
ijpds-3543	102	53	,	,	PUNCT
ijpds-3543	102	54	which	which	PRON
ijpds-3543	102	55	was	be	AUX
ijpds-3543	102	56	accompanied	accompany	VERB
ijpds-3543	102	57	by	by	ADP
ijpds-3543	102	58	a	a	DET
ijpds-3543	102	59	significant	significant	ADJ
ijpds-3543	102	60	,	,	PUNCT
ijpds-3543	102	61	dose	dose	NOUN
ijpds-3543	102	62	-	-	PUNCT
ijpds-3543	102	63	dependent	dependent	ADJ
ijpds-3543	102	64	reduction	reduction	NOUN
ijpds-3543	102	65	in	in	ADP
ijpds-3543	102	66	mip-1α	mip-1α	PROPN
ijpds-3543	102	67	mrna	mrna	PROPN
ijpds-3543	102	68	(	(	PUNCT
ijpds-3543	102	69	figure	figure	NOUN
ijpds-3543	102	70	2	2	NUM
ijpds-3543	102	71	)	)	PUNCT
ijpds-3543	102	72	.	.	PUNCT
ijpds-3543	103	1	mip-1α	mip-1α	NOUN
ijpds-3543	103	2	mrna	mrna	PROPN
ijpds-3543	103	3	expression	expression	NOUN
ijpds-3543	103	4	was	be	AUX
ijpds-3543	103	5	unaffected	unaffected	ADJ
ijpds-3543	103	6	by	by	ADP
ijpds-3543	103	7	adenosine	adenosine	NOUN
ijpds-3543	103	8	or	or	CCONJ
ijpds-3543	103	9	the	the	DET
ijpds-3543	103	10	a1	a1	NOUN
ijpds-3543	103	11	agonist	agonist	NOUN
ijpds-3543	103	12	,	,	PUNCT
ijpds-3543	103	13	however	however	ADV
ijpds-3543	103	14	,	,	PUNCT
ijpds-3543	103	15	steadystate	steadystate	VERB
ijpds-3543	103	16	mrna	mrna	PROPN
ijpds-3543	103	17	levels	level	NOUN
ijpds-3543	103	18	were	be	AUX
ijpds-3543	103	19	decreased	decrease	VERB
ijpds-3543	103	20	by	by	ADP
ijpds-3543	103	21	the	the	DET
ijpds-3543	103	22	a2	a2	PROPN
ijpds-3543	103	23	agonist	agonist	NOUN
ijpds-3543	103	24	cgs2180	cgs2180	NOUN
ijpds-3543	103	25	(	(	PUNCT
ijpds-3543	103	26	figure	figure	NOUN
ijpds-3543	103	27	2	2	NUM
ijpds-3543	103	28	)	)	PUNCT
ijpds-3543	103	29	.	.	PUNCT
ijpds-3543	104	1	overall	overall	ADV
ijpds-3543	104	2	,	,	PUNCT
ijpds-3543	104	3	the	the	DET
ijpds-3543	104	4	degree	degree	NOUN
ijpds-3543	104	5	of	of	ADP
ijpds-3543	104	6	inhibition	inhibition	NOUN
ijpds-3543	104	7	of	of	ADP
ijpds-3543	104	8	mip-1α	mip-1α	NOUN
ijpds-3543	104	9	protein	protein	NOUN
ijpds-3543	104	10	and	and	CCONJ
ijpds-3543	104	11	mip-1α	mip-1α	NOUN
ijpds-3543	104	12	mrna	mrna	NOUN
ijpds-3543	104	13	expression	expression	NOUN
ijpds-3543	104	14	by	by	ADP
ijpds-3543	104	15	adenosine	adenosine	NOUN
ijpds-3543	104	16	agonists	agonist	NOUN
ijpds-3543	104	17	had	have	VERB
ijpds-3543	104	18	a	a	DET
ijpds-3543	104	19	fairly	fairly	ADV
ijpds-3543	104	20	high	high	ADJ
ijpds-3543	104	21	association	association	NOUN
ijpds-3543	104	22	.	.	PUNCT
ijpds-3543	105	1	the	the	DET
ijpds-3543	105	2	degree	degree	NOUN
ijpds-3543	105	3	of	of	ADP
ijpds-3543	105	4	suppression	suppression	NOUN
ijpds-3543	105	5	of	of	ADP
ijpds-3543	105	6	mip-1α	mip-1α	PROPN
ijpds-3543	105	7	mrna	mrna	PROPN
ijpds-3543	105	8	levels	level	NOUN
ijpds-3543	105	9	and	and	CCONJ
ijpds-3543	105	10	protein	protein	NOUN
ijpds-3543	105	11	levels	level	NOUN
ijpds-3543	105	12	,	,	PUNCT
ijpds-3543	105	13	on	on	ADP
ijpds-3543	105	14	the	the	DET
ijpds-3543	105	15	other	other	ADJ
ijpds-3543	105	16	hand	hand	NOUN
ijpds-3543	105	17	,	,	PUNCT
ijpds-3543	105	18	did	do	AUX
ijpds-3543	105	19	not	not	PART
ijpds-3543	105	20	always	always	ADV
ijpds-3543	105	21	match	match	VERB
ijpds-3543	105	22	.	.	PUNCT
ijpds-3543	106	1	using	use	VERB
ijpds-3543	106	2	the	the	DET
ijpds-3543	106	3	elisa	elisa	NOUN
ijpds-3543	106	4	approach	approach	NOUN
ijpds-3543	106	5	,	,	PUNCT
ijpds-3543	106	6	we	we	PRON
ijpds-3543	106	7	discovered	discover	VERB
ijpds-3543	106	8	that	that	SCONJ
ijpds-3543	106	9	cgs	cgs	NOUN
ijpds-3543	106	10	(	(	PUNCT
ijpds-3543	106	11	at	at	ADP
ijpds-3543	106	12	200	200	NUM
ijpds-3543	106	13	m	m	NOUN
ijpds-3543	106	14	)	)	PUNCT
ijpds-3543	106	15	suppressed	suppress	VERB
ijpds-3543	106	16	mip-1α	mip-1α	NOUN
ijpds-3543	106	17	protein	protein	NOUN
ijpds-3543	106	18	synthesis	synthesis	NOUN
ijpds-3543	106	19	by	by	ADP
ijpds-3543	106	20	roughly	roughly	ADV
ijpds-3543	106	21	50	50	NUM
ijpds-3543	106	22	%	%	NOUN
ijpds-3543	106	23	whereas	whereas	SCONJ
ijpds-3543	106	24	the	the	DET
ijpds-3543	106	25	inhibition	inhibition	NOUN
ijpds-3543	106	26	of	of	ADP
ijpds-3543	106	27	mip-1α	mip-1α	NOUN
ijpds-3543	106	28	protein	protein	NOUN
ijpds-3543	106	29	production	production	NOUN
ijpds-3543	106	30	by	by	ADP
ijpds-3543	106	31	nearly	nearly	ADV
ijpds-3543	106	32	50	50	NUM
ijpds-3543	106	33	%	%	NOUN
ijpds-3543	106	34	(	(	PUNCT
ijpds-3543	106	35	figure	figure	NOUN
ijpds-3543	106	36	1	1	NUM
ijpds-3543	106	37	)	)	PUNCT
ijpds-3543	106	38	lps	lps	PROPN
ijpds-3543	106	39	elicited	elicit	VERB
ijpds-3543	106	40	the	the	DET
ijpds-3543	106	41	synthesis	synthesis	NOUN
ijpds-3543	106	42	of	of	ADP
ijpds-3543	106	43	mrna	mrna	PROPN
ijpds-3543	106	44	was	be	AUX
ijpds-3543	106	45	virtually	virtually	ADV
ijpds-3543	106	46	completely	completely	ADV
ijpds-3543	106	47	eliminated	eliminate	VERB
ijpds-3543	106	48	differences	difference	NOUN
ijpds-3543	106	49	in	in	ADP
ijpds-3543	106	50	measurement	measurement	NOUN
ijpds-3543	106	51	duration	duration	NOUN
ijpds-3543	106	52	(	(	PUNCT
ijpds-3543	106	53	protein	protein	NOUN
ijpds-3543	106	54	was	be	AUX
ijpds-3543	106	55	tested	test	VERB
ijpds-3543	106	56	3	3	NUM
ijpds-3543	106	57	hours	hour	NOUN
ijpds-3543	106	58	after	after	ADP
ijpds-3543	106	59	lps	lps	PROPN
ijpds-3543	106	60	,	,	PUNCT
ijpds-3543	106	61	mrna	mrna	NOUN
ijpds-3543	106	62	2	2	NUM
ijpds-3543	106	63	hours	hour	NOUN
ijpds-3543	106	64	after	after	ADP
ijpds-3543	106	65	lps	lps	PROPN
ijpds-3543	106	66	)	)	PUNCT
ijpds-3543	106	67	and/or	and/or	CCONJ
ijpds-3543	106	68	sensitivity	sensitivity	NOUN
ijpds-3543	106	69	of	of	ADP
ijpds-3543	106	70	the	the	DET
ijpds-3543	106	71	two	two	NUM
ijpds-3543	106	72	assays	assay	NOUN
ijpds-3543	106	73	.	.	PUNCT
ijpds-3543	107	1	these	these	DET
ijpds-3543	107	2	disparities	disparity	NOUN
ijpds-3543	107	3	could	could	AUX
ijpds-3543	107	4	be	be	AUX
ijpds-3543	107	5	due	due	ADJ
ijpds-3543	107	6	to	to	ADP
ijpds-3543	107	7	the	the	DET
ijpds-3543	107	8	methods	method	NOUN
ijpds-3543	107	9	utilized	utilize	VERB
ijpds-3543	107	10	(	(	PUNCT
ijpds-3543	107	11	elisa	elisa	X
ijpds-3543	107	12	versus	versus	ADP
ijpds-3543	107	13	northern	northern	ADJ
ijpds-3543	107	14	blotting	blotting	NOUN
ijpds-3543	107	15	)	)	PUNCT
ijpds-3543	107	16	.	.	PUNCT
ijpds-3543	108	1	ib	ib	PROPN
ijpds-3543	108	2	-	-	PUNCT
ijpds-3543	108	3	meca	meca	PROPN
ijpds-3543	108	4	inhibited	inhibit	VERB
ijpds-3543	108	5	mip-1α	mip-1α	NOUN
ijpds-3543	108	6	production	production	NOUN
ijpds-3543	108	7	the	the	DET
ijpds-3543	108	8	most	most	ADV
ijpds-3543	108	9	strongly	strongly	ADV
ijpds-3543	108	10	of	of	ADP
ijpds-3543	108	11	all	all	DET
ijpds-3543	108	12	the	the	DET
ijpds-3543	108	13	adenosine	adenosine	NOUN
ijpds-3543	108	14	agonists	agonist	NOUN
ijpds-3543	108	15	tested	test	VERB
ijpds-3543	108	16	.	.	PUNCT
ijpds-3543	109	1	as	as	ADP
ijpds-3543	109	2	a	a	DET
ijpds-3543	109	3	result	result	NOUN
ijpds-3543	109	4	,	,	PUNCT
ijpds-3543	109	5	we	we	PRON
ijpds-3543	109	6	examined	examine	VERB
ijpds-3543	109	7	the	the	DET
ijpds-3543	109	8	effect	effect	NOUN
ijpds-3543	109	9	of	of	ADP
ijpds-3543	109	10	this	this	DET
ijpds-3543	109	11	agonist	agonist	NOUN
ijpds-3543	109	12	on	on	ADP
ijpds-3543	109	13	the	the	DET
ijpds-3543	109	14	generation	generation	NOUN
ijpds-3543	109	15	of	of	ADP
ijpds-3543	109	16	other	other	ADJ
ijpds-3543	109	17	inflammatory	inflammatory	ADJ
ijpds-3543	109	18	mediators	mediator	NOUN
ijpds-3543	109	19	(	(	PUNCT
ijpds-3543	109	20	il-12	il-12	NOUN
ijpds-3543	109	21	,	,	PUNCT
ijpds-3543	109	22	il-	il-	PRON
ijpds-3543	109	23	,	,	PUNCT
ijpds-3543	109	24	no	no	INTJ
ijpds-3543	109	25	)	)	PUNCT
ijpds-3543	109	26	by	by	ADP
ijpds-3543	109	27	activated	activate	VERB
ijpds-3543	109	28	macrophages	macrophage	NOUN
ijpds-3543	109	29	and	and	CCONJ
ijpds-3543	109	30	in	in	ADP
ijpds-3543	109	31	an	an	DET
ijpds-3543	109	32	in	in	ADP
ijpds-3543	109	33	vivo	vivo	NOUN
ijpds-3543	109	34	model	model	NOUN
ijpds-3543	109	35	of	of	ADP
ijpds-3543	109	36	inflammation	inflammation	NOUN
ijpds-3543	109	37	in	in	ADP
ijpds-3543	109	38	the	the	DET
ijpds-3543	109	39	following	follow	VERB
ijpds-3543	109	40	experiments	experiment	NOUN
ijpds-3543	109	41	.	.	PUNCT
ijpds-3543	110	1	lps	lps	PROPN
ijpds-3543	110	2	(	(	PUNCT
ijpds-3543	110	3	10	10	NUM
ijpds-3543	110	4	g	g	PROPN
ijpds-3543	110	5	ml—1	ml—1	NOUN
ijpds-3543	110	6	)	)	PUNCT
ijpds-3543	110	7	or	or	CCONJ
ijpds-3543	110	8	ifn(200	ifn(200	PRON
ijpds-3543	110	9	u	u	NOUN
ijpds-3543	110	10	ml—1	ml—1	NOUN
ijpds-3543	110	11	)	)	PUNCT
ijpds-3543	110	12	did	do	AUX
ijpds-3543	110	13	not	not	PART
ijpds-3543	110	14	elicit	elicit	VERB
ijpds-3543	110	15	measurable	measurable	ADJ
ijpds-3543	110	16	levels	level	NOUN
ijpds-3543	110	17	of	of	ADP
ijpds-3543	110	18	il-12	il-12	NOUN
ijpds-3543	110	19	(	(	PUNCT
ijpds-3543	110	20	p40	p40	NOUN
ijpds-3543	110	21	or	or	CCONJ
ijpds-3543	110	22	p70	p70	NOUN
ijpds-3543	110	23	)	)	PUNCT
ijpds-3543	110	24	sonwani	sonwani	NOUN
ijpds-3543	110	25	et	et	PROPN
ijpds-3543	110	26	al	al	PROPN
ijpds-3543	110	27	.	.	PROPN
ijpds-3543	110	28	role	role	NOUN
ijpds-3543	110	29	of	of	ADP
ijpds-3543	110	30	adenosine	adenosine	ADJ
ijpds-3543	110	31	receptor	receptor	NOUN
ijpds-3543	110	32	agonists	agonist	NOUN
ijpds-3543	110	33	in	in	ADP
ijpds-3543	110	34	inflammatory	inflammatory	ADJ
ijpds-3543	110	35	conditions	condition	NOUN
ijpds-3543	110	36	vol	vol	NOUN
ijpds-3543	110	37	2	2	NUM
ijpds-3543	110	38	|	|	NOUN
ijpds-3543	110	39	issue	issue	NOUN
ijpds-3543	110	40	2	2	NUM
ijpds-3543	110	41	|	|	ADV
ijpds-3543	110	42	apr	apr	ADV
ijpds-3543	110	43	–	–	PUNCT
ijpds-3543	110	44	jun	jun	PROPN
ijpds-3543	110	45	2023	2023	NUM
ijpds-3543	110	46	indian	indian	PROPN
ijpds-3543	110	47	j	j	PROPN
ijpds-3543	110	48	pharm	pharm	PROPN
ijpds-3543	110	49	drug	drug	PROPN
ijpds-3543	110	50	studies	study	NOUN
ijpds-3543	110	51	|	|	ADV
ijpds-3543	110	52	72	72	NUM
ijpds-3543	110	53	in	in	ADP
ijpds-3543	110	54	raw	raw	ADJ
ijpds-3543	110	55	24.7	24.7	NUM
ijpds-3543	110	56	macrophages	macrophage	NOUN
ijpds-3543	110	57	after	after	ADP
ijpds-3543	110	58	a	a	DET
ijpds-3543	110	59	24	24	NUM
ijpds-3543	110	60	-	-	PUNCT
ijpds-3543	110	61	hour	hour	NOUN
ijpds-3543	110	62	treatment	treatment	NOUN
ijpds-3543	110	63	even	even	ADV
ijpds-3543	110	64	though	though	SCONJ
ijpds-3543	110	65	the	the	DET
ijpds-3543	110	66	combination	combination	NOUN
ijpds-3543	110	67	of	of	ADP
ijpds-3543	110	68	lps	lps	PROPN
ijpds-3543	110	69	(	(	PUNCT
ijpds-3543	110	70	10	10	NUM
ijpds-3543	110	71	g	g	PROPN
ijpds-3543	110	72	ml—1	ml—1	NOUN
ijpds-3543	110	73	)	)	PUNCT
ijpds-3543	110	74	and	and	CCONJ
ijpds-3543	110	75	ifn(200	ifn(200	ADP
ijpds-3543	110	76	u	u	PROPN
ijpds-3543	110	77	ml—1	ml—1	NOUN
ijpds-3543	110	78	)	)	PUNCT
ijpds-3543	110	79	promoted	promote	VERB
ijpds-3543	110	80	the	the	DET
ijpds-3543	110	81	production	production	NOUN
ijpds-3543	110	82	of	of	ADP
ijpds-3543	110	83	il-12	il-12	DET
ijpds-3543	110	84	p40	p40	NOUN
ijpds-3543	110	85	(	(	PUNCT
ijpds-3543	110	86	figure	figure	NOUN
ijpds-3543	110	87	4a	4a	NUM
ijpds-3543	110	88	)	)	PUNCT
ijpds-3543	110	89	,	,	PUNCT
ijpds-3543	110	90	il-12	il-12	VERB
ijpds-3543	110	91	p70	p70	PROPN
ijpds-3543	110	92	was	be	AUX
ijpds-3543	110	93	not	not	PART
ijpds-3543	110	94	generated	generate	VERB
ijpds-3543	110	95	in	in	ADP
ijpds-3543	110	96	measurable	measurable	ADJ
ijpds-3543	110	97	amounts	amount	NOUN
ijpds-3543	110	98	.	.	PUNCT
ijpds-3543	111	1	pretreatment	pretreatment	NOUN
ijpds-3543	111	2	of	of	ADP
ijpds-3543	111	3	cells	cell	NOUN
ijpds-3543	111	4	with	with	ADP
ijpds-3543	111	5	ib	ib	PROPN
ijpds-3543	111	6	-	-	PUNCT
ijpds-3543	111	7	meca	meca	NOUN
ijpds-3543	111	8	30	30	NUM
ijpds-3543	111	9	minutes	minute	NOUN
ijpds-3543	111	10	before	before	ADP
ijpds-3543	111	11	lps	lps	PROPN
ijpds-3543	111	12	+	+	CCONJ
ijpds-3543	111	13	ifnresulted	ifnresulte	VERB
ijpds-3543	111	14	in	in	ADP
ijpds-3543	111	15	a	a	DET
ijpds-3543	111	16	concentrationdependent	concentrationdependent	NOUN
ijpds-3543	111	17	reduction	reduction	NOUN
ijpds-3543	111	18	of	of	ADP
ijpds-3543	111	19	il-12	il-12	DET
ijpds-3543	111	20	p40	p40	NOUN
ijpds-3543	111	21	production	production	NOUN
ijpds-3543	111	22	,	,	PUNCT
ijpds-3543	111	23	as	as	SCONJ
ijpds-3543	111	24	measured	measure	VERB
ijpds-3543	111	25	at	at	ADP
ijpds-3543	111	26	24	24	NUM
ijpds-3543	111	27	hours	hour	NOUN
ijpds-3543	111	28	(	(	PUNCT
ijpds-3543	111	29	figure	figure	NOUN
ijpds-3543	111	30	4a	4a	NUM
ijpds-3543	111	31	)	)	PUNCT
ijpds-3543	111	32	.	.	PUNCT
ijpds-3543	112	1	as	as	SCONJ
ijpds-3543	112	2	determined	determine	VERB
ijpds-3543	112	3	24	24	NUM
ijpds-3543	112	4	hours	hour	NOUN
ijpds-3543	112	5	after	after	ADP
ijpds-3543	112	6	stimulation	stimulation	NOUN
ijpds-3543	112	7	,	,	PUNCT
ijpds-3543	112	8	lps	lps	PROPN
ijpds-3543	112	9	(	(	PUNCT
ijpds-3543	112	10	10	10	NUM
ijpds-3543	112	11	g	g	PROPN
ijpds-3543	112	12	ml—1	ml—1	NOUN
ijpds-3543	112	13	)	)	PUNCT
ijpds-3543	112	14	stimulated	stimulate	VERB
ijpds-3543	112	15	the	the	DET
ijpds-3543	112	16	release	release	NOUN
ijpds-3543	112	17	of	of	ADP
ijpds-3543	112	18	iland	iland	ADJ
ijpds-3543	112	19	nitrite	nitrite	NOUN
ijpds-3543	112	20	(	(	PUNCT
ijpds-3543	112	21	the	the	DET
ijpds-3543	112	22	breakdown	breakdown	ADJ
ijpds-3543	112	23	product	product	NOUN
ijpds-3543	112	24	of	of	ADP
ijpds-3543	112	25	no	no	NOUN
ijpds-3543	112	26	)	)	PUNCT
ijpds-3543	112	27	in	in	ADP
ijpds-3543	112	28	the	the	DET
ijpds-3543	112	29	culture	culture	NOUN
ijpds-3543	112	30	supernatants	supernatant	NOUN
ijpds-3543	112	31	of	of	ADP
ijpds-3543	112	32	raw	raw	ADJ
ijpds-3543	112	33	24.7	24.7	NUM
ijpds-3543	112	34	cells	cell	NOUN
ijpds-3543	112	35	.	.	PUNCT
ijpds-3543	113	1	ib	ib	PROPN
ijpds-3543	113	2	-	-	PUNCT
ijpds-3543	113	3	meca	meca	PROPN
ijpds-3543	113	4	,	,	PUNCT
ijpds-3543	113	5	administered	administer	VERB
ijpds-3543	113	6	30	30	NUM
ijpds-3543	113	7	minutes	minute	NOUN
ijpds-3543	113	8	before	before	ADP
ijpds-3543	113	9	lps	lps	PROPN
ijpds-3543	113	10	,	,	PUNCT
ijpds-3543	113	11	reduced	reduce	VERB
ijpds-3543	113	12	the	the	DET
ijpds-3543	113	13	generation	generation	NOUN
ijpds-3543	113	14	of	of	ADP
ijpds-3543	113	15	iland	iland	ADJ
ijpds-3543	113	16	nitrite	nitrite	NOUN
ijpds-3543	113	17	(	(	PUNCT
ijpds-3543	113	18	figure	figure	VERB
ijpds-3543	113	19	4b	4b	NOUN
ijpds-3543	113	20	and	and	CCONJ
ijpds-3543	113	21	c	c	NOUN
ijpds-3543	113	22	)	)	PUNCT
ijpds-3543	113	23	.	.	PUNCT
ijpds-3543	114	1	in	in	ADP
ijpds-3543	114	2	all	all	PRON
ijpds-3543	114	3	of	of	ADP
ijpds-3543	114	4	these	these	DET
ijpds-3543	114	5	trials	trial	NOUN
ijpds-3543	114	6	,	,	PUNCT
ijpds-3543	114	7	ib	ib	PROPN
ijpds-3543	114	8	-	-	PUNCT
ijpds-3543	114	9	meca	meca	PROPN
ijpds-3543	114	10	had	have	VERB
ijpds-3543	114	11	no	no	DET
ijpds-3543	114	12	effect	effect	NOUN
ijpds-3543	114	13	on	on	ADP
ijpds-3543	114	14	cell	cell	NOUN
ijpds-3543	114	15	viability	viability	NOUN
ijpds-3543	114	16	as	as	SCONJ
ijpds-3543	114	17	assessed	assess	VERB
ijpds-3543	114	18	by	by	ADP
ijpds-3543	114	19	the	the	DET
ijpds-3543	114	20	mtt	mtt	NOUN
ijpds-3543	114	21	assay	assay	NOUN
ijpds-3543	114	22	(	(	PUNCT
ijpds-3543	114	23	not	not	PART
ijpds-3543	114	24	shown	show	VERB
ijpds-3543	114	25	)	)	PUNCT
ijpds-3543	114	26	.	.	PUNCT
ijpds-3543	115	1	ibstronger	ibstronger	PROPN
ijpds-3543	115	2	meca	meca	PROPN
ijpds-3543	115	3	's	's	PART
ijpds-3543	115	4	inhibition	inhibition	NOUN
ijpds-3543	115	5	of	of	ADP
ijpds-3543	115	6	il-12	il-12	NOUN
ijpds-3543	115	7	and	and	CCONJ
ijpds-3543	115	8	mip-1α	mip-1α	NOUN
ijpds-3543	115	9	and	and	CCONJ
ijpds-3543	115	10	less	less	ADJ
ijpds-3543	115	11	reduction	reduction	NOUN
ijpds-3543	115	12	of	of	ADP
ijpds-3543	115	13	no	no	PRON
ijpds-3543	115	14	and	and	CCONJ
ijpds-3543	115	15	ilproduction	ilproduction	NOUN
ijpds-3543	115	16	could	could	AUX
ijpds-3543	115	17	be	be	AUX
ijpds-3543	115	18	due	due	ADJ
ijpds-3543	115	19	to	to	ADP
ijpds-3543	115	20	two	two	NUM
ijpds-3543	115	21	distinct	distinct	ADJ
ijpds-3543	115	22	a3	a3	NOUN
ijpds-3543	115	23	receptor	receptor	NOUN
ijpds-3543	115	24	subtypes	subtype	NOUN
ijpds-3543	115	25	.	.	PUNCT
ijpds-3543	116	1	the	the	DET
ijpds-3543	116	2	recent	recent	ADJ
ijpds-3543	116	3	research	research	NOUN
ijpds-3543	116	4	,	,	PUNCT
ijpds-3543	116	5	on	on	ADP
ijpds-3543	116	6	the	the	DET
ijpds-3543	116	7	other	other	ADJ
ijpds-3543	116	8	hand	hand	NOUN
ijpds-3543	116	9	.	.	PUNCT
ijpds-3543	117	1	ib	ib	PROPN
ijpds-3543	117	2	-	-	PUNCT
ijpds-3543	117	3	meca	meca	PROPN
ijpds-3543	117	4	therapy	therapy	NOUN
ijpds-3543	117	5	protects	protect	VERB
ijpds-3543	117	6	mice	mouse	NOUN
ijpds-3543	117	7	from	from	ADP
ijpds-3543	117	8	collagen	collagen	NOUN
ijpds-3543	117	9	-	-	PUNCT
ijpds-3543	117	10	induced	induce	VERB
ijpds-3543	117	11	arthritis	arthritis	NOUN
ijpds-3543	117	12	:	:	PUNCT
ijpds-3543	117	13	the	the	DET
ijpds-3543	117	14	majority	majority	NOUN
ijpds-3543	117	15	of	of	ADP
ijpds-3543	117	16	the	the	DET
ijpds-3543	117	17	vehicle	vehicle	NOUN
ijpds-3543	117	18	-	-	PUNCT
ijpds-3543	117	19	treated	treat	VERB
ijpds-3543	117	20	mice	mouse	NOUN
ijpds-3543	117	21	developed	develop	VERB
ijpds-3543	117	22	arthritis	arthritis	NOUN
ijpds-3543	117	23	between	between	ADP
ijpds-3543	117	24	days	day	NOUN
ijpds-3543	117	25	2	2	NUM
ijpds-3543	117	26	and	and	CCONJ
ijpds-3543	117	27	35	35	NUM
ijpds-3543	117	28	after	after	ADP
ijpds-3543	117	29	the	the	DET
ijpds-3543	117	30	first	first	ADJ
ijpds-3543	117	31	collagen	collagen	NOUN
ijpds-3543	117	32	immunization	immunization	NOUN
ijpds-3543	117	33	treatment	treatment	NOUN
ijpds-3543	117	34	with	with	ADP
ijpds-3543	117	35	ib	ib	PROPN
ijpds-3543	117	36	-	-	PUNCT
ijpds-3543	117	37	meca	meca	PROPN
ijpds-3543	117	38	(	(	PUNCT
ijpds-3543	117	39	0.5	0.5	NUM
ijpds-3543	117	40	mg	mg	PROPN
ijpds-3543	117	41	/	/	SYM
ijpds-3543	117	42	kg	kg	PROPN
ijpds-3543	117	43	once	once	ADV
ijpds-3543	117	44	day	day	PROPN
ijpds-3543	117	45	i.p	i.p	PROPN
ijpds-3543	117	46	.	.	PROPN
ijpds-3543	117	47	)	)	PUNCT
ijpds-3543	118	1	reduced	reduce	VERB
ijpds-3543	118	2	the	the	DET
ijpds-3543	118	3	occurrence	occurrence	NOUN
ijpds-3543	118	4	of	of	ADP
ijpds-3543	118	5	arthritis	arthritis	NOUN
ijpds-3543	118	6	and	and	CCONJ
ijpds-3543	118	7	lowered	lower	VERB
ijpds-3543	118	8	the	the	DET
ijpds-3543	118	9	disease	disease	NOUN
ijpds-3543	118	10	's	's	PART
ijpds-3543	118	11	severity	severity	NOUN
ijpds-3543	118	12	.	.	PUNCT
ijpds-3543	119	1	the	the	DET
ijpds-3543	119	2	paws	paw	NOUN
ijpds-3543	119	3	of	of	ADP
ijpds-3543	119	4	the	the	DET
ijpds-3543	119	5	vehicletreated	vehicletreate	VERB
ijpds-3543	119	6	arthritic	arthritic	ADJ
ijpds-3543	119	7	animals	animal	NOUN
ijpds-3543	119	8	showed	show	VERB
ijpds-3543	119	9	evidence	evidence	NOUN
ijpds-3543	119	10	of	of	ADP
ijpds-3543	119	11	severe	severe	ADJ
ijpds-3543	119	12	suppurative	suppurative	ADJ
ijpds-3543	119	13	arthritis	arthritis	NOUN
ijpds-3543	119	14	at	at	ADP
ijpds-3543	119	15	day	day	NOUN
ijpds-3543	119	16	35	35	NUM
ijpds-3543	119	17	,	,	PUNCT
ijpds-3543	119	18	with	with	ADP
ijpds-3543	119	19	extensive	extensive	ADJ
ijpds-3543	119	20	neutrophil	neutrophil	ADJ
ijpds-3543	119	21	,	,	PUNCT
ijpds-3543	119	22	macrophage	macrophage	ADJ
ijpds-3543	119	23	,	,	PUNCT
ijpds-3543	119	24	and	and	CCONJ
ijpds-3543	119	25	lymphocyte	lymphocyte	ADJ
ijpds-3543	119	26	infiltration	infiltration	NOUN
ijpds-3543	119	27	.	.	PUNCT
ijpds-3543	120	1	in	in	ADP
ijpds-3543	120	2	addition	addition	NOUN
ijpds-3543	120	3	,	,	PUNCT
ijpds-3543	120	4	there	there	PRON
ijpds-3543	120	5	was	be	VERB
ijpds-3543	120	6	severe	severe	ADJ
ijpds-3543	120	7	or	or	CCONJ
ijpds-3543	120	8	moderate	moderate	ADJ
ijpds-3543	120	9	necrosis	necrosis	NOUN
ijpds-3543	120	10	,	,	PUNCT
ijpds-3543	120	11	hyperplasia	hyperplasia	NOUN
ijpds-3543	120	12	,	,	PUNCT
ijpds-3543	120	13	and	and	CCONJ
ijpds-3543	120	14	sloughing	sloughing	NOUN
ijpds-3543	120	15	of	of	ADP
ijpds-3543	120	16	the	the	DET
ijpds-3543	120	17	synovium	synovium	NOUN
ijpds-3543	120	18	,	,	PUNCT
ijpds-3543	120	19	as	as	ADV
ijpds-3543	120	20	well	well	ADV
ijpds-3543	120	21	as	as	ADP
ijpds-3543	120	22	inflammation	inflammation	NOUN
ijpds-3543	120	23	spreading	spread	VERB
ijpds-3543	120	24	into	into	ADP
ijpds-3543	120	25	the	the	DET
ijpds-3543	120	26	neighboring	neighboring	NOUN
ijpds-3543	120	27	musculature	musculature	NOUN
ijpds-3543	120	28	the	the	DET
ijpds-3543	120	29	degree	degree	NOUN
ijpds-3543	120	30	of	of	ADP
ijpds-3543	120	31	arthritis	arthritis	NOUN
ijpds-3543	120	32	was	be	AUX
ijpds-3543	120	33	dramatically	dramatically	ADV
ijpds-3543	120	34	reduced	reduce	VERB
ijpds-3543	120	35	in	in	ADP
ijpds-3543	120	36	the	the	DET
ijpds-3543	120	37	ib	ib	PROPN
ijpds-3543	120	38	-	-	PUNCT
ijpds-3543	120	39	meca	meca	PROPN
ijpds-3543	120	40	treated	treat	VERB
ijpds-3543	120	41	mice	mouse	NOUN
ijpds-3543	120	42	,	,	PUNCT
ijpds-3543	120	43	with	with	ADP
ijpds-3543	120	44	moderate	moderate	ADJ
ijpds-3543	120	45	cell	cell	NOUN
ijpds-3543	120	46	infiltration	infiltration	NOUN
ijpds-3543	120	47	,	,	PUNCT
ijpds-3543	120	48	mild	mild	ADJ
ijpds-3543	120	49	to	to	ADP
ijpds-3543	120	50	moderate	moderate	ADJ
ijpds-3543	120	51	necrosis	necrosis	NOUN
ijpds-3543	120	52	,	,	PUNCT
ijpds-3543	120	53	and	and	CCONJ
ijpds-3543	120	54	synovial	synovial	ADJ
ijpds-3543	120	55	hyperplasia	hyperplasia	NOUN
ijpds-3543	120	56	the	the	DET
ijpds-3543	120	57	reduction	reduction	NOUN
ijpds-3543	120	58	in	in	ADP
ijpds-3543	120	59	neutrophil	neutrophil	ADJ
ijpds-3543	120	60	infiltration	infiltration	NOUN
ijpds-3543	120	61	was	be	AUX
ijpds-3543	120	62	measured	measure	VERB
ijpds-3543	120	63	by	by	ADP
ijpds-3543	120	64	paw	paw	PROPN
ijpds-3543	120	65	myeloperoxidase	myeloperoxidase	NOUN
ijpds-3543	120	66	.	.	PUNCT
ijpds-3543	121	1	arthritis	arthritis	NOUN
ijpds-3543	121	2	induced	induce	VERB
ijpds-3543	121	3	a	a	DET
ijpds-3543	121	4	991	991	NUM
ijpds-3543	121	5	mu	mu	NOUN
ijpds-3543	121	6	/	/	SYM
ijpds-3543	121	7	mg	mg	PROPN
ijpds-3543	121	8	protein	protein	NOUN
ijpds-3543	121	9	increase	increase	NOUN
ijpds-3543	121	10	in	in	ADP
ijpds-3543	121	11	myeloperoxidase	myeloperoxidase	NOUN
ijpds-3543	121	12	levels	level	NOUN
ijpds-3543	121	13	(	(	PUNCT
ijpds-3543	121	14	n=12	n=12	NOUN
ijpds-3543	121	15	)	)	PUNCT
ijpds-3543	121	16	.	.	PUNCT
ijpds-3543	122	1	there	there	PRON
ijpds-3543	122	2	was	be	VERB
ijpds-3543	122	3	a	a	DET
ijpds-3543	122	4	significant	significant	ADJ
ijpds-3543	122	5	increase	increase	NOUN
ijpds-3543	122	6	in	in	ADP
ijpds-3543	122	7	the	the	DET
ijpds-3543	122	8	number	number	NOUN
ijpds-3543	122	9	of	of	ADP
ijpds-3543	122	10	ib	ib	PROPN
ijpds-3543	122	11	-	-	PUNCT
ijpds-3543	122	12	meca	meca	NOUN
ijpds-3543	122	13	-	-	PUNCT
ijpds-3543	122	14	treated	treat	VERB
ijpds-3543	122	15	animals	animal	NOUN
ijpds-3543	122	16	.	.	PUNCT
ijpds-3543	123	1	at	at	ADP
ijpds-3543	123	2	the	the	DET
ijpds-3543	123	3	end	end	NOUN
ijpds-3543	123	4	of	of	ADP
ijpds-3543	123	5	arthritis	arthritis	NOUN
ijpds-3543	123	6	,	,	PUNCT
ijpds-3543	123	7	there	there	PRON
ijpds-3543	123	8	was	be	VERB
ijpds-3543	123	9	a	a	DET
ijpds-3543	123	10	substantially	substantially	ADV
ijpds-3543	123	11	decreased	decrease	VERB
ijpds-3543	123	12	degree	degree	NOUN
ijpds-3543	123	13	of	of	ADP
ijpds-3543	123	14	rise	rise	NOUN
ijpds-3543	123	15	in	in	ADP
ijpds-3543	123	16	the	the	DET
ijpds-3543	123	17	paw	paw	PROPN
ijpds-3543	123	18	myeloperoxidase	myeloperoxidase	NOUN
ijpds-3543	123	19	concentration	concentration	NOUN
ijpds-3543	123	20	(	(	PUNCT
ijpds-3543	123	21	3	3	NUM
ijpds-3543	123	22	mu	mu	NOUN
ijpds-3543	123	23	/	/	SYM
ijpds-3543	123	24	mg	mg	PROPN
ijpds-3543	123	25	protein	protein	NOUN
ijpds-3543	123	26	;	;	PUNCT
ijpds-3543	123	27	n=12	n=12	NOUN
ijpds-3543	123	28	,	,	PUNCT
ijpds-3543	123	29	p0.01	p0.01	PROPN
ijpds-3543	123	30	)	)	PUNCT
ijpds-3543	123	31	.	.	PUNCT
ijpds-3543	124	1	at	at	ADP
ijpds-3543	124	2	35	35	NUM
ijpds-3543	124	3	days	day	NOUN
ijpds-3543	124	4	,	,	PUNCT
ijpds-3543	124	5	there	there	PRON
ijpds-3543	124	6	was	be	VERB
ijpds-3543	124	7	a	a	DET
ijpds-3543	124	8	considerable	considerable	ADJ
ijpds-3543	124	9	increase	increase	NOUN
ijpds-3543	124	10	in	in	ADP
ijpds-3543	124	11	mip-1α	mip-1α	NOUN
ijpds-3543	124	12	and	and	CCONJ
ijpds-3543	124	13	il-12	il-12	PRON
ijpds-3543	124	14	p40	p40	NOUN
ijpds-3543	124	15	levels	level	NOUN
ijpds-3543	124	16	in	in	ADP
ijpds-3543	124	17	the	the	DET
ijpds-3543	124	18	aqueous	aqueous	ADJ
ijpds-3543	124	19	extracts	extract	NOUN
ijpds-3543	124	20	of	of	ADP
ijpds-3543	124	21	the	the	DET
ijpds-3543	124	22	arthritic	arthritic	ADJ
ijpds-3543	124	23	paws	paw	NOUN
ijpds-3543	124	24	,	,	PUNCT
ijpds-3543	124	25	but	but	CCONJ
ijpds-3543	124	26	no	no	DET
ijpds-3543	124	27	detectable	detectable	ADJ
ijpds-3543	124	28	tnf	tnf	PROPN
ijpds-3543	124	29	-	-	PUNCT
ijpds-3543	124	30	α	α	PROPN
ijpds-3543	124	31	or	or	CCONJ
ijpds-3543	124	32	il12	il12	PROPN
ijpds-3543	124	33	p70	p70	NOUN
ijpds-3543	124	34	levels	level	NOUN
ijpds-3543	124	35	in	in	ADP
ijpds-3543	124	36	the	the	DET
ijpds-3543	124	37	extracts	extract	NOUN
ijpds-3543	124	38	ibmeca	ibmeca	NOUN
ijpds-3543	124	39	therapy	therapy	NOUN
ijpds-3543	124	40	reduced	reduce	VERB
ijpds-3543	124	41	the	the	DET
ijpds-3543	124	42	formation	formation	NOUN
ijpds-3543	124	43	of	of	ADP
ijpds-3543	124	44	lps	lps	PROPN
ijpds-3543	124	45	-	-	PUNCT
ijpds-3543	124	46	stimulated	stimulate	VERB
ijpds-3543	124	47	cells	cell	NOUN
ijpds-3543	124	48	or	or	CCONJ
ijpds-3543	124	49	lps	lps	PROPN
ijpds-3543	124	50	-	-	PUNCT
ijpds-3543	124	51	challenged	challenge	VERB
ijpds-3543	124	52	animals	animal	NOUN
ijpds-3543	124	53	,	,	PUNCT
ijpds-3543	124	54	according	accord	VERB
ijpds-3543	124	55	to	to	ADP
ijpds-3543	124	56	the	the	DET
ijpds-3543	124	57	results	result	NOUN
ijpds-3543	124	58	in	in	ADP
ijpds-3543	124	59	lps	lps	PROPN
ijpds-3543	124	60	-	-	PUNCT
ijpds-3543	124	61	stimulated	stimulate	VERB
ijpds-3543	124	62	cells	cell	NOUN
ijpds-3543	124	63	or	or	CCONJ
ijpds-3543	124	64	lps	lps	PROPN
ijpds-3543	124	65	-	-	PUNCT
ijpds-3543	124	66	challenged	challenge	VERB
ijpds-3543	124	67	animals	animal	NOUN
ijpds-3543	124	68	.	.	PUNCT
ijpds-3543	125	1	increased	increase	VERB
ijpds-3543	125	2	levels	level	NOUN
ijpds-3543	125	3	of	of	ADP
ijpds-3543	125	4	il12	il12	PROPN
ijpds-3543	125	5	p40	p40	NOUN
ijpds-3543	125	6	and	and	CCONJ
ijpds-3543	125	7	mip-1α	mip-1α	NOUN
ijpds-3543	125	8	in	in	ADP
ijpds-3543	125	9	the	the	DET
ijpds-3543	125	10	joints	joint	NOUN
ijpds-3543	125	11	(	(	PUNCT
ijpds-3543	125	12	figure	figure	NOUN
ijpds-3543	125	13	7	7	NUM
ijpds-3543	125	14	)	)	PUNCT
ijpds-3543	125	15	.	.	PUNCT
ijpds-3543	126	1	we	we	PRON
ijpds-3543	126	2	detected	detect	VERB
ijpds-3543	126	3	the	the	DET
ijpds-3543	126	4	emergence	emergence	NOUN
ijpds-3543	126	5	of	of	ADP
ijpds-3543	126	6	nitrotyrosine	nitrotyrosine	NOUN
ijpds-3543	126	7	-	-	PUNCT
ijpds-3543	126	8	positive	positive	ADJ
ijpds-3543	126	9	staining	staining	NOUN
ijpds-3543	126	10	in	in	ADP
ijpds-3543	126	11	the	the	DET
ijpds-3543	126	12	inflamed	inflame	VERB
ijpds-3543	126	13	joints	joint	NOUN
ijpds-3543	126	14	using	use	VERB
ijpds-3543	126	15	immunohistochemistry	immunohistochemistry	NOUN
ijpds-3543	126	16	and	and	CCONJ
ijpds-3543	126	17	western	western	ADJ
ijpds-3543	126	18	blotting	blotting	NOUN
ijpds-3543	126	19	of	of	ADP
ijpds-3543	126	20	proteins	protein	NOUN
ijpds-3543	126	21	in	in	ADP
ijpds-3543	126	22	aqueous	aqueous	ADJ
ijpds-3543	126	23	joint	joint	ADJ
ijpds-3543	126	24	extracts	extract	NOUN
ijpds-3543	126	25	,	,	PUNCT
ijpds-3543	126	26	but	but	CCONJ
ijpds-3543	126	27	not	not	PART
ijpds-3543	126	28	in	in	ADP
ijpds-3543	126	29	healthy	healthy	ADJ
ijpds-3543	126	30	control	control	NOUN
ijpds-3543	126	31	animals	animal	NOUN
ijpds-3543	126	32	.	.	PUNCT
ijpds-3543	127	1	the	the	DET
ijpds-3543	127	2	degree	degree	NOUN
ijpds-3543	127	3	of	of	ADP
ijpds-3543	127	4	nitrotyrosine	nitrotyrosine	NOUN
ijpds-3543	127	5	staining	stain	VERB
ijpds-3543	127	6	was	be	AUX
ijpds-3543	127	7	lowered	lower	VERB
ijpds-3543	127	8	after	after	ADP
ijpds-3543	127	9	ibmeca	ibmeca	NOUN
ijpds-3543	127	10	therapy	therapy	NOUN
ijpds-3543	127	11	(	(	PUNCT
ijpds-3543	127	12	figure	figure	NOUN
ijpds-3543	127	13	3	3	NUM
ijpds-3543	127	14	,	,	PUNCT
ijpds-3543	127	15	4	4	NUM
ijpds-3543	127	16	&	&	CCONJ
ijpds-3543	127	17	5	5	NUM
ijpds-3543	127	18	)	)	PUNCT
ijpds-3543	127	19	.	.	PUNCT
ijpds-3543	128	1	figure	figure	NOUN
ijpds-3543	128	2	1	1	NUM
ijpds-3543	128	3	(	(	PUNCT
ijpds-3543	128	4	a	a	PRON
ijpds-3543	128	5	):	):	PUNCT
ijpds-3543	128	6	effect	effect	NOUN
ijpds-3543	128	7	of	of	ADP
ijpds-3543	128	8	adenosine	adenosine	NOUN
ijpds-3543	129	1	[	[	X
ijpds-3543	129	2	ado	ado	X
ijpds-3543	129	3	]	]	X
ijpds-3543	129	4	,	,	PUNCT
ijpds-3543	129	5	the	the	DET
ijpds-3543	129	6	a1	a1	NOUN
ijpds-3543	129	7	agonist	agonist	NOUN
ijpds-3543	129	8	ccpa	ccpa	NOUN
ijpds-3543	129	9	,	,	PUNCT
ijpds-3543	129	10	the	the	DET
ijpds-3543	129	11	a2	a2	PROPN
ijpds-3543	129	12	agonist	agonist	NOUN
ijpds-3543	129	13	cgs	cgs	NOUN
ijpds-3543	129	14	,	,	PUNCT
ijpds-3543	129	15	and	and	CCONJ
ijpds-3543	129	16	the	the	DET
ijpds-3543	129	17	a3	a3	NOUN
ijpds-3543	129	18	agonist	agonist	NOUN
ijpds-3543	129	19	ibmeca	ibmeca	NOUN
ijpds-3543	129	20	on	on	ADP
ijpds-3543	129	21	the	the	DET
ijpds-3543	129	22	production	production	NOUN
ijpds-3543	129	23	of	of	ADP
ijpds-3543	129	24	mip-1α	mip-1α	PROPN
ijpds-3543	129	25	mrna	mrna	NOUN
ijpds-3543	129	26	in	in	ADP
ijpds-3543	129	27	response	response	NOUN
ijpds-3543	129	28	to	to	PART
ijpds-3543	129	29	stimulation	stimulation	VERB
ijpds-3543	129	30	with	with	ADP
ijpds-3543	129	31	bacterial	bacterial	ADJ
ijpds-3543	129	32	lipopoly	lipopoly	ADJ
ijpds-3543	129	33	-	-	PUNCT
ijpds-3543	129	34	saccharide	saccharide	NOUN
ijpds-3543	129	35	lps	lps	PROPN
ijpds-3543	129	36	(	(	PUNCT
ijpds-3543	129	37	10	10	NUM
ijpds-3543	129	38	ng	ng	PROPN
ijpds-3543	129	39	ml—1	ml—1	NOUN
ijpds-3543	129	40	)	)	PUNCT
ijpds-3543	129	41	in	in	ADP
ijpds-3543	129	42	raw	raw	ADJ
ijpds-3543	129	43	macrophages	macrophage	NOUN
ijpds-3543	129	44	.	.	PUNCT
ijpds-3543	130	1	(	(	PUNCT
ijpds-3543	130	2	a	a	X
ijpds-3543	130	3	)	)	PUNCT
ijpds-3543	130	4	dose	dose	NOUN
ijpds-3543	130	5	-	-	PUNCT
ijpds-3543	130	6	response	response	NOUN
ijpds-3543	130	7	showing	show	VERB
ijpds-3543	130	8	the	the	DET
ijpds-3543	130	9	effect	effect	NOUN
ijpds-3543	130	10	of	of	ADP
ijpds-3543	130	11	0.5	0.5	NUM
ijpds-3543	130	12	,	,	PUNCT
ijpds-3543	130	13	5	5	NUM
ijpds-3543	130	14	,	,	PUNCT
ijpds-3543	130	15	50	50	NUM
ijpds-3543	130	16	,	,	PUNCT
ijpds-3543	130	17	and	and	CCONJ
ijpds-3543	130	18	100	100	NUM
ijpds-3543	130	19	μm	μm	NUM
ijpds-3543	130	20	ib	ib	NOUN
ijpds-3543	130	21	-	-	PUNCT
ijpds-3543	130	22	meca	meca	NOUN
ijpds-3543	130	23	on	on	ADP
ijpds-3543	130	24	the	the	DET
ijpds-3543	130	25	production	production	NOUN
ijpds-3543	130	26	of	of	ADP
ijpds-3543	130	27	mip-1α	mip-1α	PROPN
ijpds-3543	130	28	mrna	mrna	NOUN
ijpds-3543	130	29	at	at	ADP
ijpds-3543	130	30	3	3	NUM
ijpds-3543	130	31	h	h	NOUN
ijpds-3543	130	32	after	after	ADP
ijpds-3543	130	33	stimulation	stimulation	NOUN
ijpds-3543	130	34	.	.	PUNCT
ijpds-3543	131	1	(	(	PUNCT
ijpds-3543	131	2	b	b	X
ijpds-3543	131	3	)	)	PUNCT
ijpds-3543	131	4	effect	effect	NOUN
ijpds-3543	131	5	of	of	ADP
ijpds-3543	131	6	adenosine	adenosine	NOUN
ijpds-3543	131	7	,	,	PUNCT
ijpds-3543	131	8	ccpa	ccpa	NOUN
ijpds-3543	131	9	,	,	PUNCT
ijpds-3543	131	10	cgs	cgs	NOUN
ijpds-3543	131	11	,	,	PUNCT
ijpds-3543	131	12	and	and	CCONJ
ijpds-3543	131	13	ib	ib	PROPN
ijpds-3543	131	14	-	-	PUNCT
ijpds-3543	131	15	meca	meca	PROPN
ijpds-3543	131	16	(	(	PUNCT
ijpds-3543	131	17	200	200	NUM
ijpds-3543	131	18	μm	μm	NOUN
ijpds-3543	131	19	each	each	PRON
ijpds-3543	131	20	)	)	PUNCT
ijpds-3543	131	21	on	on	ADP
ijpds-3543	131	22	the	the	DET
ijpds-3543	131	23	production	production	NOUN
ijpds-3543	131	24	of	of	ADP
ijpds-3543	131	25	mip-1α	mip-1α	PROPN
ijpds-3543	131	26	mrna	mrna	NOUN
ijpds-3543	131	27	at	at	ADP
ijpds-3543	131	28	3	3	NUM
ijpds-3543	131	29	h	h	NOUN
ijpds-3543	131	30	after	after	ADP
ijpds-3543	131	31	stimulation	stimulation	NOUN
ijpds-3543	131	32	.	.	PUNCT
ijpds-3543	132	1	representative	representative	ADJ
ijpds-3543	132	2	blots	blot	NOUN
ijpds-3543	132	3	of	of	ADP
ijpds-3543	132	4	n=3	n=3	PUNCT
ijpds-3543	132	5	−	−	ADP
ijpds-3543	132	6	4	4	NUM
ijpds-3543	132	7	blots	blot	NOUN
ijpds-3543	132	8	are	be	AUX
ijpds-3543	132	9	shown	show	VERB
ijpds-3543	132	10	;	;	PUNCT
ijpds-3543	132	11	18s	18s	NUM
ijpds-3543	132	12	mrna	mrna	PROPN
ijpds-3543	132	13	was	be	AUX
ijpds-3543	132	14	unaffected	unaffected	ADJ
ijpds-3543	132	15	by	by	ADP
ijpds-3543	132	16	any	any	PRON
ijpds-3543	132	17	of	of	ADP
ijpds-3543	132	18	the	the	DET
ijpds-3543	132	19	treatments	treatment	NOUN
ijpds-3543	132	20	were	be	AUX
ijpds-3543	132	21	.	.	PUNCT
ijpds-3543	133	1	this	this	DET
ijpds-3543	133	2	possibility	possibility	NOUN
ijpds-3543	133	3	was	be	AUX
ijpds-3543	133	4	not	not	PART
ijpds-3543	133	5	intended	intend	VERB
ijpds-3543	133	6	to	to	PART
ijpds-3543	133	7	be	be	AUX
ijpds-3543	133	8	explored	explore	VERB
ijpds-3543	133	9	.	.	PUNCT
ijpds-3543	134	1	figure	figure	NOUN
ijpds-3543	134	2	2	2	NUM
ijpds-3543	134	3	:	:	PUNCT
ijpds-3543	134	4	effect	effect	NOUN
ijpds-3543	134	5	of	of	ADP
ijpds-3543	134	6	adenosine	adenosine	NOUN
ijpds-3543	135	1	[	[	X
ijpds-3543	135	2	ado	ado	X
ijpds-3543	135	3	]	]	X
ijpds-3543	135	4	,	,	PUNCT
ijpds-3543	135	5	the	the	DET
ijpds-3543	135	6	a1	a1	NOUN
ijpds-3543	135	7	agonist	agonist	NOUN
ijpds-3543	135	8	ccpa	ccpa	NOUN
ijpds-3543	135	9	,	,	PUNCT
ijpds-3543	135	10	the	the	DET
ijpds-3543	135	11	a2	a2	PROPN
ijpds-3543	135	12	agonist	agonist	NOUN
ijpds-3543	135	13	cgs	cgs	NOUN
ijpds-3543	135	14	,	,	PUNCT
ijpds-3543	135	15	and	and	CCONJ
ijpds-3543	135	16	the	the	DET
ijpds-3543	135	17	a3	a3	NOUN
ijpds-3543	135	18	agonist	agonist	NOUN
ijpds-3543	135	19	ibmeca	ibmeca	NOUN
ijpds-3543	135	20	on	on	ADP
ijpds-3543	135	21	the	the	DET
ijpds-3543	135	22	production	production	NOUN
ijpds-3543	135	23	of	of	ADP
ijpds-3543	135	24	mip-1α	mip-1α	NOUN
ijpds-3543	135	25	at	at	ADP
ijpds-3543	135	26	3	3	NUM
ijpds-3543	135	27	h	h	NOUN
ijpds-3543	135	28	after	after	ADP
ijpds-3543	135	29	stimulation	stimulation	NOUN
ijpds-3543	135	30	with	with	ADP
ijpds-3543	135	31	bacterial	bacterial	ADJ
ijpds-3543	135	32	lipopolysaccharide	lipopolysaccharide	ADJ
ijpds-3543	135	33	lps	lps	PROPN
ijpds-3543	135	34	(	(	PUNCT
ijpds-3543	135	35	10	10	NUM
ijpds-3543	135	36	ng	ng	PROPN
ijpds-3543	135	37	ml—1	ml—1	NOUN
ijpds-3543	135	38	)	)	PUNCT
ijpds-3543	135	39	in	in	ADP
ijpds-3543	135	40	raw	raw	ADJ
ijpds-3543	135	41	macrophages	macrophage	NOUN
ijpds-3543	135	42	.	.	PUNCT
ijpds-3543	136	1	mip-1α	mip-1α	NOUN
ijpds-3543	136	2	production	production	NOUN
ijpds-3543	136	3	in	in	ADP
ijpds-3543	136	4	the	the	DET
ijpds-3543	136	5	absence	absence	NOUN
ijpds-3543	136	6	of	of	ADP
ijpds-3543	136	7	the	the	DET
ijpds-3543	136	8	inhibitors	inhibitor	NOUN
ijpds-3543	136	9	amounted	amount	VERB
ijpds-3543	136	10	to	to	ADP
ijpds-3543	136	11	б.б±1.3	б.б±1.3	PROPN
ijpds-3543	136	12	ng	ng	PROPN
ijpds-3543	136	13	ml—1	ml—1	NOUN
ijpds-3543	136	14	,	,	PUNCT
ijpds-3543	136	15	and	and	CCONJ
ijpds-3543	136	16	was	be	AUX
ijpds-3543	136	17	considered	consider	VERB
ijpds-3543	136	18	100	100	NUM
ijpds-3543	136	19	%	%	NOUN
ijpds-3543	136	20	.	.	PUNCT
ijpds-3543	137	1	n	n	CCONJ
ijpds-3543	138	1	=	=	NOUN
ijpds-3543	138	2	б	б	NOUN
ijpds-3543	138	3	−	−	PROPN
ijpds-3543	138	4	9	9	NUM
ijpds-3543	138	5	wells	well	NOUN
ijpds-3543	138	6	from	from	ADP
ijpds-3543	138	7	two	two	NUM
ijpds-3543	138	8	to	to	PART
ijpds-3543	138	9	three	three	NUM
ijpds-3543	138	10	independent	independent	ADJ
ijpds-3543	138	11	experiments	experiment	NOUN
ijpds-3543	138	12	.	.	PUNCT
ijpds-3543	139	1	*	*	PUNCT
ijpds-3543	139	2	p<0.05	p<0.05	NOUN
ijpds-3543	139	3	and	and	CCONJ
ijpds-3543	139	4	*	*	NOUN
ijpds-3543	139	5	*	*	PUNCT
ijpds-3543	139	6	p<0.01	p<0.01	PROPN
ijpds-3543	139	7	indicate	indicate	VERB
ijpds-3543	139	8	significant	significant	ADJ
ijpds-3543	139	9	inhibition	inhibition	NOUN
ijpds-3543	139	10	of	of	ADP
ijpds-3543	139	11	the	the	DET
ijpds-3543	139	12	production	production	NOUN
ijpds-3543	139	13	of	of	ADP
ijpds-3543	139	14	mip1α	mip1α	PROPN
ijpds-3543	139	15	.	.	PUNCT
ijpds-3543	139	16	sonwani	sonwani	PROPN
ijpds-3543	139	17	et	et	PROPN
ijpds-3543	139	18	al	al	PROPN
ijpds-3543	139	19	.	.	PROPN
ijpds-3543	139	20	role	role	NOUN
ijpds-3543	139	21	of	of	ADP
ijpds-3543	139	22	adenosine	adenosine	ADJ
ijpds-3543	139	23	receptor	receptor	NOUN
ijpds-3543	139	24	agonists	agonist	NOUN
ijpds-3543	139	25	in	in	ADP
ijpds-3543	139	26	inflammatory	inflammatory	ADJ
ijpds-3543	139	27	conditions	condition	NOUN
ijpds-3543	139	28	vol	vol	NOUN
ijpds-3543	139	29	2	2	NUM
ijpds-3543	139	30	|	|	NOUN
ijpds-3543	139	31	issue	issue	NOUN
ijpds-3543	139	32	2	2	NUM
ijpds-3543	139	33	|	|	ADV
ijpds-3543	139	34	apr	apr	ADV
ijpds-3543	139	35	–	–	PUNCT
ijpds-3543	139	36	jun	jun	PROPN
ijpds-3543	139	37	2023	2023	NUM
ijpds-3543	139	38	indian	indian	PROPN
ijpds-3543	139	39	j	j	PROPN
ijpds-3543	139	40	pharm	pharm	PROPN
ijpds-3543	139	41	drug	drug	PROPN
ijpds-3543	139	42	studies	study	NOUN
ijpds-3543	139	43	|	|	ADV
ijpds-3543	139	44	73	73	NUM
ijpds-3543	139	45	figure	figure	NOUN
ijpds-3543	139	46	3	3	NUM
ijpds-3543	139	47	–	–	PUNCT
ijpds-3543	139	48	(	(	PUNCT
ijpds-3543	139	49	a	a	NOUN
ijpds-3543	139	50	)	)	PUNCT
ijpds-3543	139	51	ib	ib	NOUN
ijpds-3543	139	52	-	-	PUNCT
ijpds-3543	139	53	meca	meca	PROPN
ijpds-3543	139	54	suppresses	suppress	VERB
ijpds-3543	139	55	collagen	collagen	NOUN
ijpds-3543	139	56	-	-	PUNCT
ijpds-3543	139	57	induced	induce	VERB
ijpds-3543	139	58	arthritis	arthritis	NOUN
ijpds-3543	139	59	in	in	ADP
ijpds-3543	139	60	mice	mouse	NOUN
ijpds-3543	139	61	.	.	PUNCT
ijpds-3543	140	1	the	the	DET
ijpds-3543	140	2	percentage	percentage	NOUN
ijpds-3543	140	3	of	of	ADP
ijpds-3543	140	4	arthritic	arthritic	ADJ
ijpds-3543	140	5	mice	mouse	NOUN
ijpds-3543	140	6	(	(	PUNCT
ijpds-3543	140	7	mice	mouse	NOUN
ijpds-3543	140	8	showing	show	VERB
ijpds-3543	140	9	clinical	clinical	ADJ
ijpds-3543	140	10	scores	score	NOUN
ijpds-3543	140	11	of	of	ADP
ijpds-3543	140	12	arthritis	arthritis	NOUN
ijpds-3543	140	13	>	>	X
ijpds-3543	140	14	1	1	NUM
ijpds-3543	140	15	)	)	PUNCT
ijpds-3543	140	16	is	be	AUX
ijpds-3543	140	17	represented	represent	VERB
ijpds-3543	140	18	.	.	PUNCT
ijpds-3543	141	1	(	(	PUNCT
ijpds-3543	141	2	b	b	X
ijpds-3543	141	3	)	)	PUNCT
ijpds-3543	141	4	effect	effect	NOUN
ijpds-3543	141	5	of	of	ADP
ijpds-3543	141	6	ib	ib	PROPN
ijpds-3543	141	7	-	-	PUNCT
ijpds-3543	141	8	meca	meca	NOUN
ijpds-3543	141	9	on	on	ADP
ijpds-3543	141	10	the	the	DET
ijpds-3543	141	11	severity	severity	NOUN
ijpds-3543	141	12	of	of	ADP
ijpds-3543	141	13	collagen	collagen	NOUN
ijpds-3543	141	14	-	-	PUNCT
ijpds-3543	141	15	induced	induce	VERB
ijpds-3543	141	16	arthritis	arthritis	NOUN
ijpds-3543	141	17	.	.	PUNCT
ijpds-3543	142	1	the	the	DET
ijpds-3543	142	2	median	median	ADJ
ijpds-3543	142	3	arthritic	arthritic	ADJ
ijpds-3543	142	4	score	score	NOUN
ijpds-3543	142	5	during	during	ADP
ijpds-3543	142	6	collageninduced	collageninduce	VERB
ijpds-3543	142	7	arthritis	arthritis	NOUN
ijpds-3543	142	8	.	.	PUNCT
ijpds-3543	143	1	n=10	n=10	PRON
ijpds-3543	143	2	−	−	PROPN
ijpds-3543	143	3	12	12	NUM
ijpds-3543	143	4	.	.	PUNCT
ijpds-3543	144	1	there	there	PRON
ijpds-3543	144	2	was	be	VERB
ijpds-3543	144	3	a	a	DET
ijpds-3543	144	4	significant	significant	ADJ
ijpds-3543	144	5	increase	increase	NOUN
ijpds-3543	144	6	in	in	ADP
ijpds-3543	144	7	the	the	DET
ijpds-3543	144	8	arthritic	arthritic	ADJ
ijpds-3543	144	9	score	score	NOUN
ijpds-3543	144	10	from	from	ADP
ijpds-3543	144	11	day	day	NOUN
ijpds-3543	144	12	28	28	NUM
ijpds-3543	144	13	(	(	PUNCT
ijpds-3543	144	14	*	*	PUNCT
ijpds-3543	144	15	p<0.01	p<0.01	PROPN
ijpds-3543	144	16	)	)	PUNCT
ijpds-3543	144	17	,	,	PUNCT
ijpds-3543	144	18	and	and	CCONJ
ijpds-3543	144	19	there	there	PRON
ijpds-3543	144	20	was	be	VERB
ijpds-3543	144	21	significant	significant	ADJ
ijpds-3543	144	22	suppression	suppression	NOUN
ijpds-3543	144	23	of	of	ADP
ijpds-3543	144	24	the	the	DET
ijpds-3543	144	25	arthritic	arthritic	ADJ
ijpds-3543	144	26	score	score	NOUN
ijpds-3543	144	27	by	by	ADP
ijpds-3543	144	28	ib	ib	PROPN
ijpds-3543	144	29	-	-	PUNCT
ijpds-3543	144	30	meca	meca	PROPN
ijpds-3543	144	31	from	from	ADP
ijpds-3543	144	32	day	day	NOUN
ijpds-3543	144	33	30	30	NUM
ijpds-3543	144	34	(	(	PUNCT
ijpds-3543	144	35	¢p<0.05	¢p<0.05	NOUN
ijpds-3543	144	36	)	)	PUNCT
ijpds-3543	144	37	.	.	PUNCT
ijpds-3543	145	1	figure	figure	VERB
ijpds-3543	145	2	4	4	NUM
ijpds-3543	145	3	:	:	PUNCT
ijpds-3543	145	4	ib	ib	PROPN
ijpds-3543	145	5	-	-	PUNCT
ijpds-3543	145	6	meca	meca	PROPN
ijpds-3543	145	7	suppresses	suppress	VERB
ijpds-3543	145	8	the	the	DET
ijpds-3543	145	9	production	production	NOUN
ijpds-3543	145	10	of	of	ADP
ijpds-3543	145	11	inflammatory	inflammatory	ADJ
ijpds-3543	145	12	mediators	mediator	NOUN
ijpds-3543	145	13	in	in	ADP
ijpds-3543	145	14	immune	immune	NOUN
ijpds-3543	145	15	-	-	PUNCT
ijpds-3543	145	16	stimulated	stimulate	VERB
ijpds-3543	145	17	cultured	cultured	ADJ
ijpds-3543	145	18	raw	raw	ADJ
ijpds-3543	145	19	macrophages	macrophage	NOUN
ijpds-3543	145	20	.	.	PUNCT
ijpds-3543	146	1	cells	cell	NOUN
ijpds-3543	146	2	were	be	AUX
ijpds-3543	146	3	stimulated	stimulate	VERB
ijpds-3543	146	4	with	with	ADP
ijpds-3543	146	5	lps	lps	PROPN
ijpds-3543	146	6	(	(	PUNCT
ijpds-3543	146	7	10	10	NUM
ijpds-3543	146	8	μg	μg	PROPN
ijpds-3543	146	9	ml—1	ml—1	NOUN
ijpds-3543	146	10	)	)	PUNCT
ijpds-3543	146	11	and	and	CCONJ
ijpds-3543	146	12	ifn	ifn	PROPN
ijpds-3543	146	13	-	-	PUNCT
ijpds-3543	146	14	ц	ц	PROPN
ijpds-3543	146	15	(	(	PUNCT
ijpds-3543	146	16	200	200	NUM
ijpds-3543	146	17	mu	mu	NOUN
ijpds-3543	146	18	/	/	SYM
ijpds-3543	146	19	ml	ml	NOUN
ijpds-3543	146	20	)	)	PUNCT
ijpds-3543	146	21	for	for	ADP
ijpds-3543	146	22	24	24	NUM
ijpds-3543	146	23	h	h	NOUN
ijpds-3543	146	24	for	for	ADP
ijpds-3543	146	25	the	the	DET
ijpds-3543	146	26	measurement	measurement	NOUN
ijpds-3543	146	27	of	of	ADP
ijpds-3543	146	28	il-12	il-12	PRON
ijpds-3543	146	29	(	(	PUNCT
ijpds-3543	146	30	p40	p40	NOUN
ijpds-3543	146	31	)	)	PUNCT
ijpds-3543	146	32	,	,	PUNCT
ijpds-3543	146	33	with	with	ADP
ijpds-3543	146	34	lps	lps	PROPN
ijpds-3543	146	35	(	(	PUNCT
ijpds-3543	146	36	10	10	NUM
ijpds-3543	146	37	μg	μg	PROPN
ijpds-3543	146	38	ml—1	ml—1	NOUN
ijpds-3543	146	39	)	)	PUNCT
ijpds-3543	146	40	for	for	ADP
ijpds-3543	146	41	24	24	NUM
ijpds-3543	146	42	h	h	NOUN
ijpds-3543	146	43	for	for	ADP
ijpds-3543	146	44	il	il	PROPN
ijpds-3543	146	45	-	-	PROPN
ijpds-3543	146	46	б	б	PROPN
ijpds-3543	146	47	and	and	CCONJ
ijpds-3543	146	48	nitrite	nitrite	NOUN
ijpds-3543	146	49	measurements	measurement	NOUN
ijpds-3543	146	50	,	,	PUNCT
ijpds-3543	146	51	or	or	CCONJ
ijpds-3543	146	52	with	with	ADP
ijpds-3543	146	53	lps	lps	PROPN
ijpds-3543	146	54	(	(	PUNCT
ijpds-3543	146	55	10	10	NUM
ijpds-3543	146	56	ng	ng	PROPN
ijpds-3543	146	57	/	/	SYM
ijpds-3543	146	58	ml	ml	PROPN
ijpds-3543	146	59	)	)	PUNCT
ijpds-3543	146	60	and	and	CCONJ
ijpds-3543	146	61	ifn	ifn	PROPN
ijpds-3543	146	62	-	-	PUNCT
ijpds-3543	146	63	ц(200	ц(200	NOUN
ijpds-3543	146	64	mu	mu	NOUN
ijpds-3543	146	65	ml—1	ml—1	NOUN
ijpds-3543	146	66	)	)	PUNCT
ijpds-3543	146	67	for	for	ADP
ijpds-3543	146	68	3	3	NUM
ijpds-3543	146	69	h	h	NOUN
ijpds-3543	146	70	for	for	ADP
ijpds-3543	146	71	the	the	DET
ijpds-3543	146	72	measurement	measurement	NOUN
ijpds-3543	146	73	of	of	ADP
ijpds-3543	146	74	mip-1α	mip-1α	PROPN
ijpds-3543	146	75	absolute	absolute	ADJ
ijpds-3543	146	76	values	value	NOUN
ijpds-3543	146	77	of	of	ADP
ijpds-3543	146	78	il-12	il-12	NOUN
ijpds-3543	146	79	,	,	PUNCT
ijpds-3543	146	80	il	il	PROPN
ijpds-3543	146	81	-	-	PROPN
ijpds-3543	146	82	б	б	NOUN
ijpds-3543	146	83	,	,	PUNCT
ijpds-3543	146	84	and	and	CCONJ
ijpds-3543	146	85	nitrite	nitrite	NOUN
ijpds-3543	146	86	in	in	ADP
ijpds-3543	146	87	the	the	DET
ijpds-3543	146	88	absence	absence	NOUN
ijpds-3543	146	89	of	of	ADP
ijpds-3543	146	90	ibmeca	ibmeca	ADJ
ijpds-3543	146	91	treatment	treatment	NOUN
ijpds-3543	146	92	amounted	amount	VERB
ijpds-3543	146	93	to	to	ADP
ijpds-3543	146	94	378±23	378±23	NUM
ijpds-3543	146	95	pg	pg	NOUN
ijpds-3543	146	96	ml—1	ml—1	NOUN
ijpds-3543	146	97	,	,	PUNCT
ijpds-3543	146	98	7б±4	7б±4	PROPN
ijpds-3543	146	99	ng	ng	PROPN
ijpds-3543	146	100	ml—1	ml—1	NOUN
ijpds-3543	146	101	and	and	CCONJ
ijpds-3543	146	102	49±5	49±5	NOUN
ijpds-3543	146	103	μm	μm	NUM
ijpds-3543	146	104	respectively	respectively	ADV
ijpds-3543	146	105	,	,	PUNCT
ijpds-3543	146	106	and	and	CCONJ
ijpds-3543	146	107	were	be	AUX
ijpds-3543	146	108	considered	consider	VERB
ijpds-3543	146	109	100	100	NUM
ijpds-3543	146	110	%	%	NOUN
ijpds-3543	146	111	.	.	PUNCT
ijpds-3543	147	1	n	n	CCONJ
ijpds-3543	148	1	=	=	NOUN
ijpds-3543	148	2	б	б	NOUN
ijpds-3543	148	3	−	−	PROPN
ijpds-3543	148	4	9	9	NUM
ijpds-3543	148	5	wells	well	NOUN
ijpds-3543	148	6	from	from	ADP
ijpds-3543	148	7	two	two	NUM
ijpds-3543	148	8	to	to	PART
ijpds-3543	148	9	three	three	NUM
ijpds-3543	148	10	independent	independent	ADJ
ijpds-3543	148	11	experiments	experiment	NOUN
ijpds-3543	148	12	.	.	PUNCT
ijpds-3543	149	1	*	*	PUNCT
ijpds-3543	149	2	p<0.05	p<0.05	NOUN
ijpds-3543	149	3	and	and	CCONJ
ijpds-3543	149	4	*	*	NOUN
ijpds-3543	149	5	*	*	PUNCT
ijpds-3543	149	6	p<0.01	p<0.01	PROPN
ijpds-3543	149	7	indicate	indicate	VERB
ijpds-3543	149	8	significant	significant	ADJ
ijpds-3543	149	9	inhibition	inhibition	NOUN
ijpds-3543	149	10	by	by	ADP
ijpds-3543	149	11	ib	ib	PROPN
ijpds-3543	149	12	-	-	PUNCT
ijpds-3543	149	13	meca	meca	PROPN
ijpds-3543	149	14	treatment	treatment	NOUN
ijpds-3543	149	15	.	.	PUNCT
ijpds-3543	150	1	figure	figure	NOUN
ijpds-3543	150	2	5	5	NUM
ijpds-3543	150	3	ib	ib	NOUN
ijpds-3543	150	4	-	-	PUNCT
ijpds-3543	150	5	meca	meca	PROPN
ijpds-3543	150	6	suppresses	suppress	VERB
ijpds-3543	150	7	the	the	DET
ijpds-3543	150	8	production	production	NOUN
ijpds-3543	150	9	of	of	ADP
ijpds-3543	150	10	inflammatory	inflammatory	ADJ
ijpds-3543	150	11	mediators	mediator	NOUN
ijpds-3543	150	12	in	in	ADP
ijpds-3543	150	13	aqueous	aqueous	ADJ
ijpds-3543	150	14	paw	paw	NOUN
ijpds-3543	150	15	extracts	extract	NOUN
ijpds-3543	150	16	of	of	ADP
ijpds-3543	150	17	mice	mouse	NOUN
ijpds-3543	150	18	subjected	subject	VERB
ijpds-3543	150	19	to	to	ADP
ijpds-3543	150	20	collagen	collagen	NOUN
ijpds-3543	150	21	-	-	PUNCT
ijpds-3543	150	22	induced	induce	VERB
ijpds-3543	150	23	arthritis	arthritis	NOUN
ijpds-3543	150	24	.	.	PUNCT
ijpds-3543	151	1	levels	level	NOUN
ijpds-3543	151	2	of	of	ADP
ijpds-3543	151	3	mip-1α	mip-1α	NOUN
ijpds-3543	151	4	and	and	CCONJ
ijpds-3543	151	5	il-12	il-12	NOUN
ijpds-3543	151	6	are	be	AUX
ijpds-3543	151	7	shown	show	VERB
ijpds-3543	151	8	in	in	ADP
ijpds-3543	151	9	samples	sample	NOUN
ijpds-3543	151	10	from	from	ADP
ijpds-3543	151	11	control	control	NOUN
ijpds-3543	151	12	animals	animal	NOUN
ijpds-3543	151	13	(	(	PUNCT
ijpds-3543	151	14	c	c	NOUN
ijpds-3543	151	15	)	)	PUNCT
ijpds-3543	151	16	,	,	PUNCT
ijpds-3543	151	17	from	from	ADP
ijpds-3543	151	18	collagen	collagen	NOUN
ijpds-3543	151	19	-	-	PUNCT
ijpds-3543	151	20	induced	induce	VERB
ijpds-3543	151	21	arthritis	arthritis	NOUN
ijpds-3543	151	22	at	at	ADP
ijpds-3543	151	23	35	35	NUM
ijpds-3543	151	24	days	day	NOUN
ijpds-3543	151	25	(	(	PUNCT
ijpds-3543	151	26	a	a	NOUN
ijpds-3543	151	27	)	)	PUNCT
ijpds-3543	151	28	,	,	PUNCT
ijpds-3543	151	29	and	and	CCONJ
ijpds-3543	151	30	ib	ib	PROPN
ijpds-3543	151	31	-	-	PUNCT
ijpds-3543	151	32	meca	meca	NOUN
ijpds-3543	151	33	-	-	PUNCT
ijpds-3543	151	34	treated	treat	VERB
ijpds-3543	151	35	mice	mouse	NOUN
ijpds-3543	151	36	subjected	subject	VERB
ijpds-3543	151	37	to	to	ADP
ijpds-3543	151	38	collageninduced	collageninduce	VERB
ijpds-3543	151	39	arthritis	arthritis	NOUN
ijpds-3543	151	40	(	(	PUNCT
ijpds-3543	151	41	m	m	NOUN
ijpds-3543	151	42	)	)	PUNCT
ijpds-3543	151	43	at	at	ADP
ijpds-3543	151	44	35	35	NUM
ijpds-3543	151	45	days	day	NOUN
ijpds-3543	151	46	.	.	PUNCT
ijpds-3543	152	1	n=10	n=10	PRON
ijpds-3543	152	2	−	−	PROPN
ijpds-3543	152	3	12	12	NUM
ijpds-3543	152	4	.	.	PUNCT
ijpds-3543	153	1	*	*	NOUN
ijpds-3543	153	2	p<0.05	p<0.05	NOUN
ijpds-3543	153	3	indicates	indicate	VERB
ijpds-3543	153	4	suppression	suppression	NOUN
ijpds-3543	153	5	of	of	ADP
ijpds-3543	153	6	il-12	il-12	NOUN
ijpds-3543	153	7	and	and	CCONJ
ijpds-3543	153	8	mip-1α	mip-1α	NOUN
ijpds-3543	153	9	production	production	NOUN
ijpds-3543	153	10	in	in	ADP
ijpds-3543	153	11	arthritis	arthritis	NOUN
ijpds-3543	153	12	by	by	ADP
ijpds-3543	153	13	ibmeca	ibmeca	NOUN
ijpds-3543	153	14	.	.	PUNCT
ijpds-3543	154	1	discussion	discussion	NOUN
ijpds-3543	154	2	different	different	ADJ
ijpds-3543	154	3	adenosine	adenosine	NOUN
ijpds-3543	154	4	receptor	receptor	NOUN
ijpds-3543	154	5	subtypes	subtype	NOUN
ijpds-3543	154	6	activate	activate	VERB
ijpds-3543	154	7	different	different	ADJ
ijpds-3543	154	8	signal	signal	NOUN
ijpds-3543	154	9	transduction	transduction	NOUN
ijpds-3543	154	10	processes	process	NOUN
ijpds-3543	154	11	in	in	ADP
ijpds-3543	154	12	different	different	ADJ
ijpds-3543	154	13	cells	cell	NOUN
ijpds-3543	154	14	.	.	PUNCT
ijpds-3543	155	1	martin	martin	PROPN
ijpds-3543	155	2	and	and	CCONJ
ijpds-3543	155	3	dorf	dorf	PROPN
ijpds-3543	155	4	(	(	PUNCT
ijpds-3543	155	5	1991	1991	NUM
ijpds-3543	155	6	)	)	PUNCT
ijpds-3543	155	7	in	in	ADP
ijpds-3543	155	8	macrophages	macrophage	NOUN
ijpds-3543	155	9	,	,	PUNCT
ijpds-3543	155	10	however	however	ADV
ijpds-3543	155	11	,	,	PUNCT
ijpds-3543	155	12	a3	a3	NOUN
ijpds-3543	155	13	receptor	receptor	NOUN
ijpds-3543	155	14	stimulation	stimulation	NOUN
ijpds-3543	155	15	does	do	AUX
ijpds-3543	155	16	not	not	PART
ijpds-3543	155	17	require	require	VERB
ijpds-3543	155	18	cyclic	cyclic	ADJ
ijpds-3543	155	19	amp	amp	NOUN
ijpds-3543	155	20	,	,	PUNCT
ijpds-3543	155	21	protein	protein	NOUN
ijpds-3543	155	22	kinase	kinase	NOUN
ijpds-3543	155	23	a	a	X
ijpds-3543	155	24	,	,	PUNCT
ijpds-3543	155	25	or	or	CCONJ
ijpds-3543	155	26	the	the	DET
ijpds-3543	155	27	transcription	transcription	NOUN
ijpds-3543	155	28	factor	factor	NOUN
ijpds-3543	155	29	nf	nf	PROPN
ijpds-3543	155	30	-	-	PUNCT
ijpds-3543	155	31	kappa	kappa	NOUN
ijpds-3543	155	32	b	b	PROPN
ijpds-3543	155	33	,	,	PUNCT
ijpds-3543	155	34	despite	despite	SCONJ
ijpds-3543	155	35	the	the	DET
ijpds-3543	155	36	fact	fact	NOUN
ijpds-3543	155	37	that	that	SCONJ
ijpds-3543	155	38	stimulation	stimulation	NOUN
ijpds-3543	155	39	of	of	ADP
ijpds-3543	155	40	this	this	DET
ijpds-3543	155	41	receptor	receptor	NOUN
ijpds-3543	155	42	subtype	subtype	NOUN
ijpds-3543	155	43	might	might	AUX
ijpds-3543	155	44	change	change	VERB
ijpds-3543	155	45	the	the	DET
ijpds-3543	155	46	makeup	makeup	NOUN
ijpds-3543	155	47	of	of	ADP
ijpds-3543	155	48	the	the	DET
ijpds-3543	155	49	ap-1	ap-1	NOUN
ijpds-3543	155	50	transcription	transcription	NOUN
ijpds-3543	155	51	complex	complex	ADJ
ijpds-3543	155	52	further	further	ADJ
ijpds-3543	155	53	research	research	NOUN
ijpds-3543	155	54	is	be	AUX
ijpds-3543	155	55	needed	need	VERB
ijpds-3543	155	56	to	to	PART
ijpds-3543	155	57	determine	determine	VERB
ijpds-3543	155	58	the	the	DET
ijpds-3543	155	59	cellular	cellular	ADJ
ijpds-3543	155	60	signaling	signal	VERB
ijpds-3543	155	61	pathway	pathway	NOUN
ijpds-3543	155	62	by	by	SCONJ
ijpds-3543	155	63	which	which	DET
ijpds-3543	155	64	a3	a3	NOUN
ijpds-3543	155	65	activation	activation	NOUN
ijpds-3543	155	66	reduces	reduce	VERB
ijpds-3543	155	67	cytokine	cytokine	NOUN
ijpds-3543	155	68	or	or	CCONJ
ijpds-3543	155	69	mip-1α	mip-1α	NOUN
ijpds-3543	155	70	production	production	NOUN
ijpds-3543	156	1	[	[	X
ijpds-3543	156	2	3	3	NUM
ijpds-3543	156	3	-	-	SYM
ijpds-3543	156	4	5	5	NUM
ijpds-3543	156	5	]	]	PUNCT
ijpds-3543	156	6	.	.	PUNCT
ijpds-3543	157	1	in	in	ADP
ijpds-3543	157	2	our	our	PRON
ijpds-3543	157	3	settings	setting	NOUN
ijpds-3543	157	4	,	,	PUNCT
ijpds-3543	157	5	the	the	DET
ijpds-3543	157	6	a1	a1	NOUN
ijpds-3543	157	7	agonist	agonist	NOUN
ijpds-3543	157	8	had	have	VERB
ijpds-3543	157	9	no	no	DET
ijpds-3543	157	10	substantial	substantial	ADJ
ijpds-3543	157	11	inhibitory	inhibitory	ADJ
ijpds-3543	157	12	effect	effect	NOUN
ijpds-3543	157	13	on	on	ADP
ijpds-3543	157	14	mip-1α	mip-1α	NOUN
ijpds-3543	157	15	generation	generation	NOUN
ijpds-3543	157	16	,	,	PUNCT
ijpds-3543	157	17	but	but	CCONJ
ijpds-3543	157	18	adenosine	adenosine	NOUN
ijpds-3543	157	19	was	be	AUX
ijpds-3543	157	20	a	a	DET
ijpds-3543	157	21	weak	weak	ADJ
ijpds-3543	157	22	inhibitor	inhibitor	NOUN
ijpds-3543	157	23	.	.	PUNCT
ijpds-3543	158	1	adenosine	adenosine	NOUN
ijpds-3543	158	2	is	be	AUX
ijpds-3543	158	3	primarily	primarily	ADV
ijpds-3543	158	4	an	an	DET
ijpds-3543	158	5	a1	a1	NOUN
ijpds-3543	158	6	receptor	receptor	NOUN
ijpds-3543	158	7	agonist	agonist	NOUN
ijpds-3543	158	8	,	,	PUNCT
ijpds-3543	158	9	with	with	ADP
ijpds-3543	158	10	minor	minor	ADJ
ijpds-3543	158	11	a2	a2	PROPN
ijpds-3543	158	12	and	and	CCONJ
ijpds-3543	158	13	a3	a3	NOUN
ijpds-3543	158	14	agonist	agonist	NOUN
ijpds-3543	158	15	properties	property	NOUN
ijpds-3543	158	16	[	[	X
ijpds-3543	158	17	6	6	NUM
ijpds-3543	158	18	]	]	PUNCT
ijpds-3543	158	19	.	.	PUNCT
ijpds-3543	159	1	our	our	PRON
ijpds-3543	159	2	research	research	NOUN
ijpds-3543	159	3	with	with	ADP
ijpds-3543	159	4	the	the	DET
ijpds-3543	159	5	adenosine	adenosine	ADJ
ijpds-3543	159	6	deaminase	deaminase	NOUN
ijpds-3543	159	7	inhibitor	inhibitor	NOUN
ijpds-3543	159	8	showed	show	VERB
ijpds-3543	159	9	that	that	SCONJ
ijpds-3543	159	10	adenosine	adenosine	NOUN
ijpds-3543	159	11	deaminase	deaminase	NOUN
ijpds-3543	159	12	,	,	PUNCT
ijpds-3543	159	13	which	which	PRON
ijpds-3543	159	14	is	be	AUX
ijpds-3543	159	15	present	present	ADJ
ijpds-3543	159	16	in	in	ADP
ijpds-3543	159	17	the	the	DET
ijpds-3543	159	18	fetal	fetal	ADJ
ijpds-3543	159	19	calf	calf	NOUN
ijpds-3543	159	20	,	,	PUNCT
ijpds-3543	159	21	degrades	degrade	VERB
ijpds-3543	159	22	adenosine	adenosine	NOUN
ijpds-3543	159	23	quickly	quickly	ADV
ijpds-3543	159	24	.	.	PUNCT
ijpds-3543	160	1	the	the	DET
ijpds-3543	160	2	low	low	ADJ
ijpds-3543	160	3	amount	amount	NOUN
ijpds-3543	160	4	of	of	ADP
ijpds-3543	160	5	inhibition	inhibition	NOUN
ijpds-3543	160	6	is	be	AUX
ijpds-3543	160	7	not	not	PART
ijpds-3543	160	8	attributable	attributable	ADJ
ijpds-3543	160	9	to	to	PART
ijpds-3543	160	10	serum	serum	VERB
ijpds-3543	160	11	.	.	PUNCT
ijpds-3543	161	1	the	the	DET
ijpds-3543	161	2	lower	low	ADJ
ijpds-3543	161	3	eacacy	eacacy	NOUN
ijpds-3543	161	4	of	of	ADP
ijpds-3543	161	5	adenosine	adenosine	NOUN
ijpds-3543	161	6	in	in	ADP
ijpds-3543	161	7	mip-1α	mip-1α	NOUN
ijpds-3543	161	8	production	production	NOUN
ijpds-3543	161	9	may	may	AUX
ijpds-3543	161	10	be	be	AUX
ijpds-3543	161	11	due	due	ADJ
ijpds-3543	161	12	to	to	ADP
ijpds-3543	161	13	its	its	PRON
ijpds-3543	161	14	reduced	reduced	ADJ
ijpds-3543	161	15	potency	potency	NOUN
ijpds-3543	161	16	on	on	ADP
ijpds-3543	161	17	a2	a2	PROPN
ijpds-3543	161	18	and	and	CCONJ
ijpds-3543	161	19	a3	a3	NOUN
ijpds-3543	161	20	receptors	receptor	NOUN
ijpds-3543	161	21	,	,	PUNCT
ijpds-3543	161	22	according	accord	VERB
ijpds-3543	161	23	to	to	ADP
ijpds-3543	161	24	our	our	PRON
ijpds-3543	161	25	findings	finding	NOUN
ijpds-3543	161	26	[	[	X
ijpds-3543	161	27	7	7	NUM
ijpds-3543	161	28	]	]	PUNCT
ijpds-3543	161	29	.	.	PUNCT
ijpds-3543	162	1	in	in	ADP
ijpds-3543	162	2	addition	addition	NOUN
ijpds-3543	162	3	to	to	ADP
ijpds-3543	162	4	inhibiting	inhibit	VERB
ijpds-3543	162	5	mip-1α	mip-1α	NOUN
ijpds-3543	162	6	production	production	NOUN
ijpds-3543	162	7	,	,	PUNCT
ijpds-3543	162	8	ib	ib	PROPN
ijpds-3543	162	9	-	-	PUNCT
ijpds-3543	162	10	meca	meca	PROPN
ijpds-3543	162	11	decreased	decrease	VERB
ijpds-3543	162	12	il-12	il-12	NOUN
ijpds-3543	162	13	,	,	PUNCT
ijpds-3543	162	14	il-	il-	PRON
ijpds-3543	162	15	,	,	PUNCT
ijpds-3543	162	16	and	and	CCONJ
ijpds-3543	162	17	no	no	DET
ijpds-3543	162	18	production	production	NOUN
ijpds-3543	162	19	in	in	ADP
ijpds-3543	162	20	immune	immune	ADJ
ijpds-3543	162	21	stimulated	stimulate	VERB
ijpds-3543	162	22	cultured	cultured	ADJ
ijpds-3543	162	23	macrophages	macrophage	NOUN
ijpds-3543	162	24	,	,	PUNCT
ijpds-3543	162	25	according	accord	VERB
ijpds-3543	162	26	to	to	ADP
ijpds-3543	162	27	the	the	DET
ijpds-3543	162	28	current	current	ADJ
ijpds-3543	162	29	study	study	NOUN
ijpds-3543	162	30	.	.	PUNCT
ijpds-3543	163	1	adenosine	adenosine	ADJ
ijpds-3543	163	2	receptor	receptor	NOUN
ijpds-3543	163	3	agonists	agonist	NOUN
ijpds-3543	163	4	have	have	AUX
ijpds-3543	163	5	recently	recently	ADV
ijpds-3543	163	6	been	be	AUX
ijpds-3543	163	7	shown	show	VERB
ijpds-3543	163	8	to	to	PART
ijpds-3543	163	9	prevent	prevent	VERB
ijpds-3543	163	10	endotoxin	endotoxin	ADJ
ijpds-3543	163	11	-	-	PUNCT
ijpds-3543	163	12	mediated	mediate	VERB
ijpds-3543	163	13	stimulation	stimulation	NOUN
ijpds-3543	163	14	of	of	ADP
ijpds-3543	163	15	the	the	DET
ijpds-3543	163	16	tnf	tnf	PROPN
ijpds-3543	163	17	-	-	PUNCT
ijpds-3543	163	18	α	α	PROPN
ijpds-3543	163	19	gene	gene	NOUN
ijpds-3543	163	20	and	and	CCONJ
ijpds-3543	163	21	protein	protein	NOUN
ijpds-3543	163	22	expression	expression	NOUN
ijpds-3543	163	23	in	in	ADP
ijpds-3543	163	24	the	the	DET
ijpds-3543	163	25	murine	murine	ADJ
ijpds-3543	163	26	j774.1	j774.1	DET
ijpds-3543	163	27	macrophage	macrophage	ADJ
ijpds-3543	163	28	cell	cell	NOUN
ijpds-3543	163	29	line	line	NOUN
ijpds-3543	163	30	in	in	ADP
ijpds-3543	163	31	a	a	DET
ijpds-3543	163	32	dose	dose	NOUN
ijpds-3543	163	33	-	-	PUNCT
ijpds-3543	163	34	dependent	dependent	ADJ
ijpds-3543	163	35	manner	manner	NOUN
ijpds-3543	163	36	characteristic	characteristic	NOUN
ijpds-3543	163	37	of	of	ADP
ijpds-3543	163	38	the	the	DET
ijpds-3543	163	39	a3	a3	NOUN
ijpds-3543	163	40	receptor	receptor	NOUN
ijpds-3543	163	41	[	[	X
ijpds-3543	163	42	9	9	NUM
ijpds-3543	163	43	,	,	PUNCT
ijpds-3543	163	44	10	10	NUM
ijpds-3543	163	45	]	]	PUNCT
ijpds-3543	163	46	.	.	PUNCT
ijpds-3543	164	1	we	we	PRON
ijpds-3543	164	2	recently	recently	ADV
ijpds-3543	164	3	demonstrated	demonstrate	VERB
ijpds-3543	164	4	that	that	SCONJ
ijpds-3543	164	5	stimulating	stimulate	VERB
ijpds-3543	164	6	a3	a3	NOUN
ijpds-3543	164	7	receptors	receptor	NOUN
ijpds-3543	164	8	with	with	ADP
ijpds-3543	164	9	the	the	DET
ijpds-3543	164	10	selective	selective	ADJ
ijpds-3543	164	11	a3	a3	NOUN
ijpds-3543	164	12	receptor	receptor	NOUN
ijpds-3543	164	13	agonist	agonist	NOUN
ijpds-3543	164	14	ib	ib	PROPN
ijpds-3543	164	15	-	-	PUNCT
ijpds-3543	164	16	meca	meca	PROPN
ijpds-3543	164	17	reduced	reduce	VERB
ijpds-3543	164	18	plasma	plasma	NOUN
ijpds-3543	164	19	tnf	tnf	PROPN
ijpds-3543	164	20	-	-	PUNCT
ijpds-3543	164	21	α	α	PROPN
ijpds-3543	164	22	while	while	NOUN
ijpds-3543	164	23	sonwani	sonwani	PROPN
ijpds-3543	164	24	et	et	PROPN
ijpds-3543	164	25	al	al	PROPN
ijpds-3543	164	26	.	.	PROPN
ijpds-3543	165	1	role	role	NOUN
ijpds-3543	165	2	of	of	ADP
ijpds-3543	165	3	adenosine	adenosine	ADJ
ijpds-3543	165	4	receptor	receptor	NOUN
ijpds-3543	165	5	agonists	agonist	NOUN
ijpds-3543	165	6	in	in	ADP
ijpds-3543	165	7	inflammatory	inflammatory	ADJ
ijpds-3543	165	8	conditions	condition	NOUN
ijpds-3543	165	9	vol	vol	NOUN
ijpds-3543	165	10	2	2	NUM
ijpds-3543	165	11	|	|	NOUN
ijpds-3543	165	12	issue	issue	NOUN
ijpds-3543	165	13	2	2	NUM
ijpds-3543	165	14	|	|	ADV
ijpds-3543	165	15	apr	apr	ADV
ijpds-3543	165	16	–	–	PUNCT
ijpds-3543	165	17	jun	jun	PROPN
ijpds-3543	165	18	2023	2023	NUM
ijpds-3543	165	19	indian	indian	PROPN
ijpds-3543	165	20	j	j	PROPN
ijpds-3543	165	21	pharm	pharm	PROPN
ijpds-3543	165	22	drug	drug	PROPN
ijpds-3543	165	23	studies	study	NOUN
ijpds-3543	165	24	|	|	ADV
ijpds-3543	165	25	74	74	NUM
ijpds-3543	165	26	increasing	increase	VERB
ijpds-3543	165	27	il-10	il-10	PRON
ijpds-3543	165	28	in	in	ADP
ijpds-3543	165	29	lps	lps	PROPN
ijpds-3543	165	30	-	-	PUNCT
ijpds-3543	165	31	treated	treat	VERB
ijpds-3543	165	32	mice	mouse	NOUN
ijpds-3543	165	33	.	.	PUNCT
ijpds-3543	166	1	the	the	DET
ijpds-3543	166	2	current	current	ADJ
ijpds-3543	166	3	study	study	NOUN
ijpds-3543	166	4	's	's	PART
ijpds-3543	166	5	findings	finding	NOUN
ijpds-3543	166	6	add	add	VERB
ijpds-3543	166	7	to	to	ADP
ijpds-3543	166	8	these	these	DET
ijpds-3543	166	9	earlier	early	ADJ
ijpds-3543	166	10	findings	finding	NOUN
ijpds-3543	166	11	.	.	PUNCT
ijpds-3543	167	1	the	the	DET
ijpds-3543	167	2	raw	raw	ADJ
ijpds-3543	167	3	24.7	24.7	NUM
ijpds-3543	167	4	cell	cell	NOUN
ijpds-3543	167	5	studies	study	NOUN
ijpds-3543	167	6	are	be	AUX
ijpds-3543	167	7	merely	merely	ADV
ijpds-3543	167	8	a	a	DET
ijpds-3543	167	9	rough	rough	ADJ
ijpds-3543	167	10	approximation	approximation	NOUN
ijpds-3543	167	11	of	of	ADP
ijpds-3543	167	12	the	the	DET
ijpds-3543	167	13	properties	property	NOUN
ijpds-3543	167	14	of	of	ADP
ijpds-3543	167	15	primary	primary	ADJ
ijpds-3543	167	16	or	or	CCONJ
ijpds-3543	167	17	resident	resident	ADJ
ijpds-3543	167	18	macrophages	macrophage	NOUN
ijpds-3543	167	19	,	,	PUNCT
ijpds-3543	167	20	or	or	CCONJ
ijpds-3543	167	21	the	the	DET
ijpds-3543	167	22	in	in	ADP
ijpds-3543	167	23	vivo	vivo	ADJ
ijpds-3543	167	24	scenario	scenario	NOUN
ijpds-3543	167	25	in	in	ADP
ijpds-3543	167	26	arthritis	arthritis	NOUN
ijpds-3543	167	27	,	,	PUNCT
ijpds-3543	167	28	where	where	SCONJ
ijpds-3543	167	29	resident	resident	ADJ
ijpds-3543	167	30	macrophages	macrophage	NOUN
ijpds-3543	167	31	play	play	VERB
ijpds-3543	167	32	a	a	DET
ijpds-3543	167	33	role	role	NOUN
ijpds-3543	167	34	in	in	ADP
ijpds-3543	167	35	the	the	DET
ijpds-3543	167	36	production	production	NOUN
ijpds-3543	167	37	of	of	ADP
ijpds-3543	167	38	chemokines	chemokine	NOUN
ijpds-3543	167	39	,	,	PUNCT
ijpds-3543	167	40	cytokines	cytokine	NOUN
ijpds-3543	167	41	,	,	PUNCT
ijpds-3543	167	42	and	and	CCONJ
ijpds-3543	167	43	no	no	PRON
ijpds-3543	168	1	[	[	NOUN
ijpds-3543	168	2	11	11	NUM
ijpds-3543	168	3	]	]	PUNCT
ijpds-3543	168	4	.	.	PUNCT
ijpds-3543	169	1	despite	despite	SCONJ
ijpds-3543	169	2	this	this	PRON
ijpds-3543	169	3	,	,	PUNCT
ijpds-3543	169	4	the	the	DET
ijpds-3543	169	5	control	control	NOUN
ijpds-3543	169	6	of	of	ADP
ijpds-3543	169	7	chemokine	chemokine	ADJ
ijpds-3543	169	8	,	,	PUNCT
ijpds-3543	169	9	cytokine	cytokine	NOUN
ijpds-3543	169	10	,	,	PUNCT
ijpds-3543	169	11	and	and	CCONJ
ijpds-3543	169	12	no	no	DET
ijpds-3543	169	13	production	production	NOUN
ijpds-3543	169	14	by	by	ADP
ijpds-3543	169	15	adrenergic	adrenergic	ADJ
ijpds-3543	169	16	,	,	PUNCT
ijpds-3543	169	17	purinergic	purinergic	NOUN
ijpds-3543	169	18	receptors	receptor	NOUN
ijpds-3543	169	19	in	in	ADP
ijpds-3543	169	20	monocytic	monocytic	ADJ
ijpds-3543	169	21	/	/	SYM
ijpds-3543	169	22	macrophage	macrophage	ADJ
ijpds-3543	169	23	cells	cell	NOUN
ijpds-3543	169	24	and	and	CCONJ
ijpds-3543	169	25	primary	primary	ADJ
ijpds-3543	169	26	monocytes/	monocytes/	NUM
ijpds-3543	169	27	macrophages	macrophage	NOUN
ijpds-3543	169	28	displays	display	VERB
ijpds-3543	169	29	striking	strike	VERB
ijpds-3543	169	30	parallels	parallel	VERB
ijpds-3543	169	31	the	the	PRON
ijpds-3543	169	32	in	in	ADP
ijpds-3543	169	33	vivo	vivo	ADJ
ijpds-3543	169	34	assessments	assessment	NOUN
ijpds-3543	169	35	of	of	ADP
ijpds-3543	169	36	no	no	PRON
ijpds-3543	169	37	,	,	PUNCT
ijpds-3543	169	38	il-12	il-12	NOUN
ijpds-3543	169	39	,	,	PUNCT
ijpds-3543	169	40	and	and	CCONJ
ijpds-3543	169	41	mip-1α	mip-1α	NOUN
ijpds-3543	169	42	production	production	NOUN
ijpds-3543	169	43	in	in	ADP
ijpds-3543	169	44	joint	joint	ADJ
ijpds-3543	169	45	extracts	extract	NOUN
ijpds-3543	169	46	in	in	ADP
ijpds-3543	169	47	the	the	DET
ijpds-3543	169	48	current	current	ADJ
ijpds-3543	169	49	investigation	investigation	NOUN
ijpds-3543	169	50	were	be	AUX
ijpds-3543	169	51	similarly	similarly	ADV
ijpds-3543	169	52	in	in	ADP
ijpds-3543	169	53	good	good	ADJ
ijpds-3543	169	54	agreement	agreement	NOUN
ijpds-3543	169	55	with	with	ADP
ijpds-3543	169	56	our	our	PRON
ijpds-3543	169	57	in	in	X
ijpds-3543	169	58	vitro	vitro	X
ijpds-3543	169	59	findings	finding	NOUN
ijpds-3543	169	60	in	in	ADP
ijpds-3543	169	61	raw	raw	ADJ
ijpds-3543	169	62	cells	cell	NOUN
ijpds-3543	169	63	.	.	PUNCT
ijpds-3543	170	1	in	in	ADP
ijpds-3543	170	2	the	the	DET
ijpds-3543	170	3	arthritis	arthritis	NOUN
ijpds-3543	170	4	model	model	NOUN
ijpds-3543	170	5	,	,	PUNCT
ijpds-3543	170	6	it	it	PRON
ijpds-3543	170	7	's	be	AUX
ijpds-3543	170	8	possible	possible	ADJ
ijpds-3543	170	9	that	that	SCONJ
ijpds-3543	170	10	ibmeca	ibmeca	NOUN
ijpds-3543	170	11	inhibits	inhibit	VERB
ijpds-3543	170	12	the	the	DET
ijpds-3543	170	13	synthesis	synthesis	NOUN
ijpds-3543	170	14	of	of	ADP
ijpds-3543	170	15	il-12	il-12	NOUN
ijpds-3543	170	16	,	,	PUNCT
ijpds-3543	170	17	mip-1α	mip-1α	NOUN
ijpds-3543	170	18	,	,	PUNCT
ijpds-3543	170	19	and	and	CCONJ
ijpds-3543	170	20	no	no	INTJ
ijpds-3543	170	21	,	,	PUNCT
ijpds-3543	170	22	which	which	PRON
ijpds-3543	170	23	are	be	AUX
ijpds-3543	170	24	all	all	PRON
ijpds-3543	170	25	significant	significant	ADJ
ijpds-3543	170	26	anti	anti	ADJ
ijpds-3543	170	27	-	-	ADJ
ijpds-3543	170	28	inflammatory	inflammatory	ADJ
ijpds-3543	170	29	mechanisms	mechanism	NOUN
ijpds-3543	170	30	[	[	X
ijpds-3543	170	31	12	12	NUM
ijpds-3543	170	32	-	-	SYM
ijpds-3543	170	33	14	14	NUM
ijpds-3543	170	34	]	]	PUNCT
ijpds-3543	170	35	.	.	PUNCT
ijpds-3543	171	1	it	it	PRON
ijpds-3543	171	2	is	be	AUX
ijpds-3543	171	3	widely	widely	ADV
ijpds-3543	171	4	known	know	VERB
ijpds-3543	171	5	that	that	SCONJ
ijpds-3543	171	6	il-12	il-12	NOUN
ijpds-3543	171	7	plays	play	VERB
ijpds-3543	171	8	a	a	DET
ijpds-3543	171	9	key	key	ADJ
ijpds-3543	171	10	role	role	NOUN
ijpds-3543	171	11	in	in	ADP
ijpds-3543	171	12	the	the	DET
ijpds-3543	171	13	early	early	ADJ
ijpds-3543	171	14	events	event	NOUN
ijpds-3543	171	15	of	of	ADP
ijpds-3543	171	16	the	the	DET
ijpds-3543	171	17	arthritis	arthritis	NOUN
ijpds-3543	171	18	induction	induction	NOUN
ijpds-3543	171	19	phase	phase	NOUN
ijpds-3543	171	20	.	.	PUNCT
ijpds-3543	172	1	the	the	DET
ijpds-3543	172	2	research	research	NOUN
ijpds-3543	172	3	best	well	ADV
ijpds-3543	172	4	confirmed	confirm	VERB
ijpds-3543	172	5	this	this	PRON
ijpds-3543	172	6	,	,	PUNCT
ijpds-3543	172	7	showing	show	VERB
ijpds-3543	172	8	that	that	SCONJ
ijpds-3543	172	9	il-12	il-12	NOUN
ijpds-3543	172	10	may	may	AUX
ijpds-3543	172	11	substitute	substitute	VERB
ijpds-3543	172	12	mycobacteria	mycobacterium	NOUN
ijpds-3543	172	13	and	and	CCONJ
ijpds-3543	172	14	cause	cause	VERB
ijpds-3543	172	15	autoimmune	autoimmune	ADJ
ijpds-3543	172	16	arthritis	arthritis	NOUN
ijpds-3543	172	17	in	in	ADP
ijpds-3543	172	18	dba/1	dba/1	PROPN
ijpds-3543	172	19	mice	mouse	NOUN
ijpds-3543	172	20	inoculated	inoculate	VERB
ijpds-3543	172	21	with	with	ADP
ijpds-3543	172	22	chicken	chicken	NOUN
ijpds-3543	172	23	cii	cii	PROPN
ijpds-3543	172	24	in	in	ADP
ijpds-3543	172	25	incomplete	incomplete	ADJ
ijpds-3543	172	26	freund	freund	PROPN
ijpds-3543	172	27	's	's	PART
ijpds-3543	172	28	adjuvant	adjuvant	NOUN
ijpds-3543	172	29	[	[	X
ijpds-3543	172	30	15	15	NUM
ijpds-3543	172	31	]	]	PUNCT
ijpds-3543	172	32	.	.	PUNCT
ijpds-3543	173	1	furthermore	furthermore	ADV
ijpds-3543	173	2	,	,	PUNCT
ijpds-3543	173	3	these	these	DET
ijpds-3543	173	4	researchers	researcher	NOUN
ijpds-3543	173	5	discovered	discover	VERB
ijpds-3543	173	6	that	that	SCONJ
ijpds-3543	173	7	il-12	il-12	NOUN
ijpds-3543	173	8	could	could	AUX
ijpds-3543	173	9	aggravate	aggravate	VERB
ijpds-3543	173	10	arthritis	arthritis	NOUN
ijpds-3543	173	11	caused	cause	VERB
ijpds-3543	173	12	by	by	ADP
ijpds-3543	173	13	chicken	chicken	NOUN
ijpds-3543	173	14	cii	cii	PROPN
ijpds-3543	173	15	in	in	ADP
ijpds-3543	173	16	cfa	cfa	PROPN
ijpds-3543	173	17	mice	mouse	NOUN
ijpds-3543	173	18	.	.	PUNCT
ijpds-3543	174	1	the	the	DET
ijpds-3543	174	2	course	course	NOUN
ijpds-3543	174	3	of	of	ADP
ijpds-3543	174	4	the	the	DET
ijpds-3543	174	5	disease	disease	NOUN
ijpds-3543	174	6	was	be	AUX
ijpds-3543	174	7	suppressed	suppress	VERB
ijpds-3543	174	8	in	in	ADP
ijpds-3543	174	9	il-12	il-12	NOUN
ijpds-3543	174	10	deficient	deficient	ADJ
ijpds-3543	174	11	animals	animal	NOUN
ijpds-3543	174	12	or	or	CCONJ
ijpds-3543	174	13	mice	mouse	NOUN
ijpds-3543	174	14	treated	treat	VERB
ijpds-3543	174	15	with	with	ADP
ijpds-3543	174	16	anti	anti	NOUN
ijpds-3543	174	17	-	-	NOUN
ijpds-3543	174	18	mil-12	mil-12	NOUN
ijpds-3543	174	19	antibodies	antibody	NOUN
ijpds-3543	174	20	[	[	X
ijpds-3543	174	21	13	13	NUM
ijpds-3543	174	22	]	]	PUNCT
ijpds-3543	174	23	.	.	PUNCT
ijpds-3543	175	1	after	after	SCONJ
ijpds-3543	175	2	il-12	il-12	NOUN
ijpds-3543	175	3	initiates	initiate	VERB
ijpds-3543	175	4	the	the	DET
ijpds-3543	175	5	inflammatory	inflammatory	ADJ
ijpds-3543	175	6	process	process	NOUN
ijpds-3543	175	7	,	,	PUNCT
ijpds-3543	175	8	macrophages	macrophage	NOUN
ijpds-3543	175	9	and	and	CCONJ
ijpds-3543	175	10	other	other	ADJ
ijpds-3543	175	11	cell	cell	NOUN
ijpds-3543	175	12	types	type	NOUN
ijpds-3543	175	13	become	become	VERB
ijpds-3543	175	14	activated	activated	ADJ
ijpds-3543	175	15	and	and	CCONJ
ijpds-3543	175	16	release	release	VERB
ijpds-3543	175	17	a	a	DET
ijpds-3543	175	18	range	range	NOUN
ijpds-3543	175	19	of	of	ADP
ijpds-3543	175	20	mediators	mediator	NOUN
ijpds-3543	175	21	such	such	ADJ
ijpds-3543	175	22	as	as	ADP
ijpds-3543	175	23	tnfa	tnfa	NOUN
ijpds-3543	175	24	,	,	PUNCT
ijpds-3543	175	25	il-	il-	PRON
ijpds-3543	175	26	,	,	PUNCT
ijpds-3543	175	27	il-1	il-1	ADP
ijpds-3543	175	28	,	,	PUNCT
ijpds-3543	175	29	mip1α	mip1α	PROPN
ijpds-3543	175	30	,	,	PUNCT
ijpds-3543	175	31	and	and	CCONJ
ijpds-3543	175	32	no	no	INTJ
ijpds-3543	175	33	,	,	PUNCT
ijpds-3543	175	34	which	which	PRON
ijpds-3543	175	35	keep	keep	VERB
ijpds-3543	175	36	the	the	DET
ijpds-3543	175	37	inflammatory	inflammatory	ADJ
ijpds-3543	175	38	state	state	NOUN
ijpds-3543	175	39	alive	alive	ADJ
ijpds-3543	175	40	.	.	PUNCT
ijpds-3543	176	1	the	the	DET
ijpds-3543	176	2	chemokine	chemokine	ADJ
ijpds-3543	176	3	mip-1α	mip-1α	NOUN
ijpds-3543	176	4	,	,	PUNCT
ijpds-3543	176	5	which	which	PRON
ijpds-3543	176	6	is	be	AUX
ijpds-3543	176	7	generated	generate	VERB
ijpds-3543	176	8	by	by	ADP
ijpds-3543	176	9	fibroblasts	fibroblast	NOUN
ijpds-3543	176	10	or	or	CCONJ
ijpds-3543	176	11	macrophages	macrophage	NOUN
ijpds-3543	176	12	,	,	PUNCT
ijpds-3543	176	13	appears	appear	VERB
ijpds-3543	176	14	to	to	PART
ijpds-3543	176	15	be	be	AUX
ijpds-3543	176	16	a	a	DET
ijpds-3543	176	17	key	key	ADJ
ijpds-3543	176	18	pathogenic	pathogenic	ADJ
ijpds-3543	176	19	element	element	NOUN
ijpds-3543	176	20	in	in	ADP
ijpds-3543	176	21	the	the	DET
ijpds-3543	176	22	development	development	NOUN
ijpds-3543	176	23	of	of	ADP
ijpds-3543	176	24	arthritis	arthritis	NOUN
ijpds-3543	176	25	,	,	PUNCT
ijpds-3543	176	26	owing	owe	VERB
ijpds-3543	176	27	to	to	ADP
ijpds-3543	176	28	its	its	PRON
ijpds-3543	176	29	chemotactic	chemotactic	ADJ
ijpds-3543	176	30	action	action	NOUN
ijpds-3543	176	31	on	on	ADP
ijpds-3543	176	32	inflammatory	inflammatory	ADJ
ijpds-3543	176	33	cells	cell	NOUN
ijpds-3543	176	34	.	.	PUNCT
ijpds-3543	177	1	the	the	DET
ijpds-3543	177	2	decrease	decrease	NOUN
ijpds-3543	177	3	of	of	ADP
ijpds-3543	177	4	paw	paw	NOUN
ijpds-3543	177	5	mip-1α	mip-1α	NOUN
ijpds-3543	177	6	levels	level	NOUN
ijpds-3543	177	7	may	may	AUX
ijpds-3543	177	8	contribute	contribute	VERB
ijpds-3543	177	9	to	to	ADP
ijpds-3543	177	10	the	the	DET
ijpds-3543	177	11	reduction	reduction	NOUN
ijpds-3543	177	12	of	of	ADP
ijpds-3543	177	13	neutrophil	neutrophil	ADJ
ijpds-3543	177	14	recruitment	recruitment	NOUN
ijpds-3543	177	15	(	(	PUNCT
ijpds-3543	177	16	as	as	SCONJ
ijpds-3543	177	17	evidenced	evidence	VERB
ijpds-3543	177	18	by	by	ADP
ijpds-3543	177	19	the	the	DET
ijpds-3543	177	20	suppression	suppression	NOUN
ijpds-3543	177	21	of	of	ADP
ijpds-3543	177	22	paw	paw	PROPN
ijpds-3543	177	23	myeloperoxidase	myeloperoxidase	NOUN
ijpds-3543	177	24	levels	level	NOUN
ijpds-3543	177	25	in	in	ADP
ijpds-3543	177	26	the	the	DET
ijpds-3543	177	27	current	current	ADJ
ijpds-3543	177	28	investigation	investigation	NOUN
ijpds-3543	177	29	)	)	PUNCT
ijpds-3543	178	1	[	[	X
ijpds-3543	178	2	14	14	NUM
ijpds-3543	178	3	-	-	SYM
ijpds-3543	178	4	16	16	NUM
ijpds-3543	178	5	]	]	PUNCT
ijpds-3543	178	6	.	.	PUNCT
ijpds-3543	179	1	the	the	DET
ijpds-3543	179	2	a3	a3	NOUN
ijpds-3543	179	3	has	have	VERB
ijpds-3543	179	4	an	an	DET
ijpds-3543	179	5	inhibiting	inhibit	VERB
ijpds-3543	179	6	action	action	NOUN
ijpds-3543	179	7	.	.	PUNCT
ijpds-3543	180	1	over	over	ADP
ijpds-3543	180	2	production	production	NOUN
ijpds-3543	180	3	of	of	ADP
ijpds-3543	180	4	this	this	DET
ijpds-3543	180	5	free	free	ADJ
ijpds-3543	180	6	radical	radical	NOUN
ijpds-3543	180	7	,	,	PUNCT
ijpds-3543	180	8	as	as	ADV
ijpds-3543	180	9	well	well	ADV
ijpds-3543	180	10	as	as	ADP
ijpds-3543	180	11	its	its	PRON
ijpds-3543	180	12	reactive	reactive	ADJ
ijpds-3543	180	13	reaction	reaction	NOUN
ijpds-3543	180	14	product	product	NOUN
ijpds-3543	180	15	,	,	PUNCT
ijpds-3543	180	16	peroxynitrite	peroxynitrite	ADJ
ijpds-3543	180	17	,	,	PUNCT
ijpds-3543	180	18	has	have	AUX
ijpds-3543	180	19	been	be	AUX
ijpds-3543	180	20	demonstrated	demonstrate	VERB
ijpds-3543	180	21	to	to	PART
ijpds-3543	180	22	contribute	contribute	VERB
ijpds-3543	180	23	to	to	ADP
ijpds-3543	180	24	the	the	DET
ijpds-3543	180	25	pathogenesis	pathogenesis	NOUN
ijpds-3543	180	26	of	of	ADP
ijpds-3543	180	27	the	the	DET
ijpds-3543	180	28	inflammatory	inflammatory	ADJ
ijpds-3543	180	29	joint	joint	ADJ
ijpds-3543	180	30	disease	disease	NOUN
ijpds-3543	180	31	,	,	PUNCT
ijpds-3543	180	32	therefore	therefore	ADV
ijpds-3543	180	33	a	a	DET
ijpds-3543	180	34	receptor	receptor	NOUN
ijpds-3543	180	35	agonist	agonist	NOUN
ijpds-3543	180	36	on	on	ADP
ijpds-3543	180	37	no	no	DET
ijpds-3543	180	38	release	release	NOUN
ijpds-3543	180	39	could	could	AUX
ijpds-3543	180	40	be	be	AUX
ijpds-3543	180	41	advantageous	advantageous	ADJ
ijpds-3543	180	42	although	although	SCONJ
ijpds-3543	180	43	recent	recent	ADJ
ijpds-3543	180	44	research	research	NOUN
ijpds-3543	180	45	postulated	postulate	VERB
ijpds-3543	180	46	alternate	alternate	ADJ
ijpds-3543	180	47	mechanisms	mechanism	NOUN
ijpds-3543	180	48	of	of	ADP
ijpds-3543	180	49	tyrosine	tyrosine	NOUN
ijpds-3543	180	50	nitration	nitration	NOUN
ijpds-3543	180	51	,	,	PUNCT
ijpds-3543	180	52	connected	connect	VERB
ijpds-3543	180	53	to	to	ADP
ijpds-3543	180	54	myeloperoxidase	myeloperoxidase	NOUN
ijpds-3543	180	55	-	-	PUNCT
ijpds-3543	180	56	dependent	dependent	ADJ
ijpds-3543	180	57	conversion	conversion	NOUN
ijpds-3543	180	58	of	of	ADP
ijpds-3543	180	59	nitrite	nitrite	NOUN
ijpds-3543	180	60	to	to	ADP
ijpds-3543	180	61	no2cl	no2cl	PROPN
ijpds-3543	180	62	and	and	CCONJ
ijpds-3543	180	63	no2	no2	PROPN
ijpds-3543	180	64	,	,	PUNCT
ijpds-3543	180	65	nitrotyrosine	nitrotyrosine	PROPN
ijpds-3543	180	66	production	production	NOUN
ijpds-3543	180	67	is	be	AUX
ijpds-3543	180	68	largely	largely	ADV
ijpds-3543	180	69	acknowledged	acknowledge	VERB
ijpds-3543	180	70	as	as	ADP
ijpds-3543	180	71	a	a	DET
ijpds-3543	180	72	specific	specific	ADJ
ijpds-3543	180	73	'	'	PUNCT
ijpds-3543	180	74	footprint	footprint	NOUN
ijpds-3543	180	75	'	'	PUNCT
ijpds-3543	180	76	of	of	ADP
ijpds-3543	180	77	peroxynitrite	peroxynitrite	NOUN
ijpds-3543	180	78	in	in	ADP
ijpds-3543	180	79	the	the	DET
ijpds-3543	180	80	joints	joint	NOUN
ijpds-3543	180	81	,	,	PUNCT
ijpds-3543	180	82	nitrotyrosine	nitrotyrosine	PROPN
ijpds-3543	180	83	could	could	AUX
ijpds-3543	180	84	operate	operate	VERB
ijpds-3543	180	85	as	as	ADP
ijpds-3543	180	86	a	a	DET
ijpds-3543	180	87	collective	collective	ADJ
ijpds-3543	180	88	indication	indication	NOUN
ijpds-3543	180	89	for	for	ADP
ijpds-3543	180	90	the	the	DET
ijpds-3543	180	91	formation	formation	NOUN
ijpds-3543	180	92	of	of	ADP
ijpds-3543	180	93	reactive	reactive	ADJ
ijpds-3543	180	94	nitrogen	nitrogen	NOUN
ijpds-3543	180	95	species	specie	NOUN
ijpds-3543	180	96	[	[	X
ijpds-3543	180	97	17	17	NUM
ijpds-3543	180	98	-	-	SYM
ijpds-3543	180	99	20	20	NUM
ijpds-3543	180	100	]	]	PUNCT
ijpds-3543	180	101	.	.	PUNCT
ijpds-3543	181	1	the	the	DET
ijpds-3543	181	2	current	current	ADJ
ijpds-3543	181	3	work	work	NOUN
ijpds-3543	181	4	shows	show	VERB
ijpds-3543	181	5	that	that	SCONJ
ijpds-3543	181	6	stimulating	stimulate	VERB
ijpds-3543	181	7	the	the	DET
ijpds-3543	181	8	a3	a3	NOUN
ijpds-3543	181	9	and	and	CCONJ
ijpds-3543	181	10	a2	a2	NOUN
ijpds-3543	181	11	receptors	receptor	NOUN
ijpds-3543	181	12	reduces	reduce	VERB
ijpds-3543	181	13	mip-1α	mip-1α	NOUN
ijpds-3543	181	14	production.by	production.by	X
ijpds-3543	181	15	inhibiting	inhibit	VERB
ijpds-3543	181	16	the	the	DET
ijpds-3543	181	17	expression	expression	NOUN
ijpds-3543	181	18	of	of	ADP
ijpds-3543	181	19	its	its	PRON
ijpds-3543	181	20	mrna	mrna	NOUN
ijpds-3543	181	21	furthermore	furthermore	ADV
ijpds-3543	181	22	,	,	PUNCT
ijpds-3543	181	23	the	the	DET
ijpds-3543	181	24	current	current	ADJ
ijpds-3543	181	25	study	study	NOUN
ijpds-3543	181	26	shows	show	VERB
ijpds-3543	181	27	that	that	SCONJ
ijpds-3543	181	28	an	an	DET
ijpds-3543	181	29	a3	a3	NOUN
ijpds-3543	181	30	receptor	receptor	NOUN
ijpds-3543	181	31	agonist	agonist	NOUN
ijpds-3543	181	32	reduces	reduce	VERB
ijpds-3543	181	33	inflammation	inflammation	NOUN
ijpds-3543	181	34	in	in	ADP
ijpds-3543	181	35	collagen	collagen	NOUN
ijpds-3543	181	36	-	-	PUNCT
ijpds-3543	181	37	induced	induce	VERB
ijpds-3543	181	38	arthritis	arthritis	NOUN
ijpds-3543	181	39	.	.	PUNCT
ijpds-3543	182	1	downregulation	downregulation	NOUN
ijpds-3543	182	2	of	of	ADP
ijpds-3543	182	3	the	the	DET
ijpds-3543	182	4	proinflammatory	proinflammatory	ADJ
ijpds-3543	182	5	mediators	mediator	NOUN
ijpds-3543	182	6	mip-1α	mip-1α	NOUN
ijpds-3543	182	7	,	,	PUNCT
ijpds-3543	182	8	il-12	il-12	NOUN
ijpds-3543	182	9	,	,	PUNCT
ijpds-3543	182	10	and	and	CCONJ
ijpds-3543	182	11	no	no	PRON
ijpds-3543	182	12	is	be	AUX
ijpds-3543	182	13	one	one	NUM
ijpds-3543	182	14	of	of	ADP
ijpds-3543	182	15	the	the	DET
ijpds-3543	182	16	mechanisms	mechanism	NOUN
ijpds-3543	182	17	underlying	underlie	VERB
ijpds-3543	182	18	this	this	DET
ijpds-3543	182	19	anti	anti	ADJ
ijpds-3543	182	20	-	-	ADJ
ijpds-3543	182	21	inflammatory	inflammatory	ADJ
ijpds-3543	182	22	action	action	NOUN
ijpds-3543	182	23	.	.	PUNCT
ijpds-3543	183	1	the	the	DET
ijpds-3543	183	2	ability	ability	NOUN
ijpds-3543	183	3	of	of	ADP
ijpds-3543	183	4	drugs	drug	NOUN
ijpds-3543	183	5	like	like	ADP
ijpds-3543	183	6	methotrexate	methotrexate	VERB
ijpds-3543	183	7	sulphasalazine	sulphasalazine	ADJ
ijpds-3543	183	8	and	and	CCONJ
ijpds-3543	183	9	adenosine	adenosine	ADJ
ijpds-3543	183	10	kinase	kinase	NOUN
ijpds-3543	183	11	inhibitors	inhibitor	NOUN
ijpds-3543	183	12	to	to	PART
ijpds-3543	183	13	release	release	VERB
ijpds-3543	183	14	adenosine	adenosine	NOUN
ijpds-3543	183	15	at	at	ADP
ijpds-3543	183	16	the	the	DET
ijpds-3543	183	17	sites	site	NOUN
ijpds-3543	183	18	of	of	ADP
ijpds-3543	183	19	inflammation	inflammation	NOUN
ijpds-3543	183	20	is	be	AUX
ijpds-3543	183	21	linked	link	VERB
ijpds-3543	183	22	to	to	ADP
ijpds-3543	183	23	their	their	PRON
ijpds-3543	183	24	anti	anti	ADJ
ijpds-3543	183	25	-	-	ADJ
ijpds-3543	183	26	inflammatory	inflammatory	ADJ
ijpds-3543	183	27	properties	property	NOUN
ijpds-3543	183	28	.	.	PUNCT
ijpds-3543	184	1	these	these	DET
ijpds-3543	184	2	anti	anti	ADJ
ijpds-3543	184	3	-	-	ADJ
ijpds-3543	184	4	inflammatory	inflammatory	ADJ
ijpds-3543	184	5	actions	action	NOUN
ijpds-3543	184	6	may	may	AUX
ijpds-3543	184	7	be	be	AUX
ijpds-3543	184	8	related	relate	VERB
ijpds-3543	184	9	to	to	PART
ijpds-3543	184	10	a3	a3	VERB
ijpds-3543	184	11	and	and	CCONJ
ijpds-3543	184	12	a2	a2	PROPN
ijpds-3543	184	13	,	,	PUNCT
ijpds-3543	184	14	at	at	ADP
ijpds-3543	184	15	least	least	ADJ
ijpds-3543	184	16	in	in	ADP
ijpds-3543	184	17	part	part	NOUN
ijpds-3543	184	18	,	,	PUNCT
ijpds-3543	184	19	according	accord	VERB
ijpds-3543	184	20	to	to	ADP
ijpds-3543	184	21	our	our	PRON
ijpds-3543	184	22	hypothesis	hypothesis	NOUN
ijpds-3543	184	23	of	of	ADP
ijpds-3543	184	24	activation	activation	NOUN
ijpds-3543	184	25	of	of	ADP
ijpds-3543	184	26	receptors	receptor	NOUN
ijpds-3543	184	27	.	.	PUNCT
ijpds-3543	185	1	we	we	PRON
ijpds-3543	185	2	believe	believe	VERB
ijpds-3543	185	3	that	that	SCONJ
ijpds-3543	185	4	stimulating	stimulate	VERB
ijpds-3543	185	5	the	the	DET
ijpds-3543	185	6	adenosine	adenosine	ADJ
ijpds-3543	185	7	receptor	receptor	NOUN
ijpds-3543	185	8	subtypes	subtype	NOUN
ijpds-3543	185	9	a3	a3	NOUN
ijpds-3543	185	10	and	and	CCONJ
ijpds-3543	185	11	a2	a2	PROPN
ijpds-3543	185	12	could	could	AUX
ijpds-3543	185	13	be	be	AUX
ijpds-3543	185	14	a	a	DET
ijpds-3543	185	15	promising	promising	ADJ
ijpds-3543	185	16	technique	technique	NOUN
ijpds-3543	185	17	for	for	ADP
ijpds-3543	185	18	the	the	DET
ijpds-3543	185	19	treatment	treatment	NOUN
ijpds-3543	185	20	of	of	ADP
ijpds-3543	185	21	acute	acute	ADJ
ijpds-3543	185	22	and	and	CCONJ
ijpds-3543	185	23	chronic	chronic	ADJ
ijpds-3543	185	24	inflammatory	inflammatory	ADJ
ijpds-3543	185	25	diseases	disease	NOUN
ijpds-3543	185	26	.	.	PUNCT
ijpds-3543	186	1	references	reference	NOUN
ijpds-3543	186	2	1	1	NUM
ijpds-3543	186	3	.	.	PUNCT
ijpds-3543	186	4	standiford	standiford	PROPN
ijpds-3543	186	5	tj	tj	PROPN
ijpds-3543	186	6	,	,	PUNCT
ijpds-3543	186	7	kunkel	kunkel	PROPN
ijpds-3543	186	8	sl	sl	PROPN
ijpds-3543	186	9	,	,	PUNCT
ijpds-3543	186	10	lukacs	lukacs	PROPN
ijpds-3543	186	11	nw	nw	PROPN
ijpds-3543	186	12	,	,	PUNCT
ijpds-3543	186	13	et	et	PROPN
ijpds-3543	186	14	al	al	PROPN
ijpds-3543	186	15	.	.	PUNCT
ijpds-3543	187	1	macrophage	macrophage	ADJ
ijpds-3543	187	2	inflammatory	inflammatory	ADJ
ijpds-3543	187	3	protein-1	protein-1	NUM
ijpds-3543	187	4	alpha	alpha	NOUN
ijpds-3543	187	5	mediates	mediate	NOUN
ijpds-3543	187	6	lung	lung	NOUN
ijpds-3543	187	7	leukocyte	leukocyte	NOUN
ijpds-3543	187	8	recruitment	recruitment	NOUN
ijpds-3543	187	9	,	,	PUNCT
ijpds-3543	187	10	lung	lung	NOUN
ijpds-3543	187	11	capillary	capillary	ADJ
ijpds-3543	187	12	leak	leak	NOUN
ijpds-3543	187	13	,	,	PUNCT
ijpds-3543	187	14	and	and	CCONJ
ijpds-3543	187	15	early	early	ADJ
ijpds-3543	187	16	mortality	mortality	NOUN
ijpds-3543	187	17	in	in	ADP
ijpds-3543	187	18	murine	murine	ADJ
ijpds-3543	187	19	endotoxemia	endotoxemia	NOUN
ijpds-3543	187	20	.	.	PUNCT
ijpds-3543	188	1	j	j	PROPN
ijpds-3543	188	2	immunol	immunol	NOUN
ijpds-3543	189	1	[	[	X
ijpds-3543	189	2	internet	internet	NOUN
ijpds-3543	189	3	]	]	X
ijpds-3543	189	4	.	.	PUNCT
ijpds-3543	190	1	1995	1995	NUM
ijpds-3543	191	1	[	[	X
ijpds-3543	191	2	cited	cite	VERB
ijpds-3543	191	3	2023	2023	NUM
ijpds-3543	191	4	apr	apr	NOUN
ijpds-3543	191	5	10];155(3):1515–24	10];155(3):1515–24	NUM
ijpds-3543	191	6	.	.	NOUN
ijpds-3543	192	1	2	2	NUM
ijpds-3543	192	2	.	.	X
ijpds-3543	192	3	szabó	szabó	PROPN
ijpds-3543	192	4	c	c	PROPN
ijpds-3543	192	5	,	,	PUNCT
ijpds-3543	192	6	lim	lim	PROPN
ijpds-3543	192	7	lh	lh	PROPN
ijpds-3543	192	8	,	,	PUNCT
ijpds-3543	192	9	cuzzocrea	cuzzocrea	PROPN
ijpds-3543	192	10	s	s	PROPN
ijpds-3543	192	11	,	,	PUNCT
ijpds-3543	192	12	et	et	PROPN
ijpds-3543	192	13	al	al	PROPN
ijpds-3543	192	14	.	.	PROPN
ijpds-3543	192	15	inhibition	inhibition	NOUN
ijpds-3543	192	16	of	of	ADP
ijpds-3543	192	17	poly	poly	ADJ
ijpds-3543	192	18	(	(	PUNCT
ijpds-3543	192	19	adpribose	adpribose	ADJ
ijpds-3543	192	20	)	)	PUNCT
ijpds-3543	192	21	synthetase	synthetase	NOUN
ijpds-3543	192	22	attenuates	attenuate	VERB
ijpds-3543	192	23	neutrophil	neutrophil	ADJ
ijpds-3543	192	24	recruitment	recruitment	NOUN
ijpds-3543	192	25	and	and	CCONJ
ijpds-3543	192	26	exerts	exert	VERB
ijpds-3543	192	27	antiinflammatory	antiinflammatory	NOUN
ijpds-3543	192	28	effects	effect	NOUN
ijpds-3543	192	29	.	.	PUNCT
ijpds-3543	193	1	j	j	PROPN
ijpds-3543	193	2	exp	exp	NOUN
ijpds-3543	193	3	med	med	PROPN
ijpds-3543	193	4	[	[	X
ijpds-3543	193	5	internet	internet	NOUN
ijpds-3543	193	6	]	]	PUNCT
ijpds-3543	193	7	.	.	PUNCT
ijpds-3543	194	1	1997	1997	NUM
ijpds-3543	194	2	[	[	X
ijpds-3543	194	3	cited	cite	VERB
ijpds-3543	194	4	2023	2023	NUM
ijpds-3543	194	5	apr	apr	NOUN
ijpds-3543	194	6	10];186(7):1041–9	10];186(7):1041–9	NUM
ijpds-3543	194	7	.	.	PROPN
ijpds-3543	195	1	3	3	X
ijpds-3543	195	2	.	.	X
ijpds-3543	195	3	tracey	tracey	PROPN
ijpds-3543	195	4	wr	wr	PROPN
ijpds-3543	195	5	,	,	PUNCT
ijpds-3543	195	6	magee	magee	PROPN
ijpds-3543	195	7	w	w	PROPN
ijpds-3543	195	8	,	,	PUNCT
ijpds-3543	195	9	masamune	masamune	PROPN
ijpds-3543	195	10	h	h	PROPN
ijpds-3543	195	11	,	,	PUNCT
ijpds-3543	195	12	et	et	PROPN
ijpds-3543	195	13	al	al	PROPN
ijpds-3543	195	14	.	.	PROPN
ijpds-3543	195	15	selective	selective	ADJ
ijpds-3543	195	16	adenosine	adenosine	NOUN
ijpds-3543	195	17	a3	a3	NOUN
ijpds-3543	195	18	receptor	receptor	NOUN
ijpds-3543	195	19	stimulation	stimulation	NOUN
ijpds-3543	195	20	reduces	reduce	VERB
ijpds-3543	195	21	ischemic	ischemic	ADJ
ijpds-3543	195	22	myocardial	myocardial	ADJ
ijpds-3543	195	23	injury	injury	NOUN
ijpds-3543	195	24	in	in	ADP
ijpds-3543	195	25	the	the	DET
ijpds-3543	195	26	rabbit	rabbit	NOUN
ijpds-3543	195	27	heart	heart	NOUN
ijpds-3543	195	28	.	.	PUNCT
ijpds-3543	196	1	cardiovasc	cardiovasc	PROPN
ijpds-3543	196	2	res	re	VERB
ijpds-3543	196	3	[	[	X
ijpds-3543	196	4	internet	internet	NOUN
ijpds-3543	196	5	]	]	PUNCT
ijpds-3543	196	6	.	.	PUNCT
ijpds-3543	197	1	1997	1997	NUM
ijpds-3543	198	1	[	[	X
ijpds-3543	198	2	cited	cite	VERB
ijpds-3543	198	3	2023	2023	NUM
ijpds-3543	198	4	apr	apr	NOUN
ijpds-3543	198	5	10];33(2):410–5	10];33(2):410–5	NUM
ijpds-3543	198	6	.	.	NOUN
ijpds-3543	199	1	4	4	NUM
ijpds-3543	199	2	.	.	X
ijpds-3543	199	3	lubitz	lubitz	PROPN
ijpds-3543	199	4	dkje	dkje	PROPN
ijpds-3543	199	5	,	,	PUNCT
ijpds-3543	199	6	lin	lin	PROPN
ijpds-3543	199	7	rc	rc	PROPN
ijpds-3543	199	8	-	-	PUNCT
ijpds-3543	199	9	s	s	PROPN
ijpds-3543	199	10	,	,	PUNCT
ijpds-3543	199	11	popik	popik	NOUN
ijpds-3543	199	12	p	p	X
ijpds-3543	199	13	,	,	PUNCT
ijpds-3543	199	14	et	et	PROPN
ijpds-3543	199	15	al	al	PROPN
ijpds-3543	199	16	.	.	PROPN
ijpds-3543	199	17	adenosine	adenosine	PROPN
ijpds-3543	199	18	a3	a3	NOUN
ijpds-3543	199	19	receptor	receptor	NOUN
ijpds-3543	199	20	stimulation	stimulation	NOUN
ijpds-3543	199	21	and	and	CCONJ
ijpds-3543	199	22	cerebral	cerebral	ADJ
ijpds-3543	199	23	ischemia	ischemia	NOUN
ijpds-3543	199	24	.	.	PUNCT
ijpds-3543	200	1	eur	eur	PROPN
ijpds-3543	200	2	j	j	PROPN
ijpds-3543	200	3	pharmacol	pharmacol	PROPN
ijpds-3543	201	1	[	[	X
ijpds-3543	201	2	internet	internet	NOUN
ijpds-3543	201	3	]	]	PUNCT
ijpds-3543	201	4	.	.	PUNCT
ijpds-3543	202	1	1994;263(1–2):59–67	1994;263(1–2):59–67	X
ijpds-3543	202	2	.	.	NOUN
ijpds-3543	202	3	5	5	NUM
ijpds-3543	202	4	.	.	PUNCT
ijpds-3543	202	5	wolberg	wolberg	PROPN
ijpds-3543	202	6	g	g	PROPN
ijpds-3543	202	7	,	,	PUNCT
ijpds-3543	202	8	zimmerman	zimmerman	PROPN
ijpds-3543	202	9	tp	tp	PROPN
ijpds-3543	202	10	.	.	PUNCT
ijpds-3543	202	11	effects	effect	NOUN
ijpds-3543	202	12	of	of	ADP
ijpds-3543	202	13	adenosine	adenosine	ADJ
ijpds-3543	202	14	deaminase	deaminase	NOUN
ijpds-3543	202	15	inhibitors	inhibitor	NOUN
ijpds-3543	202	16	on	on	ADP
ijpds-3543	202	17	lymphocyte	lymphocyte	NOUN
ijpds-3543	202	18	-	-	PUNCT
ijpds-3543	202	19	mediated	mediate	VERB
ijpds-3543	202	20	cytolysis	cytolysis	NOUN
ijpds-3543	202	21	.	.	PUNCT
ijpds-3543	203	1	ann	ann	PROPN
ijpds-3543	203	2	n	n	PROPN
ijpds-3543	203	3	y	y	PROPN
ijpds-3543	203	4	acad	acad	PROPN
ijpds-3543	203	5	sci	sci	PROPN
ijpds-3543	204	1	[	[	X
ijpds-3543	204	2	internet	internet	NOUN
ijpds-3543	204	3	]	]	PUNCT
ijpds-3543	204	4	.	.	PUNCT
ijpds-3543	205	1	1985;451(1):215–26	1985;451(1):215–26	NUM
ijpds-3543	205	2	.	.	PUNCT
ijpds-3543	206	1	6	6	NUM
ijpds-3543	206	2	.	.	X
ijpds-3543	206	3	al	al	PROPN
ijpds-3543	206	4	-	-	PUNCT
ijpds-3543	206	5	mughales	mughales	PROPN
ijpds-3543	206	6	j	j	PROPN
ijpds-3543	206	7	,	,	PUNCT
ijpds-3543	206	8	blyth	blyth	PROPN
ijpds-3543	206	9	th	th	PROPN
ijpds-3543	206	10	,	,	PUNCT
ijpds-3543	206	11	hunter	hunter	PROPN
ijpds-3543	206	12	ja	ja	PROPN
ijpds-3543	206	13	,	,	PUNCT
ijpds-3543	206	14	et	et	PROPN
ijpds-3543	206	15	al	al	PROPN
ijpds-3543	206	16	.	.	PUNCT
ijpds-3543	207	1	the	the	DET
ijpds-3543	207	2	chemoattractant	chemoattractant	ADJ
ijpds-3543	207	3	activity	activity	NOUN
ijpds-3543	207	4	of	of	ADP
ijpds-3543	207	5	rheumatoid	rheumatoid	ADJ
ijpds-3543	207	6	synovial	synovial	ADJ
ijpds-3543	207	7	fluid	fluid	NOUN
ijpds-3543	207	8	for	for	ADP
ijpds-3543	207	9	human	human	ADJ
ijpds-3543	207	10	lymphocytes	lymphocyte	NOUN
ijpds-3543	207	11	is	be	AUX
ijpds-3543	207	12	due	due	ADJ
ijpds-3543	207	13	to	to	ADP
ijpds-3543	207	14	multiple	multiple	ADJ
ijpds-3543	207	15	cytokines	cytokine	NOUN
ijpds-3543	207	16	.	.	PUNCT
ijpds-3543	208	1	clin	clin	PROPN
ijpds-3543	208	2	exp	exp	NOUN
ijpds-3543	208	3	immunol	immunol	NOUN
ijpds-3543	209	1	[	[	X
ijpds-3543	209	2	internet	internet	NOUN
ijpds-3543	209	3	]	]	PUNCT
ijpds-3543	209	4	.	.	PUNCT
ijpds-3543	210	1	1996;106(2):230–6	1996;106(2):230–6	NUM
ijpds-3543	210	2	.	.	PUNCT
ijpds-3543	211	1	7	7	X
ijpds-3543	211	2	.	.	X
ijpds-3543	211	3	auchampach	auchampach	PROPN
ijpds-3543	211	4	ja	ja	PROPN
ijpds-3543	211	5	,	,	PUNCT
ijpds-3543	211	6	rizvi	rizvi	VERB
ijpds-3543	211	7	a	a	PRON
ijpds-3543	211	8	,	,	PUNCT
ijpds-3543	211	9	qiu	qiu	PROPN
ijpds-3543	211	10	y	y	PROPN
ijpds-3543	211	11	,	,	PUNCT
ijpds-3543	211	12	et	et	PROPN
ijpds-3543	211	13	al	al	PROPN
ijpds-3543	211	14	.	.	PROPN
ijpds-3543	211	15	selective	selective	ADJ
ijpds-3543	211	16	activation	activation	NOUN
ijpds-3543	211	17	of	of	ADP
ijpds-3543	211	18	a	a	DET
ijpds-3543	211	19	3	3	NUM
ijpds-3543	211	20	adenosine	adenosine	NOUN
ijpds-3543	211	21	receptors	receptor	NOUN
ijpds-3543	211	22	with	with	ADP
ijpds-3543	211	23	n	n	PRON
ijpds-3543	211	24	6	6	NUM
ijpds-3543	211	25	-(3	-(3	PROPN
ijpds-3543	211	26	-	-	PUNCT
ijpds-3543	211	27	iodobenzyl)adenosine-5′	iodobenzyl)adenosine-5′	PROPN
ijpds-3543	211	28	n	n	PRON
ijpds-3543	211	29	-methyluronamide	-methyluronamide	ADJ
ijpds-3543	211	30	protects	protect	VERB
ijpds-3543	211	31	against	against	ADP
ijpds-3543	211	32	myocardial	myocardial	ADJ
ijpds-3543	211	33	stunning	stunning	ADJ
ijpds-3543	211	34	and	and	CCONJ
ijpds-3543	211	35	infarction	infarction	NOUN
ijpds-3543	211	36	without	without	ADP
ijpds-3543	211	37	hemodynamic	hemodynamic	ADJ
ijpds-3543	211	38	changes	change	NOUN
ijpds-3543	211	39	in	in	ADP
ijpds-3543	211	40	conscious	conscious	ADJ
ijpds-3543	211	41	rabbits	rabbit	NOUN
ijpds-3543	211	42	.	.	PUNCT
ijpds-3543	212	1	circ	circ	PROPN
ijpds-3543	212	2	res	re	NOUN
ijpds-3543	213	1	[	[	X
ijpds-3543	213	2	internet	internet	NOUN
ijpds-3543	213	3	]	]	PUNCT
ijpds-3543	213	4	.	.	PUNCT
ijpds-3543	214	1	1997;80(6):800–9	1997;80(6):800–9	NUM
ijpds-3543	214	2	.	.	NOUN
ijpds-3543	215	1	8	8	NUM
ijpds-3543	215	2	.	.	PUNCT
ijpds-3543	216	1	beckman	beckman	PROPN
ijpds-3543	216	2	js	js	PROPN
ijpds-3543	216	3	,	,	PUNCT
ijpds-3543	216	4	koppenol	koppenol	PROPN
ijpds-3543	216	5	wh	wh	PROPN
ijpds-3543	216	6	.	.	NOUN
ijpds-3543	216	7	nitric	nitric	ADJ
ijpds-3543	216	8	oxide	oxide	NOUN
ijpds-3543	216	9	,	,	PUNCT
ijpds-3543	216	10	superoxide	superoxide	NOUN
ijpds-3543	216	11	,	,	PUNCT
ijpds-3543	216	12	and	and	CCONJ
ijpds-3543	216	13	peroxynitrite	peroxynitrite	ADJ
ijpds-3543	216	14	:	:	PUNCT
ijpds-3543	216	15	the	the	DET
ijpds-3543	216	16	good	good	NOUN
ijpds-3543	216	17	,	,	PUNCT
ijpds-3543	216	18	the	the	DET
ijpds-3543	216	19	bad	bad	ADJ
ijpds-3543	216	20	,	,	PUNCT
ijpds-3543	216	21	and	and	CCONJ
ijpds-3543	216	22	ugly	ugly	ADJ
ijpds-3543	216	23	.	.	PUNCT
ijpds-3543	216	24	am	be	AUX
ijpds-3543	216	25	j	j	PROPN
ijpds-3543	216	26	physiol	physiol	PROPN
ijpds-3543	216	27	cell	cell	PROPN
ijpds-3543	216	28	physiol	physiol	PROPN
ijpds-3543	217	1	[	[	X
ijpds-3543	217	2	internet	internet	NOUN
ijpds-3543	217	3	]	]	PUNCT
ijpds-3543	217	4	.	.	PUNCT
ijpds-3543	218	1	1996;271(5):c1424–37	1996;271(5):c1424–37	NUM
ijpds-3543	218	2	.	.	PUNCT
ijpds-3543	219	1	9	9	NUM
ijpds-3543	219	2	.	.	X
ijpds-3543	220	1	sheth	sheth	PROPN
ijpds-3543	220	2	s	s	PROPN
ijpds-3543	220	3	,	,	PUNCT
ijpds-3543	220	4	brito	brito	PROPN
ijpds-3543	220	5	r	r	PROPN
ijpds-3543	220	6	,	,	PUNCT
ijpds-3543	220	7	mukherjea	mukherjea	PROPN
ijpds-3543	220	8	d	d	PROPN
ijpds-3543	220	9	,	,	PUNCT
ijpds-3543	220	10	et	et	PROPN
ijpds-3543	220	11	al	al	PROPN
ijpds-3543	220	12	.	.	PROPN
ijpds-3543	220	13	adenosine	adenosine	NOUN
ijpds-3543	220	14	receptors	receptor	NOUN
ijpds-3543	220	15	:	:	PUNCT
ijpds-3543	220	16	expression	expression	NOUN
ijpds-3543	220	17	,	,	PUNCT
ijpds-3543	220	18	function	function	NOUN
ijpds-3543	220	19	and	and	CCONJ
ijpds-3543	220	20	regulation	regulation	NOUN
ijpds-3543	220	21	.	.	PUNCT
ijpds-3543	221	1	int	int	PROPN
ijpds-3543	221	2	j	j	PROPN
ijpds-3543	221	3	mol	mol	ADP
ijpds-3543	221	4	sci	sci	PROPN
ijpds-3543	222	1	[	[	X
ijpds-3543	222	2	internet	internet	NOUN
ijpds-3543	222	3	]	]	PUNCT
ijpds-3543	222	4	.	.	PUNCT
ijpds-3543	223	1	2014;15(2):2024–52	2014;15(2):2024–52	NUM
ijpds-3543	223	2	.	.	PUNCT
ijpds-3543	224	1	10	10	NUM
ijpds-3543	224	2	.	.	PUNCT
ijpds-3543	224	3	connor	connor	PROPN
ijpds-3543	224	4	jr	jr	PROPN
ijpds-3543	224	5	,	,	PUNCT
ijpds-3543	224	6	manning	man	VERB
ijpds-3543	224	7	pt	pt	NOUN
ijpds-3543	224	8	,	,	PUNCT
ijpds-3543	224	9	settle	settle	NOUN
ijpds-3543	224	10	sl	sl	INTJ
ijpds-3543	224	11	,	,	PUNCT
ijpds-3543	224	12	et	et	PROPN
ijpds-3543	224	13	al	al	PROPN
ijpds-3543	224	14	.	.	PROPN
ijpds-3543	224	15	suppression	suppression	NOUN
ijpds-3543	224	16	of	of	ADP
ijpds-3543	224	17	adjuvant	adjuvant	NOUN
ijpds-3543	224	18	-	-	PUNCT
ijpds-3543	224	19	induced	induce	VERB
ijpds-3543	224	20	arthritis	arthritis	NOUN
ijpds-3543	224	21	by	by	ADP
ijpds-3543	224	22	selective	selective	ADJ
ijpds-3543	224	23	inhibition	inhibition	NOUN
ijpds-3543	224	24	of	of	ADP
ijpds-3543	224	25	inducible	inducible	ADJ
ijpds-3543	224	26	nitric	nitric	ADJ
ijpds-3543	224	27	oxide	oxide	NOUN
ijpds-3543	224	28	synthase	synthase	NOUN
ijpds-3543	224	29	.	.	PUNCT
ijpds-3543	225	1	eur	eur	PROPN
ijpds-3543	225	2	j	j	PROPN
ijpds-3543	225	3	pharmacol	pharmacol	PROPN
ijpds-3543	226	1	[	[	X
ijpds-3543	226	2	internet	internet	NOUN
ijpds-3543	226	3	]	]	PUNCT
ijpds-3543	226	4	.	.	PUNCT
ijpds-3543	227	1	1995;273(1	1995;273(1	NUM
ijpds-3543	227	2	–	–	PUNCT
ijpds-3543	227	3	2):15–24	2):15–24	NUM
ijpds-3543	227	4	.	.	PUNCT
ijpds-3543	228	1	11	11	NUM
ijpds-3543	228	2	.	.	PUNCT
ijpds-3543	229	1	haskó	haskó	PROPN
ijpds-3543	229	2	g	g	PROPN
ijpds-3543	229	3	,	,	PUNCT
ijpds-3543	229	4	cronstein	cronstein	PROPN
ijpds-3543	229	5	b.	b.	PROPN
ijpds-3543	229	6	regulation	regulation	NOUN
ijpds-3543	229	7	of	of	ADP
ijpds-3543	229	8	inflammation	inflammation	NOUN
ijpds-3543	229	9	by	by	ADP
ijpds-3543	229	10	adenosine	adenosine	NOUN
ijpds-3543	229	11	.	.	PUNCT
ijpds-3543	230	1	front	front	ADJ
ijpds-3543	230	2	immunol	immunol	NOUN
ijpds-3543	231	1	[	[	X
ijpds-3543	231	2	internet	internet	NOUN
ijpds-3543	231	3	]	]	PUNCT
ijpds-3543	231	4	.	.	PUNCT
ijpds-3543	232	1	2013;4:85	2013;4:85	PROPN
ijpds-3543	232	2	.	.	PUNCT
ijpds-3543	233	1	12	12	NUM
ijpds-3543	233	2	.	.	PUNCT
ijpds-3543	234	1	cronstein	cronstein	PROPN
ijpds-3543	234	2	bn	bn	PROPN
ijpds-3543	234	3	,	,	PUNCT
ijpds-3543	234	4	eberle	eberle	PROPN
ijpds-3543	234	5	ma	ma	PROPN
ijpds-3543	234	6	,	,	PUNCT
ijpds-3543	234	7	gruber	gruber	PROPN
ijpds-3543	234	8	he	he	PRON
ijpds-3543	234	9	,	,	PUNCT
ijpds-3543	234	10	et	et	PROPN
ijpds-3543	234	11	al	al	PROPN
ijpds-3543	234	12	.	.	PROPN
ijpds-3543	234	13	methotrexate	methotrexate	PROPN
ijpds-3543	234	14	inhibits	inhibit	VERB
ijpds-3543	234	15	neutrophil	neutrophil	ADJ
ijpds-3543	234	16	function	function	NOUN
ijpds-3543	234	17	by	by	ADP
ijpds-3543	234	18	stimulating	stimulate	VERB
ijpds-3543	234	19	adenosine	adenosine	ADJ
ijpds-3543	234	20	release	release	NOUN
ijpds-3543	234	21	from	from	ADP
ijpds-3543	234	22	connective	connective	ADJ
ijpds-3543	234	23	tissue	tissue	NOUN
ijpds-3543	234	24	cells	cell	NOUN
ijpds-3543	234	25	.	.	PUNCT
ijpds-3543	235	1	proc	proc	PROPN
ijpds-3543	235	2	natl	natl	PROPN
ijpds-3543	235	3	acad	acad	PROPN
ijpds-3543	235	4	sci	sci	PROPN
ijpds-3543	235	5	u	u	PROPN
ijpds-3543	235	6	s	s	PROPN
ijpds-3543	235	7	a	a	DET
ijpds-3543	235	8	[	[	X
ijpds-3543	235	9	internet	internet	NOUN
ijpds-3543	235	10	]	]	PUNCT
ijpds-3543	235	11	.	.	PUNCT
ijpds-3543	236	1	1991;88(6):2441–5	1991;88(6):2441–5	NUM
ijpds-3543	236	2	.	.	NOUN
ijpds-3543	236	3	13	13	NUM
ijpds-3543	236	4	.	.	X
ijpds-3543	236	5	cronstein	cronstein	PROPN
ijpds-3543	236	6	bn	bn	PROPN
ijpds-3543	236	7	,	,	PUNCT
ijpds-3543	236	8	naime	naime	PROPN
ijpds-3543	236	9	d	d	PROPN
ijpds-3543	236	10	,	,	PUNCT
ijpds-3543	236	11	ostad	ostad	PROPN
ijpds-3543	236	12	e.	e.	PROPN
ijpds-3543	236	13	the	the	DET
ijpds-3543	236	14	antiinflammatory	antiinflammatory	NOUN
ijpds-3543	236	15	mechanism	mechanism	NOUN
ijpds-3543	236	16	of	of	ADP
ijpds-3543	236	17	methotrexate	methotrexate	NOUN
ijpds-3543	236	18	.	.	PUNCT
ijpds-3543	237	1	increased	increase	VERB
ijpds-3543	237	2	adenosine	adenosine	NOUN
ijpds-3543	237	3	release	release	NOUN
ijpds-3543	237	4	at	at	ADP
ijpds-3543	237	5	sonwani	sonwani	PROPN
ijpds-3543	237	6	et	et	PROPN
ijpds-3543	237	7	al	al	PROPN
ijpds-3543	237	8	.	.	PROPN
ijpds-3543	238	1	role	role	NOUN
ijpds-3543	238	2	of	of	ADP
ijpds-3543	238	3	adenosine	adenosine	ADJ
ijpds-3543	238	4	receptor	receptor	NOUN
ijpds-3543	238	5	agonists	agonist	NOUN
ijpds-3543	238	6	in	in	ADP
ijpds-3543	238	7	inflammatory	inflammatory	ADJ
ijpds-3543	238	8	conditions	condition	NOUN
ijpds-3543	238	9	vol	vol	NOUN
ijpds-3543	238	10	2	2	NUM
ijpds-3543	238	11	|	|	NOUN
ijpds-3543	238	12	issue	issue	NOUN
ijpds-3543	238	13	2	2	NUM
ijpds-3543	238	14	|	|	ADV
ijpds-3543	238	15	apr	apr	ADV
ijpds-3543	238	16	–	–	PUNCT
ijpds-3543	238	17	jun	jun	PROPN
ijpds-3543	238	18	2023	2023	NUM
ijpds-3543	238	19	indian	indian	PROPN
ijpds-3543	238	20	j	j	PROPN
ijpds-3543	238	21	pharm	pharm	PROPN
ijpds-3543	238	22	drug	drug	PROPN
ijpds-3543	238	23	studies	study	NOUN
ijpds-3543	238	24	|	|	ADV
ijpds-3543	238	25	75	75	NUM
ijpds-3543	238	26	inflamed	inflame	VERB
ijpds-3543	238	27	sites	site	NOUN
ijpds-3543	238	28	diminishes	diminish	VERB
ijpds-3543	238	29	leukocyte	leukocyte	ADJ
ijpds-3543	238	30	accumulation	accumulation	NOUN
ijpds-3543	238	31	in	in	ADP
ijpds-3543	238	32	an	an	DET
ijpds-3543	238	33	in	in	ADP
ijpds-3543	238	34	vivo	vivo	NOUN
ijpds-3543	238	35	model	model	NOUN
ijpds-3543	238	36	of	of	ADP
ijpds-3543	238	37	inflammation	inflammation	NOUN
ijpds-3543	238	38	.	.	PUNCT
ijpds-3543	239	1	j	j	PROPN
ijpds-3543	239	2	clin	clin	PROPN
ijpds-3543	239	3	invest	invest	VERB
ijpds-3543	240	1	[	[	X
ijpds-3543	240	2	internet	internet	NOUN
ijpds-3543	240	3	]	]	PUNCT
ijpds-3543	240	4	.	.	PUNCT
ijpds-3543	241	1	1993;92(6):2675–82	1993;92(6):2675–82	X
ijpds-3543	241	2	.	.	PUNCT
ijpds-3543	242	1	14	14	NUM
ijpds-3543	242	2	.	.	PUNCT
ijpds-3543	243	1	dubyak	dubyak	ADP
ijpds-3543	243	2	gr	gr	PROPN
ijpds-3543	243	3	,	,	PUNCT
ijpds-3543	243	4	el	el	PROPN
ijpds-3543	243	5	-	-	PUNCT
ijpds-3543	243	6	moatassim	moatassim	PROPN
ijpds-3543	243	7	c.	c.	PROPN
ijpds-3543	243	8	signal	signal	PROPN
ijpds-3543	243	9	transduction	transduction	NOUN
ijpds-3543	243	10	via	via	ADP
ijpds-3543	243	11	p2purinergic	p2purinergic	ADJ
ijpds-3543	243	12	receptors	receptor	NOUN
ijpds-3543	243	13	for	for	ADP
ijpds-3543	243	14	extracellular	extracellular	ADJ
ijpds-3543	243	15	atp	atp	NOUN
ijpds-3543	243	16	and	and	CCONJ
ijpds-3543	243	17	other	other	ADJ
ijpds-3543	243	18	nucleotides	nucleotide	NOUN
ijpds-3543	243	19	.	.	PUNCT
ijpds-3543	244	1	am	be	AUX
ijpds-3543	244	2	j	j	PROPN
ijpds-3543	244	3	physiol	physiol	PROPN
ijpds-3543	244	4	cell	cell	PROPN
ijpds-3543	244	5	physiol	physiol	PROPN
ijpds-3543	245	1	[	[	X
ijpds-3543	245	2	internet	internet	NOUN
ijpds-3543	245	3	]	]	PUNCT
ijpds-3543	245	4	.	.	PUNCT
ijpds-3543	246	1	1993;265(3):c577–606	1993;265(3):c577–606	NUM
ijpds-3543	246	2	.	.	PUNCT
ijpds-3543	247	1	15	15	NUM
ijpds-3543	247	2	.	.	X
ijpds-3543	247	3	eiserich	eiserich	PROPN
ijpds-3543	247	4	jp	jp	PROPN
ijpds-3543	247	5	,	,	PUNCT
ijpds-3543	247	6	hristova	hristova	X
ijpds-3543	247	7	m	m	PROPN
ijpds-3543	247	8	,	,	PUNCT
ijpds-3543	247	9	cross	cross	PROPN
ijpds-3543	247	10	ce	ce	PROPN
ijpds-3543	247	11	,	,	PUNCT
ijpds-3543	247	12	et	et	PROPN
ijpds-3543	247	13	al	al	PROPN
ijpds-3543	247	14	.	.	PUNCT
ijpds-3543	247	15	formation	formation	NOUN
ijpds-3543	247	16	of	of	ADP
ijpds-3543	247	17	nitric	nitric	ADJ
ijpds-3543	247	18	oxide	oxide	NOUN
ijpds-3543	247	19	-	-	PUNCT
ijpds-3543	247	20	derived	derive	VERB
ijpds-3543	247	21	inflammatory	inflammatory	ADJ
ijpds-3543	247	22	oxidants	oxidant	NOUN
ijpds-3543	247	23	by	by	ADP
ijpds-3543	247	24	myeloperoxidase	myeloperoxidase	NOUN
ijpds-3543	247	25	in	in	ADP
ijpds-3543	247	26	neutrophils	neutrophil	NOUN
ijpds-3543	247	27	.	.	PUNCT
ijpds-3543	248	1	nature	nature	NOUN
ijpds-3543	249	1	[	[	X
ijpds-3543	249	2	internet	internet	NOUN
ijpds-3543	249	3	]	]	PUNCT
ijpds-3543	249	4	.	.	PUNCT
ijpds-3543	250	1	1998;391(6665):393–7	1998;391(6665):393–7	NUM
ijpds-3543	250	2	.	.	PUNCT
ijpds-3543	251	1	16	16	NUM
ijpds-3543	251	2	.	.	PUNCT
ijpds-3543	252	1	gadangi	gadangi	PROPN
ijpds-3543	252	2	p	p	X
ijpds-3543	252	3	,	,	PUNCT
ijpds-3543	252	4	longaker	longaker	PROPN
ijpds-3543	252	5	m	m	PROPN
ijpds-3543	252	6	,	,	PUNCT
ijpds-3543	252	7	naime	naime	PROPN
ijpds-3543	252	8	d	d	PROPN
ijpds-3543	252	9	,	,	PUNCT
ijpds-3543	252	10	et	et	PROPN
ijpds-3543	252	11	al	al	PROPN
ijpds-3543	252	12	.	.	PUNCT
ijpds-3543	253	1	the	the	DET
ijpds-3543	253	2	anti	anti	ADJ
ijpds-3543	253	3	-	-	ADJ
ijpds-3543	253	4	inflammatory	inflammatory	ADJ
ijpds-3543	253	5	mechanism	mechanism	NOUN
ijpds-3543	253	6	of	of	ADP
ijpds-3543	253	7	sulfasalazine	sulfasalazine	NOUN
ijpds-3543	253	8	is	be	AUX
ijpds-3543	253	9	related	relate	VERB
ijpds-3543	253	10	to	to	PART
ijpds-3543	253	11	adenosine	adenosine	VERB
ijpds-3543	253	12	release	release	NOUN
ijpds-3543	253	13	at	at	ADP
ijpds-3543	253	14	inflamed	inflame	VERB
ijpds-3543	253	15	sites	site	NOUN
ijpds-3543	253	16	.	.	PUNCT
ijpds-3543	254	1	j	j	PROPN
ijpds-3543	254	2	immunol	immunol	NOUN
ijpds-3543	255	1	[	[	X
ijpds-3543	255	2	internet	internet	NOUN
ijpds-3543	255	3	]	]	PUNCT
ijpds-3543	255	4	.	.	PUNCT
ijpds-3543	255	5	1996	1996	NUM
ijpds-3543	256	1	[	[	X
ijpds-3543	256	2	cited	cite	VERB
ijpds-3543	256	3	2023	2023	NUM
ijpds-3543	256	4	apr	apr	NOUN
ijpds-3543	256	5	10];156(5):1937–41	10];156(5):1937–41	NUM
ijpds-3543	256	6	.	.	PUNCT
ijpds-3543	257	1	17	17	NUM
ijpds-3543	257	2	.	.	PUNCT
ijpds-3543	258	1	gallo	gallo	PROPN
ijpds-3543	258	2	-	-	PUNCT
ijpds-3543	258	3	rodriguez	rodriguez	NOUN
ijpds-3543	258	4	c	c	PROPN
ijpds-3543	258	5	,	,	PUNCT
ijpds-3543	258	6	ji	ji	PROPN
ijpds-3543	258	7	x	x	PROPN
ijpds-3543	258	8	-	-	PUNCT
ijpds-3543	258	9	d	d	PROPN
ijpds-3543	258	10	,	,	PUNCT
ijpds-3543	258	11	melman	melman	PROPN
ijpds-3543	258	12	n	n	CCONJ
ijpds-3543	258	13	,	,	PUNCT
ijpds-3543	258	14	et	et	PROPN
ijpds-3543	258	15	al	al	PROPN
ijpds-3543	258	16	.	.	PUNCT
ijpds-3543	258	17	structure	structure	NOUN
ijpds-3543	258	18	-	-	PUNCT
ijpds-3543	258	19	activity	activity	NOUN
ijpds-3543	258	20	relationships	relationship	NOUN
ijpds-3543	258	21	of	of	ADP
ijpds-3543	258	22	n6	n6	PROPN
ijpds-3543	258	23	-	-	PUNCT
ijpds-3543	258	24	benzyladenosine-5’-uronamides	benzyladenosine-5’-uronamides	PROPN
ijpds-3543	258	25	as	as	ADP
ijpds-3543	258	26	a3selective	a3selective	ADJ
ijpds-3543	258	27	adenosine	adenosine	NOUN
ijpds-3543	258	28	agonists	agonist	NOUN
ijpds-3543	258	29	.	.	PUNCT
ijpds-3543	259	1	j	j	PROPN
ijpds-3543	259	2	med	med	ADJ
ijpds-3543	259	3	chem	chem	NOUN
ijpds-3543	260	1	[	[	X
ijpds-3543	260	2	internet	internet	NOUN
ijpds-3543	260	3	]	]	PUNCT
ijpds-3543	260	4	.	.	PUNCT
ijpds-3543	261	1	1994;37(5):636–46	1994;37(5):636–46	NUM
ijpds-3543	261	2	.	.	PROPN
ijpds-3543	261	3	18	18	NUM
ijpds-3543	261	4	.	.	PUNCT
ijpds-3543	262	1	halliwell	halliwell	PROPN
ijpds-3543	262	2	b.	b.	PROPN
ijpds-3543	262	3	what	what	PRON
ijpds-3543	262	4	nitrates	nitrate	VERB
ijpds-3543	262	5	tyrosine	tyrosine	NOUN
ijpds-3543	262	6	?	?	PUNCT
ijpds-3543	263	1	is	be	AUX
ijpds-3543	263	2	nitrotyrosine	nitrotyrosine	NOUN
ijpds-3543	263	3	specific	specific	ADJ
ijpds-3543	263	4	as	as	ADP
ijpds-3543	263	5	a	a	DET
ijpds-3543	263	6	biomarker	biomarker	NOUN
ijpds-3543	263	7	of	of	ADP
ijpds-3543	263	8	peroxynitrite	peroxynitrite	ADJ
ijpds-3543	263	9	formation	formation	NOUN
ijpds-3543	263	10	in	in	ADP
ijpds-3543	263	11	vivo	vivo	NOUN
ijpds-3543	263	12	?	?	PUNCT
ijpds-3543	264	1	febs	febs	NOUN
ijpds-3543	264	2	lett	lett	PROPN
ijpds-3543	265	1	[	[	X
ijpds-3543	265	2	internet	internet	NOUN
ijpds-3543	265	3	]	]	PUNCT
ijpds-3543	265	4	.	.	PUNCT
ijpds-3543	266	1	1997;411(2–3):157–60	1997;411(2–3):157–60	X
ijpds-3543	266	2	.	.	PUNCT
ijpds-3543	267	1	19	19	NUM
ijpds-3543	267	2	.	.	PUNCT
ijpds-3543	267	3	haskó	haskó	PROPN
ijpds-3543	267	4	g	g	PROPN
ijpds-3543	267	5	,	,	PUNCT
ijpds-3543	267	6	szabó	szabó	ADJ
ijpds-3543	267	7	c	c	NOUN
ijpds-3543	267	8	,	,	PUNCT
ijpds-3543	267	9	németh	németh	PROPN
ijpds-3543	267	10	zh	zh	PROPN
ijpds-3543	267	11	,	,	PUNCT
ijpds-3543	267	12	et	et	PROPN
ijpds-3543	267	13	al	al	PROPN
ijpds-3543	267	14	.	.	PROPN
ijpds-3543	267	15	adenosine	adenosine	ADJ
ijpds-3543	267	16	receptor	receptor	NOUN
ijpds-3543	267	17	agonists	agonist	NOUN
ijpds-3543	267	18	differentially	differentially	ADV
ijpds-3543	267	19	regulate	regulate	VERB
ijpds-3543	267	20	il-10	il-10	PRON
ijpds-3543	267	21	,	,	PUNCT
ijpds-3543	267	22	tnf	tnf	PROPN
ijpds-3543	267	23	-	-	PUNCT
ijpds-3543	267	24	alpha	alpha	NOUN
ijpds-3543	267	25	,	,	PUNCT
ijpds-3543	267	26	and	and	CCONJ
ijpds-3543	267	27	nitric	nitric	ADJ
ijpds-3543	267	28	oxide	oxide	NOUN
ijpds-3543	267	29	production	production	NOUN
ijpds-3543	267	30	in	in	ADP
ijpds-3543	267	31	raw	raw	ADJ
ijpds-3543	267	32	264.7	264.7	NUM
ijpds-3543	267	33	macrophages	macrophage	NOUN
ijpds-3543	267	34	and	and	CCONJ
ijpds-3543	267	35	in	in	ADP
ijpds-3543	267	36	endotoxemic	endotoxemic	ADJ
ijpds-3543	267	37	mice	mouse	NOUN
ijpds-3543	267	38	.	.	PUNCT
ijpds-3543	268	1	j	j	PROPN
ijpds-3543	268	2	immunol	immunol	NOUN
ijpds-3543	269	1	[	[	X
ijpds-3543	269	2	internet	internet	NOUN
ijpds-3543	269	3	]	]	PUNCT
ijpds-3543	269	4	.	.	PUNCT
ijpds-3543	269	5	1996	1996	NUM
ijpds-3543	270	1	[	[	X
ijpds-3543	270	2	cited	cite	VERB
ijpds-3543	270	3	2023	2023	NUM
ijpds-3543	270	4	apr	apr	NOUN
ijpds-3543	270	5	10];157(10):4634–40	10];157(10):4634–40	NUM
ijpds-3543	270	6	.	.	PROPN
ijpds-3543	270	7	20	20	NUM
ijpds-3543	270	8	.	.	PUNCT
ijpds-3543	271	1	haskó	haskó	PROPN
ijpds-3543	271	2	g	g	PROPN
ijpds-3543	271	3	,	,	PUNCT
ijpds-3543	271	4	szabó	szabó	ADJ
ijpds-3543	271	5	c	c	NOUN
ijpds-3543	271	6	,	,	PUNCT
ijpds-3543	271	7	németh	németh	PROPN
ijpds-3543	271	8	zh	zh	PROPN
ijpds-3543	271	9	,	,	PUNCT
ijpds-3543	271	10	et	et	PROPN
ijpds-3543	271	11	al	al	PROPN
ijpds-3543	271	12	.	.	PROPN
ijpds-3543	271	13	suppression	suppression	NOUN
ijpds-3543	271	14	of	of	ADP
ijpds-3543	271	15	il-12	il-12	DET
ijpds-3543	271	16	production	production	NOUN
ijpds-3543	271	17	by	by	ADP
ijpds-3543	271	18	phosphodiesterase	phosphodiesterase	NOUN
ijpds-3543	271	19	inhibition	inhibition	NOUN
ijpds-3543	271	20	in	in	ADP
ijpds-3543	271	21	murine	murine	ADJ
ijpds-3543	271	22	endotoxemia	endotoxemia	NOUN
ijpds-3543	271	23	is	be	AUX
ijpds-3543	271	24	il-10	il-10	NOUN
ijpds-3543	271	25	independent	independent	ADJ
ijpds-3543	271	26	.	.	PUNCT
ijpds-3543	272	1	eur	eur	PROPN
ijpds-3543	272	2	j	j	PROPN
ijpds-3543	272	3	immunol	immunol	NOUN
ijpds-3543	273	1	[	[	X
ijpds-3543	273	2	internet	internet	NOUN
ijpds-3543	273	3	]	]	PUNCT
ijpds-3543	273	4	.	.	PUNCT
ijpds-3543	274	1	1998	1998	NUM
ijpds-3543	275	1	[	[	X
ijpds-3543	275	2	cited	cite	VERB
ijpds-3543	275	3	2023	2023	NUM
ijpds-3543	275	4	apr	apr	NOUN
ijpds-3543	275	5	10];28(2):468–72	10];28(2):468–72	NUM
ijpds-3543	275	6	.	.	PUNCT
ijpds-3543	276	1	how	how	SCONJ
ijpds-3543	276	2	to	to	PART
ijpds-3543	276	3	cite	cite	VERB
ijpds-3543	276	4	this	this	DET
ijpds-3543	276	5	article	article	NOUN
ijpds-3543	276	6	:	:	PUNCT
ijpds-3543	276	7	hari	hari	NOUN
ijpds-3543	276	8	sonwani	sonwani	PROPN
ijpds-3543	276	9	,	,	PUNCT
ijpds-3543	276	10	virendra	virendra	PROPN
ijpds-3543	276	11	kumar	kumar	PROPN
ijpds-3543	276	12	sharma	sharma	PROPN
ijpds-3543	276	13	,	,	PUNCT
ijpds-3543	276	14	steffi	steffi	PROPN
ijpds-3543	276	15	thomas	thomas	PROPN
ijpds-3543	276	16	,	,	PUNCT
ijpds-3543	276	17	akhlesh	akhlesh	PROPN
ijpds-3543	276	18	kumar	kumar	PROPN
ijpds-3543	276	19	.	.	PUNCT
ijpds-3543	277	1	adenosine	adenosine	ADJ
ijpds-3543	277	2	receptor	receptor	NOUN
ijpds-3543	277	3	agonists	agonist	NOUN
ijpds-3543	277	4	suppress	suppress	VERB
ijpds-3543	277	5	macrophage	macrophage	ADJ
ijpds-3543	277	6	inflammatory	inflammatory	ADJ
ijpds-3543	277	7	protein	protein	NOUN
ijpds-3543	277	8	-1α	-1α	NOUN
ijpds-3543	277	9	production	production	NOUN
ijpds-3543	277	10	and	and	CCONJ
ijpds-3543	277	11	collagen	collagen	NOUN
ijpds-3543	277	12	induced	induce	VERB
ijpds-3543	277	13	arthritis	arthritis	NOUN
ijpds-3543	277	14	.	.	PUNCT
ijpds-3543	278	1	indian	indian	PROPN
ijpds-3543	278	2	j	j	PROPN
ijpds-3543	278	3	pharm	pharm	PROPN
ijpds-3543	278	4	drug	drug	PROPN
ijpds-3543	278	5	studies	study	NOUN
ijpds-3543	278	6	.	.	PUNCT
ijpds-3543	279	1	2023	2023	NUM
ijpds-3543	279	2	:	:	PUNCT
ijpds-3543	279	3	2(2	2(2	NUM
ijpds-3543	279	4	)	)	PUNCT
ijpds-3543	279	5	69	69	NUM
ijpds-3543	279	6	-	-	SYM
ijpds-3543	279	7	75	75	NUM
ijpds-3543	279	8	.	.	PUNCT
ijpds-3543	280	1	funding	funding	NOUN
ijpds-3543	280	2	:	:	PUNCT
ijpds-3543	280	3	none	none	NOUN
ijpds-3543	280	4	conflict	conflict	NOUN
ijpds-3543	280	5	of	of	ADP
ijpds-3543	280	6	interest	interest	NOUN
ijpds-3543	280	7	:	:	PUNCT
ijpds-3543	280	8	none	none	NOUN
ijpds-3543	280	9	stated	state	VERB